<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">93002</article-id><article-id pub-id-type="doi">10.7554/eLife.93002</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.93002.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Clinical phenotypes in acute and chronic infarction explained through human ventricular electromechanical modelling and simulations</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhou</surname><given-names>Xin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2814-3399</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Wang</surname><given-names>Zhinuo Jenny</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5325-909X</contrib-id><email>jenny.wang@cs.ox.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Camps</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Tomek</surname><given-names>Jakub</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0157-4386</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Santiago</surname><given-names>Alfonso</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Quintanas</surname><given-names>Adria</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Vazquez</surname><given-names>Mariano</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Vaseghi</surname><given-names>Marmar</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6361-3339</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>Department of Computer Science, University of Oxford</institution></institution-wrap><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>Department of Physiology, Anatomy and Genetics, University of Oxford</institution></institution-wrap><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05sd8tv96</institution-id><institution>Department of Computer Applications in Science and Engineering, Barcelona Supercomputing Centre (BSC)</institution></institution-wrap><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff><aff id="aff4"><label>4</label><institution>ELEM Biotech</institution><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>UCLA Cardiac Arrhythmia Center, University of California, Los Angeles</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>Neurocardiology Research Center of Excellence, University of California, Los Angeles</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chiamvimonvat</surname><given-names>Nipavan</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>University of California, Davis</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Barton</surname><given-names>Matthias</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>University of Zurich</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>23</day><month>12</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP93002</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-11-21"><day>21</day><month>11</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-11-28"><day>28</day><month>11</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.02.15.480392"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-02-23"><day>23</day><month>02</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.93002.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-11-06"><day>06</day><month>11</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.93002.2"/></event></pub-history><permissions><copyright-statement>© 2024, Zhou, Wang et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Zhou, Wang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-93002-v1.pdf"/><abstract><p>Sudden death after myocardial infarction (MI) is associated with electrophysiological heterogeneities and ionic current remodelling. Low ejection fraction (EF) is used in risk stratification, but its mechanistic links with pro-arrhythmic heterogeneities are unknown. We aim to provide mechanistic explanations of clinical phenotypes in acute and chronic MI, from ionic current remodelling to ECG and EF, using human electromechanical modelling and simulation to augment experimental and clinical investigations. A human ventricular electromechanical modelling and simulation framework is constructed and validated with rich experimental and clinical datasets, incorporating varying degrees of ionic current remodelling as reported in literature. In acute MI, T-wave inversion and Brugada phenocopy were explained by conduction abnormality and local action potential prolongation in the border zone. In chronic MI, upright tall T-waves highlight large repolarisation dispersion between the border and remote zones, which promoted ectopic propagation at fast pacing. Post-MI EF at resting heart rate was not sensitive to the extent of repolarisation heterogeneity and the risk of repolarisation abnormalities at fast pacing. T-wave and QT abnormalities are better indicators of repolarisation heterogeneities than EF in post-MI.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cardiac electromechanics</kwd><kwd>modelling and simulation</kwd><kwd>post-myocardial infarction</kwd><kwd>electrocardiogram</kwd><kwd>multiscale</kwd><kwd>disease mechanisms</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/214290</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008021</institution-id><institution>Bristol Myers Squibb</institution></institution-wrap></funding-source><award-id>R39207/CN063</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Xin</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000769</institution-id><institution>University of Oxford</institution></institution-wrap></funding-source><award-id>R39207/CN063</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Xin</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/222781</award-id><principal-award-recipient><name><surname>Tomek</surname><given-names>Jakub</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.3030/764738</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.3030/675451</award-id><principal-award-recipient><name><surname>Vazquez</surname><given-names>Mariano</given-names></name><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.3030/823712</award-id><principal-award-recipient><name><surname>Vazquez</surname><given-names>Mariano</given-names></name><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000849</institution-id><institution>National Centre for the Replacement, Refinement and Reduction of Animals in Research</institution></institution-wrap></funding-source><award-id>NC/P001076/1</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.3030/116030</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000769</institution-id><institution>University of Oxford</institution></institution-wrap></funding-source><award-id>RE/13/1/30181</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Human-based electromechanical simulations reveal electrocardiogram biomarkers are better indicators of pro-arrhythmic substrate after myocardial infarction than ejection fraction.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Sudden cardiac death in post-myocardial infarction (post-MI) patients is due to lethal arrhythmias in 50% of cases at both acute and chronic infarct stages (<xref ref-type="bibr" rid="bib92">Vazquez et al., 2009</xref>; <xref ref-type="bibr" rid="bib22">Elayi et al., 2017</xref>). Risk stratification is currently based on low left ventricular ejection fraction (LVEF) (<xref ref-type="bibr" rid="bib74">Solomon et al., 2005</xref>) to identify patients who need the implantation of defibrillator device. However, only a very small subset of patients that suffer from sudden cardiac death are identified by low LVEF, and a significant number of sudden deaths occur in patients with relatively preserved LVEF (<xref ref-type="bibr" rid="bib87">Vaduganathan et al., 2018</xref>). The mechanistic link between electrophysiological heterogeneities, ECG and LVEF phenotypes that underpin arrhythmic events is not clear. A precision medicine approach using computational modelling and simulations could help to elucidate disease mechanisms and provide an in silico alternative for therapy evaluation and risk stratification. However, a key hurdle in clinical adoption of such in silico tools is providing proof of model credibility through validation studies. In this study, we set out to achieve the dual aim of demonstrating a multi-scale approach for model validation and to identify important electrophysiological mechanisms for post-MI risk stratifications.</p><p>Various electrocardiogram (ECG) characteristics were suggested by clinical studies to be relevant to the arrhythmic risk of post-MI patients. Longer QT intervals have been associated with increased mortality as well as ventricular tachycardia and fibrillation for both the acute and chronic MI (<xref ref-type="bibr" rid="bib1">Ahnve, 1985</xref>; <xref ref-type="bibr" rid="bib60">Oikarinen et al., 1998</xref>). However, QT prolongation in single leads can be a reflection of reduced global repolarisation reserve, while the regional heterogeneity of repolarisation in different post-MI zones can be more crucial (<xref ref-type="bibr" rid="bib17">Cluitmans et al., 2021</xref>) than the global reserve for the development of re-entrant waves. QT dispersion between 12-lead ECGs was proposed as a potential marker for electrophysiological heterogeneity <xref ref-type="bibr" rid="bib75">Spargias et al., 1999</xref>; however, it was found to have good specificity but low sensitivity (<xref ref-type="bibr" rid="bib75">Spargias et al., 1999</xref>). Prolonged T-peak to T-end interval (Tpe; <xref ref-type="bibr" rid="bib73">Shenthar et al., 2015</xref>) and increased incidence of T-wave alternans (<xref ref-type="bibr" rid="bib9">Bloomfield et al., 2004</xref>) were also found to be useful risk predictors in post-MI patients. Other ECG metrics, such as QRST integral and spatial ventricular gradients have also shown some promise in improving SCD prediction (<xref ref-type="bibr" rid="bib93">Waks et al., 2016</xref>). However, despite the promising outcomes of those clinical studies, the ECG-based risk predictors are not widely applied in the clinical evaluation of the need for implantable cardioverter-defibrillators (<xref ref-type="bibr" rid="bib2">Al-Khatib et al., 2018</xref>).</p><p>A key factor that hinders the clinical utility of ECG biomarkers is the large variability in post-MI phenotypes, their progression from acute to chronic, and between different patients. Variability in QT prolongation (<xref ref-type="bibr" rid="bib1">Ahnve, 1985</xref>) and post-MI ECG morphologies constrain the use of single biomarker thresholds as predictors. Furthermore, an important limitation of non-invasive ECG biomarkers is their inability to provide direct measurements of regional electrophysiological heterogeneity caused by scar and ionic current remodelling, which is critical for the arrhythmic substrate.</p><p>Many experimental studies have investigated the underlying mechanisms of increased repolarisation dispersion in post-MI patients. Specifically, repolarisation dispersion increases after MI due to ionic differences between the border zone (BZ) surrounding the scar and the remote zone (RZ) myocardium (<xref ref-type="bibr" rid="bib55">Mendonca Costa et al., 2018</xref>). The BZ at the acute MI exhibits reduced sodium current (I<sub>Na</sub>), L-type calcium current (I<sub>CaL</sub>) (<xref ref-type="bibr" rid="bib67">Rajesh and Boyden Penelope, 1995</xref>), and rapid and slow delayed rectifier potassium currents (I<sub>Kr</sub> and I<sub>Ks</sub>) (<xref ref-type="bibr" rid="bib37">Jiang et al., 2000</xref>), as well as enhanced CaMKII activity (<xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref>) and gap junction redistribution (<xref ref-type="bibr" rid="bib96">Yao et al., 2003</xref>). After a period of scar healing, ionic current remodelling may partially recover (<xref ref-type="bibr" rid="bib85">Ursell et al., 1985</xref>), but increased late sodium current (I<sub>NaL</sub>), calcium-activated potassium and chloride currents (I<sub>KCa</sub> and I<sub>ClCa</sub>) were observed in the chronic BZ and RZ (<xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref>). Post-MI ionic current remodelling can cause conduction abnormalities, repolarisation abnormalities, as well as variable alterations in the action potential duration (APD), which act as substrates of ventricular tachycardia (<xref ref-type="bibr" rid="bib64">Pogwizd et al., 1992</xref>). It is, however, unclear how various degrees of repolarisation dispersion affect ECG biomarkers and LVEF used for risk stratification. Therefore, further studies are needed to bridge the gap between cellular electrophysiological characteristics and variable patient phenotypes post-MI. Furthermore, the wealth of cellular, tissue, and ECG data described in the literature provides an excellent multi-scale dataset for model validation. Comparisons of simulated action potential and ECG biomarkers with experimental and clinical data under acute and chronic MI conditions help to improve the credibility of the computational model.</p><p>Human-based modelling and simulations of ventricular electrophysiology and mechanics have demonstrated accurate prediction of post-MI arrhythmic risk and myocardial stress and strain (<xref ref-type="bibr" rid="bib6">Arevalo et al., 2016</xref>; <xref ref-type="bibr" rid="bib69">Sack et al., 2016</xref>). However, previous work concentrated on either electrophysiology or mechanics, while the crosstalk between the two, and the relationship between LVEF and arrhythmic risk, is yet to be investigated.</p><p>The main goal of this study is, therefore, to quantify the contribution of varying degrees of ionic current remodelling to the phenotypic variability in ECG and LVEF biomarkers observed in acute and chronic post-MI patients, and thereby create and validate models of post-MI electromechanics. Using state-of-the-art electromechanical human biventricular simulations, we aim to identify biomarkers that are most representative to the pro-arrhythmic substrate for each state, thus facilitating post-MI risk stratifications to go beyond LVEF. We hypothesise that different ECG abnormalities are explained by different degrees of ionic current remodelling leading to activation sequence abnormalities, dispersion of repolarisation, early after depolarisations (EADs) and alternans, whereas LVEF is insensitive to ionic current remodelling that underpins ECG disease markers and reflects predominantly calcium transient and structural abnormalities.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Human modelling and simulation for ECG phenotypes in acute and chronic post-MI</title><p><xref ref-type="fig" rid="fig1">Figure 1</xref> demonstrates the ability of human electromechanical simulations to reproduce a variety of clinically reported phenotypes in patients with acute and chronic infarction, in agreement with clinical measurements of ECG and pressure-volume biomarkers, as quantified in further detail in (<xref ref-type="table" rid="app1table7">Appendix 1—table 7</xref>, details of clinical database in Appendix 1.5). When imposing acute post-MI remodelling, simulated ECGs reproduced fractionated QRS complexes, T-wave inversion, Brugada phenocopy ST-segment elevation and QT interval prolongation in the anterior leads (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), which are common ECG phenotypes observed in acute post-MI patients. Simulations also recapitulated ECG morphology similar to healthy subjects with upright T-waves (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, right), which can also be present in acute post-MI.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Agreement between simulated and clinical ECGs demonstrating variability in clinical phenotypes in acute and chronic post-myocardial infarction (post-MI).</title><p>(<bold>A</bold>) In acute MI, simulated ECGs show T-wave inversion (border zone model 1 (BZ1)), Brugada phenocopy (BZ2), and normal phenotypes (BZ3), in accordance with phenotypes found in clinical databases. (<bold>B</bold>) In chronic MI, simulated ECGs show prolonged QT and upright T-waves with a range of amplitude and duration (remote zone model 1 and 2 (RZ1, RZ2)) comparable to those observed in clinical databases. (<bold>C</bold>) ECG simulations of control, and acute and chronic post-MI considering ionic current variability of the baseline ToR-ORd model. T wave morphologies for acute and chronic post-MI are mostly preserved across ionic variability.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-fig1-v1.tif"/></fig><p>In chronic post-MI, simulated ECG displayed upright T-waves, and global prolongations of QT intervals in all precordial leads (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, top row), which are characteristic of chronic patients with worse clinical outcomes (<xref ref-type="bibr" rid="bib1">Ahnve, 1985</xref>; <xref ref-type="bibr" rid="bib60">Oikarinen et al., 1998</xref>). A range of T-wave durations were present, as can be found in chronic post-MI (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, bottom row). Appendix 1.5 summarises the clinical ECGs used for comparisons in <xref ref-type="fig" rid="fig1">Figure 1</xref>. The full 12-lead ECGs for acute and chronic post-MI simulations can be found in <xref ref-type="fig" rid="app1fig7">Appendix 1—figures 7</xref> and <xref ref-type="fig" rid="app1fig8">8</xref>.</p><p>Simulations using the ventricular population of models showed that the described ECG features of acute and chronic post-MI were mostly preserved across variations in ionic current conductances (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Sensitivity analysis showed first that large changes in apex-to-base and transmural heterogeneities only altered T-wave amplitude but not its polarity and did not affect the ST-segment (<xref ref-type="fig" rid="app1fig3">Appendix 1—figures 3</xref> and <xref ref-type="fig" rid="app1fig4">4</xref>), and second that changes in mechanical parameters did not affect the ECG morphology (<xref ref-type="fig" rid="app1fig5">Appendix 1—figures 5</xref> and <xref ref-type="fig" rid="app1fig6">6</xref>). This result supports the specificity of post-MI signatures to underlying ionic current remodelling.</p></sec><sec id="s2-2"><title>In acute MI, T-wave inversion and Brugada phenocopy can indicate reversed transmural repolarisation gradient and activation failure</title><p>Analysis of simulation results enabled the uncovering of specific contributions of different degrees of ionic current remodelling to ECG phenotypes identified in acute versus chronic MI (<xref ref-type="fig" rid="fig2">Figure 2</xref> vs <xref ref-type="fig" rid="fig3">Figure 3</xref>). In acute MI, T-wave inversion phenotype was associated with a reversed transmural repolarisation gradient (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, repolarisation time map insets), due to a delayed activation time and a 57ms APD prolongation at the epicardial BZ compared with control (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, membrane potential). APD prolongation originated due to inhibition of multiple potassium currents caused by BZ1 ionic remodellling (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, the first column of I<sub>Kr</sub>, and <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref> Acute BZ1).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Multiscale explanation of ST and T-wave phenotypes in acute MI.</title><p>(<bold>A</bold>) Activation time maps reveal conduction delay in acute border zone in T-wave inversion and normal ST-T phenotypes, and conduction block in Brugada phenocopy, as well as large repolarisation dispersion and altered transmural repolarisation gradient in T-wave inversion and Brugada phenocopy. Red in activation map show regions of no activation (NA), green in repolarisation map highlights regions of no repolarisation (NR). (<bold>B</bold>) Action potential duration (APD) prolongation is present in T-wave inversion and Brugada phenocopy cellular phenotypes, while slight APD shortening is present in normal ST-T (red arrows). Decreased calcium amplitude occurs in all phenotypes, with a corresponding decrease in active tension generation. (<bold>C</bold>) I<sub>Na</sub>, I<sub>CaL</sub>, and I<sub>Kr</sub> remodelling underpin reduced conduction, reduced calcium amplitude, and alterations in action potential duration, respectively, in all acute phenotypes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-fig2-v1.tif"/></fig><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Multiscale explanation of QT and T-wave phenotypes in chronic MI.</title><p>(<bold>A</bold>) Conduction delay in chronic border zone occurs in slight QT prolongation and large T-wave phenotypes, while large repolarisation dispersion exists only in large T-wave. Red in activation map show regions of no activation (NA), green in repolarisation map show regions of no repolarisation (NR). (<bold>B</bold>) Varying degrees of action potential duration (ADP) prolongation in the remote zone (RZ) corresponding to extent of QT prolongation (blue arrows), with decreased calcium amplitude in remote and border zone of both phenotypes, and corresponding decrease in active tension generation. (<bold>C</bold>) As in acute MI, I<sub>Na</sub>, I<sub>CaL</sub>, and I<sub>Kr</sub> remodelling underpin reduced conduction, reduced calcium amplitude, and degree of prolongation in action potential duration, respectively, in both chronic phenotypes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-fig3-v1.tif"/></fig><p>Brugada phenocopy ECG phenotype was also observed in acute MI with BZ2 remodelling, causing regions of activation failure in the epicardial border zone (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, the activation and repolarisation time maps), as well as delayed repolarisation in the BZ near the apex, caused by a delayed activation time and a 29ms of epicardial APD prolongation compared with control (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, membrane potential). These were caused by strong inhibitions of sodium, calcium, and potassium ionic currents in the BZ (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, the second column of I<sub>Na</sub>, I<sub>CaL</sub>, I<sub>Kr</sub>, and <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref> Acute BZ2). In this simulation, electrical activation in the infarcted region was preserved despite the conduction block in the BZ because of higher expressions of the L-type calcium channel in the mid-myocardium (see <xref ref-type="fig" rid="app1fig11">Appendix 1—figure 11</xref>).</p><p>Acute MI with upright T-waves corresponded to a comparable transmural repolarisation gradient as in control with BZ3 ionic current remodelling (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, the repolarisation time map). In this case, the slight shortening of APD in the epicardial BZ partially compensated for the activation delay in the BZ and therefore resulted in negligible changes in the T-wave of the ECG (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, the third column of I<sub>Kr</sub>, and <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref> Acute BZ3).</p></sec><sec id="s2-3"><title>In chronic post-MI, variable T-wave width can be explained by the extent of repolarisation dispersion between border zone and remote zone</title><p>In chronic MI, global QT prolongation was due to APD prolongation in the remote myocardium (<xref ref-type="fig" rid="fig3">Figure 3</xref>, repolarisation time maps and membrane potentials). Recovery of the upright T-wave in the anterior leads (compared to acute MI) was due to a recovery of the transmural repolarisation gradient (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, repolarisation time maps, and <xref ref-type="fig" rid="app1fig10">Appendix 1—figure 10</xref>), given the milder I<sub>Kr</sub> inhibition in the border zone (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, the first column of I<sub>Kr</sub>, and <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref> Chronic BZ). Furthermore, T-wave duration in this stage was mainly determined by the gradient between remote and border zone repolarisation times (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, repolarisation time maps), where more severe APD prolongation in the RZ led to larger repolarisation gradients and, consequently, larger T-wave duration and amplitude (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Specifically, there was an APD difference of 157ms between remote and border zone cell models for the large T-wave case versus only 12ms for the slight QT-prolongation case, which accounts for the differences in T-wave peak-to-end duration (162ms vs 72ms) and QT intervals (565ms vs 380ms) between these two cases.</p></sec><sec id="s2-4"><title>LVEF failed to indicate the extent of post-MI repolarisation dispersions</title><p>In our simulations, acute MI ionic current remodelling yielded mildly reduced LVEF in the baseline ventricular models (43%–47%) compared with control (53%) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). LVEF reductions were caused by contractile dysfunction (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, active tension) due to lowered calcium amplitude in BZ (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, intracellular calcium transient), which was directly caused by inhibitions of I<sub>CaL</sub> in all acute phenotypes (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, I<sub>CaL</sub>, and <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref>). A complete loss of contractile function in the BZ resulted in a more severe reduction in LVEF in acute post-MI (to 40% for all acute phenotypes in <xref ref-type="fig" rid="app1fig9">Appendix 1—figure 9</xref>). Stroke volumes of the left and right ventricles were well-matched in control conditions (1 mL difference, see <xref ref-type="table" rid="app1table9">Appendix 1—table 9</xref>), and introducing myocardial infarction caused a decrease of stroke volume in the left ventricles in both acute and chronic MI (see <xref ref-type="table" rid="app1table9">Appendix 1—table 9</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Reduced LVEF and heterogeneous systolic deformation caused by ionic current remodelling in both acute and chronic post-myocardial infarction.</title><p>Pressure-volume loops are shown in black (control) or red (post-MI) traces for the baseline model, and in gray (control) or pink (post-MI) traces for the population of models. (<bold>A</bold>) Reduced LVEF in all acute phenotypes due to reduced active tension amplitude in the border zone (BZ1~3). Brugada phenocopy shows the lowest LVEF due to activation block and loss of contractile function in part of the border zone in addition to reduced active tension amplitude in the activated border zone due to ionic current remodelling. Reduced contractile function in infarct and border zone results in infarct thinning and bulging in systole. Systolic cross section of control simulation shown in black (CTL) with post-MI cross-sections superimposed. (<bold>B</bold>) Reduced LVEF in both chronic phenotypes due to reduced active tension amplitude in remote zone (RZ) and border zones, independent of the extent of QT prolongation (RZ1, RZ2). Scar stiffening helped to reduce infarct bulging. Systolic cross-section of control simulation shown in black (CTL) with post-MI cross-sections superimposed.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-fig4-v1.tif"/></fig><p>Activation failure in Brugada phenocopy caused loss of contractility in the affected regions in the BZ (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, activation and repolarisation time maps) and resulted in a more severely reduced LVEF to 43% with a substantial non-contracting region with significant wall thinning (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, systolic wall thinning). Acute MI with no observable ECG abnormalities can still have reduced mechanical function, as measured by an LVEF of 47% (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, the last column). Comparison between this phenotype and the inverted T-wave phenotype shows that the mechanical dysfunction can be dissociated from repolarisation gradient and T wave abnormalities.</p><p>Chronic post-MI simulations showed mild reduction in peak systolic pressure (by 1 kPa) and some reduction in LVEF (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), which were unaffected by differences in repolarisation gradients. This is because there is a consistent reduction in calcium transient amplitude in the remote zone that is independent of the extent of APD prolongation (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, intracellular calcium transient and membrane voltage). Therefore, both the acute and chronic electromechanical simulation results showed that the post-MI repolarisation dispersion were not reflected by LVEF.</p><p>For both acute and chronic post-MI, simulations done using the population of ventricular models showed similar changes to the PV loop as the baseline model across variabilities in ionic current conductances.</p></sec><sec id="s2-5"><title>T-wave alternans and abnormal wave propagation are caused at fast pacing by cellular alternans and EADs, without reduced LVEF at resting heart rate</title><p>Increased incidence of T-wave alternans is commonly observed in post-MI patients, and abnormally propagating waves generated from post-MI electrophysiological heterogeneity can trigger lethal arrhythmic events. T-wave alternans were reproduced in the ventricular chronic MI simulations at fast pacing (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), with RZ2 remodelling, and their mechanisms were revealed through analysis of the high spatio-temporal resolution of simulation data. <xref ref-type="fig" rid="fig5">Figure 5A</xref> shows upright T-wave morphology and preserved LVEF of 49% at resting rate of 75 bpm (CL = 800ms). However, at fast rates (120 bpm, CL = 500ms), significant beat-to-beat ST and T-wave morphology alterations were observed. This was due to large alternans seen in mid-myocardial single cell simulations of the remote zone at CL of 500ms (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, green trace), with EAD-driven alternans. These results support the importance of stress tests, since alternans in APD and T-wave can occur at fast heart rates with no sign of LVEF abnormalities at resting heart rate. This is consistent with reports that T-wave alternans under supine bicycle exercise testing was found to be predictive of arrhythmic event after acute post-MI (<xref ref-type="bibr" rid="bib36">Ikeda et al., 2000</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>T-wave alternans in simulations underpinned by APD and calcium alternans at fast pacing (120 bpm), albeit with preserved left ventricular ejection fraction (LVEF = 49%) at rest (75 bpm) for the chronic MI phenotype (<bold>A</bold>).</title><p>(<bold>B</bold>) Simulated APD and calcium traces in midmyocardial population of models with remote zone 2 (RZ2) remodelling. (<bold>C</bold>) Large action potential and calcium transient alternans were caused by EADs in simulations at 120 bpm with midmyocardial cells affected by RZ2 ionic current remodelling (green traces, representative example at 75 vs 120 bpm). A single cell model (in green) was selected from the population of models (in grey) for embedding into the remote region for ventricular simulations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-fig5-v1.tif"/></fig><p>Simulations with the population of virtual cardiomyocytes models revealed that in addition to the EAD-driven alternans (<xref ref-type="fig" rid="app1fig14">Appendix 1—figure 14</xref>), classical calcium-driven alternans were also observed in the population of cell models (<xref ref-type="fig" rid="app1fig12">Appendix 1—figures 12</xref> and <xref ref-type="fig" rid="app1fig13">13</xref>). The key ionic current remodelling underlying calcium-driven alternans include enhanced CaMKII activity and slower calcium release, as well as suppressed SERCA pump activity in the chronic MI, which are consistent with previous studies (<xref ref-type="bibr" rid="bib45">Livshitz and Rudy, 2007</xref>; <xref ref-type="bibr" rid="bib99">Zhou et al., 2016</xref>; <xref ref-type="bibr" rid="bib83">Tomek et al., 2018</xref>; <xref ref-type="fig" rid="app1fig15">Appendix 1—figure 15</xref>). I<sub>KCa</sub> enhancement in the chronic MI suppressed alternans generation (detailed analysis provided in <xref ref-type="fig" rid="app1fig16">Appendix 1—figures 16</xref> and <xref ref-type="fig" rid="app1fig17">17</xref>). The median of calcium amplitude was larger in the alternans models than in the non-alternating post-MI models (<xref ref-type="fig" rid="app1fig19">Appendix 1—figure 19</xref>), in agreement with the preserved LVEF in the simulations. We did not simulate the effect of this classical calcium-driven alternans on the ECG because the higher pacing rate at which this phenomenon occurs requires the model to include beta-adrenergic inotropic effects to preserve realistic systolic mechanical function.</p><p>Another case of chronic MI simulation showed prolonged QT interval of 669ms and preserved LVEF of 49% at 75 bpm (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). At 120bpm, in this case, ECG reflected chaotic activity (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, fast pacing simulation) and loss of coordinated mechanical function. Abnormal electrotonic waves were caused by large repolarisation dispersions.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Prolonged QT and preserved LVEF at rest can manifest as severely abnormal ECG at fast heart rates in chronic MI with RZ2.</title><p>(<bold>A</bold>), due to electrotonically-triggered EADs across the border zone (<bold>B</bold>). In (<bold>B</bold>), membrane potential changes for the first 1010ms of fast pacing simulation, showing ectopic wave generation driven by electrotonic gradient at 710ms (arrow from red dot to green dot in lateral view), and anticlockwise propagation of ectopic wave starting at 810ms (anticlockwise arrow in basal view, and arrow from green dot to purple dot in lateral view). Ectopic wave propagates towards the right ventricle via the posterior side at 910ms (arrow in basal view) and at 1010ms (arrow in basal view). (<bold>C</bold>) Local action potential at anterior (red), lateral (green), posterior (purple), and right ventricular (yellow) sites. (<bold>D</bold>) A population of models demonstrating chronic remote zone 2 (RZ2) remodelling in promoting EADs. A representative example was selected from the population of models that showed EAD and was embedded in ventricular simulations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-fig6-v1.tif"/></fig><p>When isolated cells that showed EADs were embedded in the RZ of a ventricular simulation at fast pacing, we saw ectopic wave propagation. This was because the EADs in the RZ generated conduction block, which enabled a large repolarisation gradient to form between the BZ and RZ, thereby leading to ectopy (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). By the end of the first heartbeat (500ms), the anterior epicardial BZ was fully repolarised (the red trace), but the RZ showed EADs (green, purple and yellow traces). This means that after the second beat stimulus, at 610ms (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), the long APD of the RZ prevented full activation in the postero-lateral LV (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, green and purple marker) while the BZ APD was shorter than RZ (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, red marker) and so could be fully activated. This led to a significant membrane potential gradient between the BZ (red marker) and RZ (green marker), leading to ectopic wave generation due to injury current caused by electronic effects at 710ms in the boundary between BZ and RZ (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, compare red and green traces) (<xref ref-type="bibr" rid="bib21">Dutta et al., 2016</xref>). This ectopic wave propagated in an anti-clockwise fashion when viewed from the base from 810 to 910ms (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, basal view). In the right ventricle at 610ms, incomplete repolarisation caused a smaller action potential to be elicited by the sinus stimulus (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, yellow trace), thus allowing successful propagation of the ectopic wave from the left to the right ventricle from 910 ms to 1010 ms (<xref ref-type="fig" rid="fig6">Figure 6B</xref>).</p><p>This episode illustrated that EADs present in the epicardial remote zone cell model (<xref ref-type="fig" rid="fig6">Figure 6D</xref>) resulted in large APD dispersion between BZ and RZ, which functioned as the trigger of ectopic wave propagation due to electrotonic gradients. Therefore, the prolonged global QT interval with large T-wave duration and amplitude in leads facing the infarct can be indicative of the risk of large repolarisation dispersion, while the LVEF can be preserved at rest.</p><p>Spontaneous EADs were frequently observed in the chronic MI cellular population of models (<xref ref-type="fig" rid="fig6">Figure 6D</xref> population of models, <xref ref-type="fig" rid="app1fig20">Appendix 1—figure 20</xref>), due to less I<sub>CaL</sub> inhibition in the chronic MI (left, <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref>). The key underlying combination of ionic current remodelling for EAD generation include the inhibition of I<sub>Kr</sub> and the enhancement of I<sub>NaL</sub>, which facilitate reactivation of I<sub>CaL</sub> (<xref ref-type="fig" rid="app1fig21">Appendix 1—figure 21</xref>). Additional contribution of baseline I<sub>CaL</sub>, I<sub>Kr</sub>, and I<sub>NCX</sub> conductances are consistently observed in all chronic EAD populations (<xref ref-type="table" rid="app1table11">Appendix 1—table 11</xref>). Similarly, the cellular models that showed EADs also had larger calcium amplitude (<xref ref-type="fig" rid="app1fig22">Appendix 1—figure 22</xref>), suggesting a preserved LVEF.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, human electromechanical modelling and simulation enables quantification of the contribution of electrophysiological abnormalities to clinical phenotypes in post-MI patients, from ionic to whole-organ dynamics (summarised in <xref ref-type="table" rid="table1">Table 1</xref>). The credibility of the human electromechanical models and simulation results is supported by their consistency with experimental and clinical data from ionic dynamics to ECG and LVEF biomarkers in healthy, acute and chronic post-MI conditions. Diverse clinical ECG phenotypes are reproduced in the simulations with different degrees of experimentally reported ionic current remodelling for acute and chronic MI; their signature on the LVEF is however weak, with only a small reduction observed. The simulated clinical ECG and LVEF phenotypes were found to be consistent across physiological variabilities in ionic current conductances in the baseline electrophysiological model. Key findings include:</p><list list-type="order"><list-item><p>In acute MI, T-wave inversion, Brugada phenocopy, and QT prolongation were explained by reversed transmural dispersion of repolarisation in the border zone and infarct, conduction abnormality in the border zone, and increased repolarisation time in the border zone, respectively. (2) In chronic MI, large T-wave duration and amplitude reflects large repolarisation dispersion between remote and border zones, and global QT prolongation was caused by AP prolongation in the remote zone.</p></list-item><list-item><p>Reduction in LVEF is ubiquitous across acute and chronic post-MI phenotypes and can be explained by decreased intracellular calcium amplitude and activation failure (in the case of Brugada phenocopy). This effect was independent of changes in the dispersion of repolarisation.</p></list-item><list-item><p>Interestingly, fast pacing simulations with T-wave alternans or abnormal propagation driven by cellular alternans or EADs both showed preserved LVEF at resting heart rate, highlighting the fact that preserved LVEF at rest does not guarantee low arrhythmic risk.</p></list-item></list><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Linking clinical ECG and left ventricular ejection fraction (LVEF) phenotypes to tissue heterogeneities and subcellular ionic current remodelling in acute and chronic post-myocardial infarction.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Clinical Phenotypes</th><th align="left" valign="bottom">Tissue or Cell Level phenomena</th><th align="left" valign="bottom">Corresponding Post Infarction Ionic Current Remodelling</th></tr></thead><tbody><tr><td align="left" valign="bottom">Acute MI T-wave inversion in ECG</td><td align="left" valign="bottom">Reversed transmural repolarisation gradient due to delayed activation and repolarisation in the epicardial border zone</td><td align="left" valign="bottom">Inhibition of potassium currents in the border zone as well as the slower transmural conduction velocity</td></tr><tr><td align="left" valign="bottom">Acute MI Brugada phenocopy in ECG</td><td align="left" valign="bottom">Delayed repolarisation, as well as a small region of activation failure in the epicardial border zone</td><td align="left" valign="bottom">Strong inhibitions of sodium, calcium and potassium ionic currents in the border zone</td></tr><tr><td align="left" valign="bottom">Chronic MI upright tall T-waves in ECG</td><td align="left" valign="bottom">Large repolarisation time gradient between remote and border zones caused by more severe delay of repolarisation in the remote zone</td><td align="left" valign="bottom">More severe potassium channel suppression in the remote zone</td></tr><tr><td align="left" valign="bottom">Chronic MI T-wave alternans</td><td align="left" valign="bottom">Cellular repolarisation alternans or early afterdepolarisation</td><td align="left" valign="bottom">Suppressed SERCA and augmented CaMKII activity for alternans; Enhanced late sodium current and suppressed hERG current for early afterdepolarisation</td></tr><tr><td align="left" valign="bottom">Acute MI reduction in LVEF</td><td align="left" valign="bottom">Reduced calcium amplitude and/or regional conduction block</td><td align="left" valign="bottom">Inhibitions of calcium and sodium currents</td></tr><tr><td align="left" valign="bottom">Chronic MI reduction in LVEF</td><td align="left" valign="bottom">Reduced calcium amplitude</td><td align="left" valign="bottom">Decreased SERCA activity</td></tr></tbody></table></table-wrap><p>Collectively, our results show the proarrhythmic post-MI electrophysiological dispersions caused by cellular remodelling of ionic currents are reflected in QT and T wave morphology biomarkers rather than in LVEF, which questions the use of LVEF as the dominant biomarker in clinical risk stratifications.</p><sec id="s3-1"><title>Acute MI T-wave inversion and Brugada phenocopy are caused by reversed transmural repolarisation gradient and regional conduction abnormality</title><p>Three distinct types of T-wave morphology were generated by our acute MI biventricular simulations: T-wave inversion, Brugada-phenocopy and normal upright T-wave. We obtained them by applying three types of acute BZs in ventricular simulations, considering both APD prolongation and shortening, as a reflection of the variable experimental results (<xref ref-type="bibr" rid="bib55">Mendonca Costa et al., 2018</xref>). Collectively, our results highlighted the importance of investigating the implications of the various degrees of experimentally-reported ionic current remodelling to explain phenotypic variability of patients with MI. T-wave inversion is a commonly observed feature in the acute MI patients, and is commonly associated with arrhythmic risk (<xref ref-type="bibr" rid="bib81">Tikkanen et al., 2015</xref>). Here, we showed the reversed transmural repolarisation gradient caused by delayed activation and APD prolongation in the epicardial BZ accounted for this phenotype. The link between transmural repolarisation gradient and T-wave polarity has been reported previously (<xref ref-type="bibr" rid="bib61">Okada et al., 2011</xref>) and is consistent with our results. Brugada-phenocopy was also observed in some acute MI patients (<xref ref-type="bibr" rid="bib5">Anselm et al., 2014</xref>), and our simulation results showed it could be a reflection of regional conduction abnormality combined with APD prolongation. Although some animal experiments showed acute MI BZ APD shortening (<xref ref-type="bibr" rid="bib55">Mendonca Costa et al., 2018</xref>), we showed the prolongation of BZ APD was underlying the QT prolongation, T-wave inversion and Brugada phenocopy in the leads facing the infarct (<xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7</xref> showing lead dispersions), which is consistent with the QTc prolongation observed in the anterior leads of acute anterior infarction patients (<xref ref-type="bibr" rid="bib29">Guaricci et al., 2018</xref>). Apart from the above, normal T-waves and QT intervals were also commonly observed in patients post percutaneous coronary intervention, which can be reproduced when the post-MI repolarisation dispersion was small between BZ and NZ (BZ3). It is worth noting that, in addition to having a mild border zone remodelling as shown in BZ3, a silent ECG signature can also be due to a reduced transmural extent of the infarct, as has been shown in previous computational studies (<xref ref-type="bibr" rid="bib46">Loewe et al., 2018</xref>; <xref ref-type="bibr" rid="bib94">Wang et al., 2021</xref>). Therefore, T-wave inversion, Brugada phenocopy and QT prolongation occur in the leads facing the infarct can be useful biomarkers indicating bigger repolarisation dispersions and/or larger transmural extent in the acute MI.</p></sec><sec id="s3-2"><title>Wide and tall T-wave is explained by large repolarisation dispersions between BZ and RZ in healed post-MI hearts</title><p>Our simulated chronic ECGs recapitulated the recovery of T-wave polarity observed in patients after a period of healing. This was achieved through the recovery of the transmural repolarisation gradient caused by the milder I<sub>Kr</sub> inhibition in the chronic BZ (<xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref>). Experimental studies in different species showed inconsistent results regarding the chronic BZ APD (<xref ref-type="bibr" rid="bib55">Mendonca Costa et al., 2018</xref>). Our chronic BZ remodelling produced slightly longer APD than the NZ, which is consistent with observations in healed human BZ (<xref ref-type="bibr" rid="bib19">Dangman et al., 1982</xref>). However, in minipigs, these remodelling caused shorter BZ APD than in NZ (<xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref>). This interesting discrepancy between minipigs and human may be due to the different balance of ionic currents across species, which showed the benefits of human electrophysiology models in overcoming the inter-species differences.</p><p>The two types of T-wave morphologies in the simulated chronic ECGs corresponded to different extents of RZ APD prolongations, which were commonly observed in healed RZ of post-MI animals (<xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref>), and in failing human myocytes (<xref ref-type="bibr" rid="bib42">Li et al., 2004</xref>). The substantial RZ APD prolongation was reflected as global QT prolongation in all leads, and the large APD dispersion between chronic BZ and RZ generated wide and tall T-waves in the precordial leads facing the infarct (<xref ref-type="fig" rid="app1fig8">Appendix 1—figure 8</xref> for global and dispersed ECG characteristics). Previous simulation studies also found the T-wave amplitude and area were proportional to the dispersion of repolarisation (<xref ref-type="bibr" rid="bib7">Arteyeva and Azarov, 2017</xref>). Therefore, these results demonstrated that in patients with global QT prolongation, leads with bigger T-wave amplitudes could reflect increased local heterogeneity in repolarisation.</p></sec><sec id="s3-3"><title>T wave alternans and severely abnormal ECGs at fast pacing are caused by alternans and EADs in chronic infarction</title><p>Post-MI ionic current remodelling promoted alternans generation, which resulted in T-wave alternans in simulated ECGs, consistent with the higher incidence of T-wave alternans reported in post-MI patients (<xref ref-type="bibr" rid="bib54">Martin et al., 2009</xref>). Two types of repolarisation abnormalities were observed in our post-MI models: EADs and alternans. One crucial mechanism promoting alternans behaviour at the cellular level is the increased activity of CaMKII, observed in the acute MI BZ (<xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref>), as well as in the hypertrophied and failing myocardium (<xref ref-type="bibr" rid="bib4">Anderson et al., 2011</xref>). Enhanced CaMKII phosphorylation may preserve the contractility of the heart through the phosphorylation of phospholamban and the L-type calcium channels, but increased RyR phosphorylation by CaMKII resulted in prolonged RyR opening as well as the enhancement of spontaneous calcium sparks, which can contribute to alternans and triggered arrhythmias (<xref ref-type="bibr" rid="bib51">Maier and Bers, 2007</xref>).</p><p>Generation of EADs due to chronic post-MI ionic current remodelling, such as I<sub>Kr</sub> inhibition and I<sub>NaL</sub> enhancement, was consistent with previous studies (<xref ref-type="bibr" rid="bib18">Coppini et al., 2013</xref>). We also found that both repolarisation reserve remodelling (I<sub>NaL</sub> and I<sub>Kr</sub>) and calcium system remodelling (J<sub>up</sub> and CaMKII) are important for the EAD-driven alternans (details provided in <xref ref-type="fig" rid="app1fig23">Appendix 1—figures 23</xref> and <xref ref-type="fig" rid="app1fig24">24</xref>). EADs in the RZ can create large repolarisation dispersion in the ventricle, facilitating abnormal electrotonic wave propagations. Similar re-entrant waves caused by electrotonic gradients were also observed in previous studies of acute ischaemia (<xref ref-type="bibr" rid="bib68">Ridley et al., 1992</xref>; <xref ref-type="bibr" rid="bib21">Dutta et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Boukens et al., 2021</xref>).</p></sec><sec id="s3-4"><title>LVEF should be combined with QT and T-wave characteristics for arrhythmic risk stratification</title><p>In this study, we observe non-structurally induced reductions of LVEF in the both the acute and the chronic post-MI stages. At both stages, ventricles with different extents of repolarisation dispersion may have similar LVEF because they have similar degrees of calcium reduction (acute MI T-wave inversion vs normal ST-T, and chronic MI two cases). Models with inducibility of T-wave alternans and arrhythmia at fast pacing rates may present with a preserved LVEF at resting heart rates (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>). Our cellular level results also showed models with inducibility of repolarisation abnormalities, such as alternans and EADs, tended to have more preserved CaT magnitudes at rest rates. Therefore, these phenomena all support the fact that preserved LVEF measured at rest does not guarantee low arrhythmic risk.</p><p>A recent clinical study of post-MI patients with preserved LVEF showed defibrillators are needed in those patients with electrophysiological risk factors, such as prolonged QTc, increased T-wave alternans, to prevent sudden cardiac death (<xref ref-type="bibr" rid="bib26">Gatzoulis et al., 2019</xref>). Consistently, we also found post-MI alternans and EADs can present as alternans of T-wave morphology and prolonged QT intervals. In addition to the global ECG changes, our simulation results also showed increased local repolarisation dispersion can be reflected in the leads facing the infarct: inverted T-wave and prolonged QT in the acute MI, and wide and tall T-wave in the chronic MI. Therefore, we suggest the consideration of these signs as markers of high arrhythmic risk.</p></sec><sec id="s3-5"><title>Limitations</title><p>The main goal of this study is to investigate phenotypic variability in ECG and LVEF biomarkers arising from post-MI ionic current remodelling. We have shown that the relationship between phenotypic variabilities and ionic current remodelling remains consistent across physiological ranges of variation of the ionic current conductances in the baseline cell model. Other sources of variability were not considered in this study including: heart anatomy, location and timing of the early activates sites, calcium sensitivity, conduction velocity. These could all modulate quantitatively the findings but we do not anticipate strong implications in the findings. The effect of variability in location and size of the scar on the ECG has been explored elsewhere (<xref ref-type="bibr" rid="bib43">Li et al., 2024</xref>). LVEF reduction in clinical cases are more significant than in our simulations due to factors other than ionic current remodelling: RZ structural remodelling and elevated myocardium stiffness, and abnormalities in anatomy. However, these effects have been well-documented elsewhere and this study serves to elucidate the non-structural mechanisms that underpin LVEF reduction that is linked to electrophysiological remodelling and arrhythmic risk. The basal plane in our simulation was fixed in space, which was necessary due to the segmented geometry from clinical MRI and to prevent unphysiological motion at the truncated basal plane. Despite this limitation, our conclusions regarding the relative comparisons of mechanical dysfunction are likely to still hold.</p><p>In addition, post-MI ionic current remodelling can be modulated by other acute and chronic factors such as autonomic modulation (beta-adrenergic effects), inflammation, cell death, and metabolic remodelling, which can be explored in future work. The limitations in this study call for a need for personalised digital twins to be generated in the future to facilitate a better understanding of the interaction between structural remodelling and electrophysiological alterations.</p></sec><sec id="s3-6"><title>Conclusions</title><p>Human-based electromechanical simulations reveal ionic mechanisms underlying T-wave inversion, Brugada phenocopy, and upright T-wave in acute post-MI, as well as the upright T-wave, QT prolongation and T-wave alternans in the healed chronic MI. In acute MI, while the potassium current reduction in the border zone was implicated for all ECG abnormalities, the more severe ECG abnormalities in the Brugada phenocopy implicates additional remodelling for the sodium and calcium currents, which were also key factors in reduced mechanical function. In chronic MI, the degree of QT prolongation and the generation of pro-arrhythmic injury currents were directly related to the severity of potassium current remodelling in the remote region. In addition, late sodium current remodelling could be an important factor underpinning T-wave alternans in chronic MI through the promotion of EAD-driven alternans. Our results show that T-wave inversion, wide and tall T-wave, and QT prolongation in the leads facing the infarct are indicative of local dispersion of repolarisation, which is independent from the reduction of LVEF. Our simulation results suggest the utilisation of T-wave morphology, T-wave alternans and QT prolongation to improve risk stratification biomarkers even when the resting LVEF is preserved.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Human multi-scale ventricular electromechanical modelling and simulation: from ionic current remodelling to ECG and LVEF</title><p>A human ventricular electromechanical modelling and simulation framework is constructed using a population of models approach and evaluated using experimental and clinical data to enable the investigations of variable post-MI patient phenotypes, from ionic current remodelling to body surface ECGs and pressure-volume (PV) loops (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). A cardiac magnetic resonance (CMR)-based biventricular anatomical mesh (<xref ref-type="fig" rid="fig7">Figure 7B</xref>) with corresponding torso geometry was used for all simulations in this study, with an anterior scar that is 75% transmural (<xref ref-type="bibr" rid="bib94">Wang et al., 2021</xref>). Electrical propagation was simulated using the monodomain equation with orthotropic diffusion based on rule-based fields for fibre directions (<xref ref-type="bibr" rid="bib79">Streeter et al., 1970</xref>) with sheet directions normal to the endocardial/epicardial surface (<xref ref-type="bibr" rid="bib41">Levrero-Florencio et al., 2020</xref>; <xref ref-type="fig" rid="fig7">Figure 7B</xref>). Transmural and apex-to-base heterogeneities (<xref ref-type="bibr" rid="bib56">Mincholé et al., 2019</xref>) were introduced and a sensitivity analysis was performed to investigate their implications in ECG biomarkers and LVEF (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Electrical stimulus via Purkinje-myocardial junctions was simulated by an endocardial fast-activation layer with root node locations to achieve realistic QRS complex morphologies simulated at clinically standard lead locations (<xref ref-type="fig" rid="fig7">Figure 7C</xref>; <xref ref-type="bibr" rid="bib56">Mincholé et al., 2019</xref>). In healthy tissue (normal zone [NZ]), monodomain diffusivities were calibrated to achieve experimentally measured orthotropic conduction velocities of 67 cm/s, 30 cm/s, and 17 cm/s (<xref ref-type="bibr" rid="bib14">Caldwell et al., 2009</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Human-based multi-scale modelling and simulation in acute and chronic myocardial infarction.</title><p>(<bold>A</bold>) Simulations using a population of ventricular models (n=17) to produce ECGs (light blue traces) and pressure-volume (PV) loops (grey traces) superimposed with the baseline ventricular model (ECG in blue and PV in black). Biomarkers are calculated from the baseline simulation of ECG and PV, as illustrated. (<bold>B</bold>) Ventricular electrophysiology is simulated using a fast endocardial activation layer to approximate Purkinje-myocardial junction, experimentally-informed transmural and apico-basal heterogeneities in action potential duration, and transmurally varying myocyte orientation. Mechanical pumping behaviour is modelled by coupling the intraventricular pressures with a two-element Windkessel model of arterial haemodynamics with a fixed basal plane. (<bold>C</bold>) An anterior 75% transmural infarction is modelled with acute and chronic ionic current remodelling embedded in the border zone and remote zones. Standard 12-lead ECG was evaluated at standard body-surface locations. (<bold>D</bold>) Simulated action potentials using populations of human ventricular models in healthy (baseline) and acute and chronic post-MI conditions with different degrees of ionic current remodelling. (<bold>E</bold>) Schematic representation of ionic fluxes, calcium dynamics and actin/myosin contraction mechanisms in the human ventricular electromechanically-coupled cellular model.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-fig7-v1.tif"/></fig><p>Since anterior infarction is very common and related to the worst prognosis (<xref ref-type="bibr" rid="bib78">Stone et al., 1988</xref>), 75% transmural extent of infarct from the endocardial surface was introduced to the anterior myocardial wall (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) to match the clinical definition of transmural infarctions (<xref ref-type="bibr" rid="bib71">Sato et al., 2008</xref>), with scar and border zones (maximum width 0.5 cm) taking up 12.4% and 11.7% of ventricular volume (or 15.8% and 15.0% of left ventricular volume), respectively. Maximum border zone width was based on various reports of systolic strain dysfunction in &lt;1 cm proximity to the infarct (<xref ref-type="bibr" rid="bib24">Gallagher et al., 1986</xref>; <xref ref-type="bibr" rid="bib89">Van Leuven et al., 1994</xref>). Electrophysiological remodelling was implemented in the border zone (BZ) and the chronic remote zone (RZ), which covered the entire non-infarcted and non-BZ region in both ventricles. In BZ and infarct zones, the diffusivities were calibrated to reproduce conduction slowing (one-third of the NZ conduction velocities). For each virtual cardiomyocyte, the electromechanical single-cell model considered the human-based ToR-ORd electrophysiological model (<xref ref-type="bibr" rid="bib84">Tomek et al., 2019</xref>; extensively validated in control, disease and drug block conditions) coupled with human excitation-contraction and active tension Land model (<xref ref-type="bibr" rid="bib40">Land et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Levrero-Florencio et al., 2020</xref>; <xref ref-type="fig" rid="fig7">Figure 7E</xref>).</p><p>The human biventricular model incorporated strongly-coupled electromechanics with orthotropic passive mechanical behaviour and balance of linear momentum with inertial effects, as in our previous work (<xref ref-type="bibr" rid="bib41">Levrero-Florencio et al., 2020</xref>; <xref ref-type="bibr" rid="bib53">Margara et al., 2021</xref>; <xref ref-type="bibr" rid="bib94">Wang et al., 2021</xref>). In brief, firstly, intracellular calcium concentration drives crossbridge cycling and force production through unblocking the crossbridge binding-site. Secondly, calcium sensitivity and force production are a function of fibre stretch ratio. Thirdly, stretch rate affects distortion-dependent cross-bridge unbinding (<xref ref-type="bibr" rid="bib40">Land et al., 2017</xref>) and the diffusivity tensor is transformed using the deformation gradient tensor such that the prescribed values describe conductivities in the deformed state (<xref ref-type="bibr" rid="bib41">Levrero-Florencio et al., 2020</xref>).</p><p>An elastic spring boundary condition was set to act perpendicularly to the epicardial surface, to simulate pericardial constraint, and the basal plane was fixed in space to prevent unphysiological tilting and expansion due to the unavailability of closed basal geometry. Pressure boundary condition on the left and right endocardial surfaces were controlled using a series of five equations (see Appendix 1.2) that controls (1) active diastolic inflation followed by electrical activation and (2) isovolumic contraction, (3) ejection coupled with two-element Windkessel aortic haemodynamics model, (4) isovolumic relaxation, and (5) passive inflation and relaxation (<xref ref-type="bibr" rid="bib94">Wang et al., 2021</xref>).</p><p>The sheet active tension was set to 30% of fibre active tension to achieve sufficient LVEF in control conditions, based on the results from a sensitivity analysis in Appendix 1.6. In brief, we evaluated the sensitivity of ECG morphology and LVEF to changes in the calcium sensitivity of troponin binding in excitation-contraction coupling and the active tension in the sheet direction as a percentage of that in the fibre direction.</p><p>The passive stiffness parameters were calibrated based on a previous sensitivity analysis (<xref ref-type="bibr" rid="bib94">Wang et al., 2021</xref>) to achieve 53% LVEF and a physiological pressure-volume (PV) loop in a control simulation (see <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref> and <xref ref-type="table" rid="app1table3">Appendix 1—table 3</xref> for a list of calibrated parameters).</p><p>The active tension was set to zero in the scar to represent the myocyte damage, and the chronic passive stiffness parameters of the infarct region were increased 10-fold to mimic fibrotic scar formation (<xref ref-type="bibr" rid="bib80">Sun et al., 2009</xref>). For each acute post-MI phenotype, a case of complete loss of contractile function (zero active tension) in the BZ was also simulated to evaluate the contribution of other non-ionic current remodelling-related abnormalities on ejection fraction.</p></sec><sec id="s4-2"><title>Experimentally-informed single cell and ventricular populations of human post-MI electromechanical models</title><p>To account for the inter-subject electrophysiological variability widely observed in clinical data, the baseline human cellular electromechanical ToR-Land model was extended to populations of healthy cellular models. Then, post-MI ionic current remodelling was applied to generate populations of post-MI virtual cardiomyocytes (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). In addition to the baseline ToR-ORd model, several representative cellular models were selected from the population and implemented into the biventricular electromechanical simulations.</p><p>An initial population of human ventricular cell models was constructed based on the ToR-ORd model by varying the conductances or magnitudes of I<sub>Na</sub>, I<sub>NaL</sub>, I<sub>to</sub>, I<sub>CaL</sub>, I<sub>Kr</sub>, I<sub>Ks</sub>, I<sub>K1</sub>, I<sub>NaCa</sub>, I<sub>NaK</sub>, J<sub>rel</sub> and J<sub>up</sub> by up to ±50% using Latin Hypercube Sampling (<xref ref-type="fig" rid="app1fig1">Appendix 1—figures 1</xref> and <xref ref-type="fig" rid="app1fig2">2</xref>). As illustrated in previous studies, small populations of models with proarrhythmic ionic current remodelling achieved similar predictability as large populations with uniform current variations (<xref ref-type="bibr" rid="bib100">Zhou et al., 2019</xref>). Therefore, we chose to start with a small healthy population (n=500) and then introduce multiple combinations of ionic current remodelling to mimic the large post-MI variability. After calibration with human experimental data (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>) and discarding those manifesting EADs at 1 Hz, 245 sets of endocardial, midmyocardial and epicardial models were accepted as the healthy population (<xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref>). From this population, a total of 17 sets of cell models were randomly selected and uniformly embedded in 17 ventricular models, to generate ventricular population of models that produce a variety of ECGs (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, light blue traces) and PV loops (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, grey traces).</p><p>Several degrees of post-MI ionic current remodelling were collated from a combination of human and animal experimental data with variability in severity of disease to explore whether such variabilities can explain variability in established clinical ECG phenotypes. These remodellings have been applied to the healthy celllular model population (n=245) to generate BZ and RZ populations for both acute and chronic post-MI. For acute post-MI (within a week post-occlusion), three types of BZ remodelling (Acute BZ1-3) were considered based on previous modelling work and experimental canine data collected within 5 days post-MI. The three models of acute border zone remodelling had in common strong inhibition of I<sub>Na</sub> (60~62%). The BZ2 model had more severe inhibition of I<sub>CaL</sub> and I<sub>Kr</sub> than the BZ1 model, alongside other minor differences. The BZ3 model, while having less severe potassium currents inhibition than BZ1, had additional remodellings in CaMKII dynamics, RyR time constants, and I<sub>Cab</sub>. For chronic post-MI, ionic current remodelling measured from minipigs 5 mo post-MI with heart failure were used to generate Chronic BZ (affecting only the BZ) and Chronic RZ1 (also affecting the remote myocardium). Another type of remodelling, Chronic RZ2, was established based on multiple experimental data from failing human cardiomyocytes. The RZ covers the entire myocardium apart from the infarct and BZ in chronic MI simulations. Furthermore, reduction of sodium current and SERCA, with enhanced CaMKII activity and slower calcium release induced by CaMKII activation were also implemented in Chronic BZ, RZ1 and RZ2, as observed in human failing cardiomyocytes (details in <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref>). Compared with RZ1, the RZ2 model had a significantly stronger inhibition of potassium currents and a lower repolarisation reserve, alongside other more minor differences. Both human recordings and animal data were used for model evaluation, given the scarcity of human tissue, summarised in <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref>; <xref ref-type="table" rid="app1table5">Appendix 1—table 5</xref>. Action potential, calcium transient, and active tension characteristics of the post-MI models are summarised in <xref ref-type="table" rid="app1table6">Appendix 1—table 6</xref>. These post-MI ionic current remodellings were then applied to the ventricular population of models (n=17) to explain ECG and PV phenotypes while considering physiological population variability in baseline ionic conductances. These remodelled cell models are embedded uniformly within each region according to a prescribed transmural heterogeneity of 30% endo, 40% mid-myocardial, and 30% epicardial cell types.</p></sec><sec id="s4-3"><title>Simulation protocols and biomarker calculation</title><p>Human virtual ventricular myocytes were paced at 1 Hz for 500 beats to detect EAD generation. For alternans generation, single cells were paced at cycle lengths (CLs) of 500ms, 400ms, and 300ms for 500 beats, and a ΔAPD greater than 3ms between the last two beats at steady state was defined as alternans.</p><p>Biventricular electromechanical simulations were performed at 800 ms CL (75 beats per minute) with 100ms allowed for active diastolic filling prior to endocardial activation for each beat. Three beats were sufficient to achieve converged ECG and PV characteristics at 800 ms CL (see <xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7</xref> for ECGs for all beats).</p><p>For chronic post-MI, an additional fast pacing protocol was applied with 500 ms CL (120 beats per minute), with 50ms allowed for active diastolic filling for each beat. From these fast pacing chronic MI simulations, two sets of cell models showing EAD and alternans behaviours, respectively, were selected from the population of models and embedded according to transmural heterogeneity in the remote zone for ventricular simulations, to test whether the arrhythmic behaviours at the cellular level can result in arrhythmic behaviour at ventricular level and manifest in the ECG. For this fast pacing protocol, six beats were necessary to achieve converged ECG and PV characteristics at 500 ms CL (see <xref ref-type="fig" rid="app1fig8">Appendix 1—figure 8</xref> for simulated ECGs of all beats).</p><p>Clinical biomarkers were quantified from the simulated ECG (including the QT interval, QRS duration, T-wave duration, T peak to T end duration, T onset to T peak duration, and QT dispersion, see definition and method of evaluation in Appendix 1.3 and biomarker results in <xref ref-type="table" rid="app1table8">Appendix 1—table 8</xref>), and from the simulated PV loop (including end diastolic and end systolic volumes, peak systolic pressures and LV and RV ejection fractions), as well as wall thickening strain (see <xref ref-type="table" rid="app1table8">Appendix 1—table 8</xref>; <xref ref-type="table" rid="app1table9">Appendix 1—table 9</xref> for ECG and PV biomarkers for all simulated beats).</p></sec><sec id="s4-4"><title>Simulation software and computational framework</title><p>Cellular electrophysiological simulations and Latin Hypercube Sampling were performed using bespoke MATLAB codes. Coupled cellular electromechanics, as well as biventricular electromechanics simulations, were performed using the high-performance numerical software, Alya, for complex coupled multi-physics and multi-scale problems (<xref ref-type="bibr" rid="bib70">Santiago et al., 2018</xref>) on the CSCS (Swiss National Supercomputing Centre) Piz Daint supercomputer multi-core clusters, granted through the PRACE (Partnership for Advanced Computing in Europe) project. The simulation input files and Alya executable required to replicate the simulated results are available upon request for scientific investigations.</p></sec><sec id="s4-5"><title>Preprint</title><p>This manuscript was first published as a preprint: Xin Zhou, Zhinuo Jenny Wang, Julia Camps, Jakub Tomek, Alfonso Santiago, Adria Quintanas, Mariano Vazquez, Marmar Vaseghi, Blanca Rodriguez (2022). [Clinical phenotypes in acute and chronic infarction explained through human ventricular electromechanical modelling and simulations]. bioRxiv. <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.02.15.480392v3">https://www.biorxiv.org/content/10.1101/2022.02.15.480392v3</ext-link>.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Software, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Software, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Software, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation, Validation, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-93002-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The current manuscript is a computational study. Source code for cellular simulations and post-processing scripts for the ventricular simulations are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/jennyhelyanwe/post_MI_postprocessing/">GitHub</ext-link> (copy archived at <xref ref-type="bibr" rid="bib95">Wang and Wang, 2024</xref>). The input files and binary for Alya simulations are hosted on <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.13993395">Zenodo</ext-link>. To replicate the study access to an installation of the code in the Nord supercomputer can be requested to mariano@elem.bio.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ZJ</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Clinical phenotypes in acute and chronic infarction explained through human ventricular electromechanical modelling and simulations</data-title><source>Zenodo</source><pub-id pub-id-type="doi">10.5281/zenodo.13993394</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors would like to acknowledge Dr Erica Dall’Armellina, Dr Arka Das, Dr Chris Kelly, and Dr Lei Wang, for discussions on the study. This work was funded in whole, or in part, by the Wellcome Trust (214290/Z/18/Z). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. This work was supported by a Wellcome Trust Fellowship in Basic Biomedical Sciences to BR (214290/Z/18/Z), an Oxford-Bristol Myers Squibb Fellowship to XZ (R39207/CN063), the Sir Henry Wellcome Fellowship to JT (222781/Z/21/Z), the Personalised In-Silico Cardiology (PIC) project, the CompBioMed 1 and 2 Centre of Excellence in Computational Biomedicine (European Commission Horizon 2020 research and innovation programme, grant agreements No. 675451 and No. 823712), an NC3Rs Infrastructure for Impact Award (NC/P001076/1), the TransQST project (Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116030, receiving support from the European Union’s Horizon 2020 research and innovation programme and EFPIA), and the Oxford BHF Centre of Research Excellence (RE/13/1/30181). Furthermore, we acknowledge PRACE for awarding access to the Piz Daint resources at the Swiss National Supercomputing Centre, Switzerland (PRACE-ICEI grants icp005 and icp013, awarded to Dr Alfonso Bueno-Orovio), and JURECA at the Juelich Supercomputing Centre (PRACE-ICEI grant icp019 awarded to Dr Zhinuo Jenny Wang) which are partially funded from the European Union’s Horizon 2020 research and innovation programme through the ICEI project under the grant agreement No. 800858.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahnve</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>QT interval prolongation in acute myocardial infarction</article-title><source>European Heart Journal</source><volume>6 Suppl D</volume><fpage>85</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/6.suppl_d.85</pub-id><pub-id pub-id-type="pmid">2417855</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Khatib</surname><given-names>SM</given-names></name><name><surname>Stevenson</surname><given-names>WG</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name><name><surname>Bryant</surname><given-names>WJ</given-names></name><name><surname>Callans</surname><given-names>DJ</given-names></name><name><surname>Curtis</surname><given-names>AB</given-names></name><name><surname>Deal</surname><given-names>BJ</given-names></name><name><surname>Dickfeld</surname><given-names>T</given-names></name><name><surname>Field</surname><given-names>ME</given-names></name><name><surname>Fonarow</surname><given-names>GC</given-names></name><name><surname>Gillis</surname><given-names>AM</given-names></name><name><surname>Granger</surname><given-names>CB</given-names></name><name><surname>Hammill</surname><given-names>SC</given-names></name><name><surname>Hlatky</surname><given-names>MA</given-names></name><name><surname>Joglar</surname><given-names>JA</given-names></name><name><surname>Kay</surname><given-names>GN</given-names></name><name><surname>Matlock</surname><given-names>DD</given-names></name><name><surname>Myerburg</surname><given-names>RJ</given-names></name><name><surname>Page</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the american college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society</article-title><source>Circulation</source><volume>138</volume><fpage>e272</fpage><lpage>e391</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000549</pub-id><pub-id pub-id-type="pmid">29084731</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosi</surname><given-names>CM</given-names></name><name><surname>Yamada</surname><given-names>KA</given-names></name><name><surname>Nerbonne</surname><given-names>JM</given-names></name><name><surname>Efimov</surname><given-names>IR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Gender differences in electrophysiological gene expression in failing and non-failing human hearts</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e54635</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0054635</pub-id><pub-id pub-id-type="pmid">23355885</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>ME</given-names></name><name><surname>Brown</surname><given-names>JH</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>CaMKII in myocardial hypertrophy and heart failure</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>51</volume><fpage>468</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.01.012</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anselm</surname><given-names>DD</given-names></name><name><surname>Evans</surname><given-names>JM</given-names></name><name><surname>Baranchuk</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Brugada phenocopy: A new electrocardiogram phenomenon</article-title><source>World Journal of Cardiology</source><volume>6</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.4330/wjc.v6.i3.81</pub-id><pub-id pub-id-type="pmid">24669289</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arevalo</surname><given-names>HJ</given-names></name><name><surname>Vadakkumpadan</surname><given-names>F</given-names></name><name><surname>Guallar</surname><given-names>E</given-names></name><name><surname>Jebb</surname><given-names>A</given-names></name><name><surname>Malamas</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>KC</given-names></name><name><surname>Trayanova</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11437</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11437</pub-id><pub-id pub-id-type="pmid">27164184</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arteyeva</surname><given-names>NV</given-names></name><name><surname>Azarov</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Effect of action potential duration on T<sub>peak</sub>-T<sub>end</sub> interval, T-wave area and T-wave amplitude as indices of dispersion of repolarization: Theoretical and simulation study in the rabbit heart</article-title><source>Journal of Electrocardiology</source><volume>50</volume><fpage>919</fpage><lpage>924</lpage><pub-id pub-id-type="doi">10.1016/j.jelectrocard.2017.07.001</pub-id><pub-id pub-id-type="pmid">28784265</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beuckelmann</surname><given-names>DJ</given-names></name><name><surname>Näbauer</surname><given-names>M</given-names></name><name><surname>Erdmann</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure</article-title><source>Circulation Research</source><volume>73</volume><fpage>379</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1161/01.res.73.2.379</pub-id><pub-id pub-id-type="pmid">8330380</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloomfield</surname><given-names>DM</given-names></name><name><surname>Steinman</surname><given-names>RC</given-names></name><name><surname>Namerow</surname><given-names>PB</given-names></name><name><surname>Parides</surname><given-names>M</given-names></name><name><surname>Davidenko</surname><given-names>J</given-names></name><name><surname>Kaufman</surname><given-names>ES</given-names></name><name><surname>Shinn</surname><given-names>T</given-names></name><name><surname>Curtis</surname><given-names>A</given-names></name><name><surname>Fontaine</surname><given-names>J</given-names></name><name><surname>Holmes</surname><given-names>D</given-names></name><name><surname>Russo</surname><given-names>A</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Bigger</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum</article-title><source>Circulation</source><volume>110</volume><fpage>1885</fpage><lpage>1889</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000143160.14610.53</pub-id><pub-id pub-id-type="pmid">15451804</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boukens</surname><given-names>BJD</given-names></name><name><surname>Dacey</surname><given-names>M</given-names></name><name><surname>Meijborg</surname><given-names>VMF</given-names></name><name><surname>Janse</surname><given-names>MJ</given-names></name><name><surname>Hadaya</surname><given-names>J</given-names></name><name><surname>Hanna</surname><given-names>P</given-names></name><name><surname>Swid</surname><given-names>MA</given-names></name><name><surname>Opthof</surname><given-names>T</given-names></name><name><surname>Ardell</surname><given-names>JL</given-names></name><name><surname>Shivkumar</surname><given-names>K</given-names></name><name><surname>Coronel</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mechanism of ventricular premature beats elicited by left stellate ganglion stimulation during acute ischaemia of the anterior left ventricle</article-title><source>Cardiovascular Research</source><volume>117</volume><fpage>2083</fpage><lpage>2091</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvaa253</pub-id><pub-id pub-id-type="pmid">32853334</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bousseljot</surname><given-names>R</given-names></name><name><surname>Kreiseler</surname><given-names>D</given-names></name><name><surname>Schnabel</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nutzung der EKG-signaldatenbank CARDIODAT der PTB über das internet</article-title><source>Biomedizinische Technik/Biomedical Engineering</source><volume>1</volume><fpage>317</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1515/bmte.1995.40.s1.317</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britton</surname><given-names>OJ</given-names></name><name><surname>Bueno-Orovio</surname><given-names>A</given-names></name><name><surname>Virág</surname><given-names>L</given-names></name><name><surname>Varró</surname><given-names>A</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Electrogenic Na<sup>+</sup>/K<sup>+</sup> pump is a key determinant of repolarization abnormality susceptibility in human ventricular cardiomyocytes: a population-based simulation study</article-title><source>Frontiers in Physiology</source><volume>8</volume><elocation-id>278</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2017.00278</pub-id><pub-id pub-id-type="pmid">28529489</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchner</surname><given-names>S</given-names></name><name><surname>Eglseer</surname><given-names>M</given-names></name><name><surname>Debl</surname><given-names>K</given-names></name><name><surname>Hetzenecker</surname><given-names>A</given-names></name><name><surname>Luchner</surname><given-names>A</given-names></name><name><surname>Husser</surname><given-names>O</given-names></name><name><surname>Stroszczynski</surname><given-names>C</given-names></name><name><surname>Hamer</surname><given-names>OW</given-names></name><name><surname>Fellner</surname><given-names>C</given-names></name><name><surname>Zeman</surname><given-names>F</given-names></name><name><surname>Pfeifer</surname><given-names>M</given-names></name><name><surname>Arzt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sleep disordered breathing and enlargement of the right heart after myocardial infarction</article-title><source>The European Respiratory Journal</source><volume>45</volume><fpage>680</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1183/09031936.00057014</pub-id><pub-id pub-id-type="pmid">25359347</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caldwell</surname><given-names>BJ</given-names></name><name><surname>Trew</surname><given-names>ML</given-names></name><name><surname>Sands</surname><given-names>GB</given-names></name><name><surname>Hooks</surname><given-names>DA</given-names></name><name><surname>LeGrice</surname><given-names>IJ</given-names></name><name><surname>Smaill</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Three distinct directions of intramural activation reveal nonuniform side-to-side electrical coupling of ventricular myocytes</article-title><source>Circulation. Arrhythmia and Electrophysiology</source><volume>2</volume><fpage>433</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1161/CIRCEP.108.830133</pub-id><pub-id pub-id-type="pmid">19808500</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>MB</given-names></name><name><surname>Trägårdh</surname><given-names>E</given-names></name><name><surname>Engblom</surname><given-names>H</given-names></name><name><surname>Hedström</surname><given-names>E</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Pahlm</surname><given-names>O</given-names></name><name><surname>Arheden</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Left ventricular mass by 12-lead electrocardiogram in healthy subjects: comparison to cardiac magnetic resonance imaging</article-title><source>Journal of Electrocardiology</source><volume>39</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.jelectrocard.2005.07.005</pub-id><pub-id pub-id-type="pmid">16387055</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>P-C</given-names></name><name><surname>Turker</surname><given-names>I</given-names></name><name><surname>Lopshire</surname><given-names>JC</given-names></name><name><surname>Masroor</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>B-L</given-names></name><name><surname>Tao</surname><given-names>W</given-names></name><name><surname>Rubart</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>P-S</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Ai</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Heterogeneous upregulation of apamin-sensitive potassium currents in failing human ventricles</article-title><source>Journal of the American Heart Association</source><volume>2</volume><elocation-id>e004713</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.112.004713</pub-id><pub-id pub-id-type="pmid">23525437</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cluitmans</surname><given-names>MJM</given-names></name><name><surname>Bear</surname><given-names>LR</given-names></name><name><surname>Nguyên</surname><given-names>UC</given-names></name><name><surname>van Rees</surname><given-names>B</given-names></name><name><surname>Stoks</surname><given-names>J</given-names></name><name><surname>Ter Bekke</surname><given-names>RMA</given-names></name><name><surname>Mihl</surname><given-names>C</given-names></name><name><surname>Heijman</surname><given-names>J</given-names></name><name><surname>Lau</surname><given-names>KD</given-names></name><name><surname>Vigmond</surname><given-names>E</given-names></name><name><surname>Bayer</surname><given-names>J</given-names></name><name><surname>Belterman</surname><given-names>CNW</given-names></name><name><surname>Abell</surname><given-names>E</given-names></name><name><surname>Labrousse</surname><given-names>L</given-names></name><name><surname>Rogier</surname><given-names>J</given-names></name><name><surname>Bernus</surname><given-names>O</given-names></name><name><surname>Haïssaguerre</surname><given-names>M</given-names></name><name><surname>Hassink</surname><given-names>RJ</given-names></name><name><surname>Dubois</surname><given-names>R</given-names></name><name><surname>Coronel</surname><given-names>R</given-names></name><name><surname>Volders</surname><given-names>PGA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Noninvasive detection of spatiotemporal activation-repolarization interactions that prime idiopathic ventricular fibrillation</article-title><source>Science Translational Medicine</source><volume>13</volume><elocation-id>eabi9317</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abi9317</pub-id><pub-id pub-id-type="pmid">34788076</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppini</surname><given-names>R</given-names></name><name><surname>Ferrantini</surname><given-names>C</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Fan</surname><given-names>P</given-names></name><name><surname>Del Lungo</surname><given-names>M</given-names></name><name><surname>Stillitano</surname><given-names>F</given-names></name><name><surname>Sartiani</surname><given-names>L</given-names></name><name><surname>Tosi</surname><given-names>B</given-names></name><name><surname>Suffredini</surname><given-names>S</given-names></name><name><surname>Tesi</surname><given-names>C</given-names></name><name><surname>Yacoub</surname><given-names>M</given-names></name><name><surname>Olivotto</surname><given-names>I</given-names></name><name><surname>Belardinelli</surname><given-names>L</given-names></name><name><surname>Poggesi</surname><given-names>C</given-names></name><name><surname>Cerbai</surname><given-names>E</given-names></name><name><surname>Mugelli</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy</article-title><source>Circulation</source><volume>127</volume><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.134932</pub-id><pub-id pub-id-type="pmid">23271797</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dangman</surname><given-names>KH</given-names></name><name><surname>Danilo</surname><given-names>P</given-names></name><name><surname>Hordof</surname><given-names>AJ</given-names></name><name><surname>Mary-Rabine</surname><given-names>L</given-names></name><name><surname>Reder</surname><given-names>RF</given-names></name><name><surname>Rosen</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Electrophysiologic characteristics of human ventricular and Purkinje fibers</article-title><source>Circulation</source><volume>65</volume><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1161/01.cir.65.2.362</pub-id><pub-id pub-id-type="pmid">7032748</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>KF</given-names></name><name><surname>Rudy</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ionic mechanisms of electrophysiological heterogeneity and conduction block in the infarct border zone</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>299</volume><fpage>H1588</fpage><lpage>H1597</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00362.2010</pub-id><pub-id pub-id-type="pmid">20709867</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>S</given-names></name><name><surname>Mincholé</surname><given-names>A</given-names></name><name><surname>Zacur</surname><given-names>E</given-names></name><name><surname>Quinn</surname><given-names>TA</given-names></name><name><surname>Taggart</surname><given-names>P</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Early afterdepolarizations promote transmural reentry in ischemic human ventricles with reduced repolarization reserve</article-title><source>Progress in Biophysics and Molecular Biology</source><volume>120</volume><fpage>236</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2016.01.008</pub-id><pub-id pub-id-type="pmid">26850675</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elayi</surname><given-names>CS</given-names></name><name><surname>Charnigo</surname><given-names>RJ</given-names></name><name><surname>Heron</surname><given-names>PM</given-names></name><name><surname>Lee</surname><given-names>BK</given-names></name><name><surname>Olgin</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Primary prevention of sudden cardiac death early post-myocardial infarction: root cause analysis for implantable cardioverter-defibrillator failure and currently available options</article-title><source>Circulation. Arrhythmia and Electrophysiology</source><volume>10</volume><elocation-id>e005194</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCEP.117.005194</pub-id><pub-id pub-id-type="pmid">28630173</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Elshrif</surname><given-names>MM</given-names></name><name><surname>Cherry</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Electrophysiological properties under heart failure conditions in A human ventricular cell: A modeling study</article-title><conf-name>2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC</conf-name><conf-loc>Chicago, IL</conf-loc><fpage>4324</fpage><lpage>4329</lpage><pub-id pub-id-type="doi">10.1109/EMBC.2014.6944581</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>KP</given-names></name><name><surname>Gerren</surname><given-names>RA</given-names></name><name><surname>Stirling</surname><given-names>MC</given-names></name><name><surname>Choy</surname><given-names>M</given-names></name><name><surname>Dysko</surname><given-names>RC</given-names></name><name><surname>McManimon</surname><given-names>SP</given-names></name><name><surname>Dunham</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>The distribution of functional impairment across the lateral border of acutely ischemic myocardium</article-title><source>Circulation Research</source><volume>58</volume><fpage>570</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1161/01.res.58.4.570</pub-id><pub-id pub-id-type="pmid">3698220</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>PI</given-names></name><name><surname>Ursell</surname><given-names>PC</given-names></name><name><surname>Fenoglio</surname><given-names>JJ</given-names></name><name><surname>Wit</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts</article-title><source>Circulation</source><volume>72</volume><fpage>596</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1161/01.cir.72.3.596</pub-id><pub-id pub-id-type="pmid">4017211</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatzoulis</surname><given-names>KA</given-names></name><name><surname>Tsiachris</surname><given-names>D</given-names></name><name><surname>Arsenos</surname><given-names>P</given-names></name><name><surname>Antoniou</surname><given-names>C-K</given-names></name><name><surname>Dilaveris</surname><given-names>P</given-names></name><name><surname>Sideris</surname><given-names>S</given-names></name><name><surname>Kanoupakis</surname><given-names>E</given-names></name><name><surname>Simantirakis</surname><given-names>E</given-names></name><name><surname>Korantzopoulos</surname><given-names>P</given-names></name><name><surname>Goudevenos</surname><given-names>I</given-names></name><name><surname>Flevari</surname><given-names>P</given-names></name><name><surname>Iliodromitis</surname><given-names>E</given-names></name><name><surname>Sideris</surname><given-names>A</given-names></name><name><surname>Vassilikos</surname><given-names>V</given-names></name><name><surname>Fragakis</surname><given-names>N</given-names></name><name><surname>Trachanas</surname><given-names>K</given-names></name><name><surname>Vernardos</surname><given-names>M</given-names></name><name><surname>Konstantinou</surname><given-names>I</given-names></name><name><surname>Tsimos</surname><given-names>K</given-names></name><name><surname>Xenogiannis</surname><given-names>I</given-names></name><name><surname>Vlachos</surname><given-names>K</given-names></name><name><surname>Saplaouras</surname><given-names>A</given-names></name><name><surname>Triantafyllou</surname><given-names>K</given-names></name><name><surname>Kallikazaros</surname><given-names>I</given-names></name><name><surname>Tousoulis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study</article-title><source>European Heart Journal</source><volume>40</volume><fpage>2940</fpage><lpage>2949</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehz260</pub-id><pub-id pub-id-type="pmid">31049557</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberger</surname><given-names>AL</given-names></name><name><surname>Amaral</surname><given-names>LA</given-names></name><name><surname>Glass</surname><given-names>L</given-names></name><name><surname>Hausdorff</surname><given-names>JM</given-names></name><name><surname>Ivanov</surname><given-names>PC</given-names></name><name><surname>Mark</surname><given-names>RG</given-names></name><name><surname>Mietus</surname><given-names>JE</given-names></name><name><surname>Moody</surname><given-names>GB</given-names></name><name><surname>Peng</surname><given-names>CK</given-names></name><name><surname>Stanley</surname><given-names>HE</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals</article-title><source>Circulation</source><volume>101</volume><fpage>E215</fpage><lpage>E220</lpage><pub-id pub-id-type="doi">10.1161/01.cir.101.23.e215</pub-id><pub-id pub-id-type="pmid">10851218</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>JF</given-names></name><name><surname>Cardona</surname><given-names>K</given-names></name><name><surname>Romero</surname><given-names>L</given-names></name><name><surname>Ferrero</surname><given-names>JM</given-names></name><name><surname>Trenor</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1D simulation study</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e106602</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0106602</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guaricci</surname><given-names>AI</given-names></name><name><surname>Carità</surname><given-names>P</given-names></name><name><surname>Lorenzoni</surname><given-names>V</given-names></name><name><surname>Casavecchia</surname><given-names>G</given-names></name><name><surname>Rabbat</surname><given-names>M</given-names></name><name><surname>Ieva</surname><given-names>R</given-names></name><name><surname>Brunetti</surname><given-names>ND</given-names></name><name><surname>Andreini</surname><given-names>D</given-names></name><name><surname>Di Biase</surname><given-names>M</given-names></name><name><surname>Marenzi</surname><given-names>G</given-names></name><name><surname>Bartorelli</surname><given-names>A</given-names></name><name><surname>Pepi</surname><given-names>M</given-names></name><name><surname>Pontone</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>QT-interval evaluation in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction for prediction of myocardial salvage index</article-title><source>PLOS ONE</source><volume>13</volume><elocation-id>e0192220</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0192220</pub-id><pub-id pub-id-type="pmid">29420570</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegyi</surname><given-names>B</given-names></name><name><surname>Bossuyt</surname><given-names>J</given-names></name><name><surname>Griffiths</surname><given-names>LG</given-names></name><name><surname>Shimkunas</surname><given-names>R</given-names></name><name><surname>Coulibaly</surname><given-names>Z</given-names></name><name><surname>Jian</surname><given-names>Z</given-names></name><name><surname>Grimsrud</surname><given-names>KN</given-names></name><name><surname>Sondergaard</surname><given-names>CS</given-names></name><name><surname>Ginsburg</surname><given-names>KS</given-names></name><name><surname>Chiamvimonvat</surname><given-names>N</given-names></name><name><surname>Belardinelli</surname><given-names>L</given-names></name><name><surname>Varró</surname><given-names>A</given-names></name><name><surname>Papp</surname><given-names>JG</given-names></name><name><surname>Pollesello</surname><given-names>P</given-names></name><name><surname>Levijoki</surname><given-names>J</given-names></name><name><surname>Izu</surname><given-names>LT</given-names></name><name><surname>Boyd</surname><given-names>WD</given-names></name><name><surname>Bányász</surname><given-names>T</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name><name><surname>Chen-Izu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Complex electrophysiological remodeling in postinfarction ischemic heart failure</article-title><source>PNAS</source><volume>115</volume><fpage>E3036</fpage><lpage>E3044</lpage><pub-id pub-id-type="doi">10.1073/pnas.1718211115</pub-id><pub-id pub-id-type="pmid">29531045</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoch</surname><given-names>B</given-names></name><name><surname>Meyer</surname><given-names>R</given-names></name><name><surname>Hetzer</surname><given-names>R</given-names></name><name><surname>Krause</surname><given-names>EG</given-names></name><name><surname>Karczewski</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium</article-title><source>Circulation Research</source><volume>84</volume><fpage>713</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1161/01.res.84.6.713</pub-id><pub-id pub-id-type="pmid">10189359</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzapfel</surname><given-names>GA</given-names></name><name><surname>Ogden</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Constitutive modelling of passive myocardium: a structurally based framework for material characterization</article-title><source>Philosophical Transactions of the Royal Society A</source><volume>367</volume><fpage>3445</fpage><lpage>3475</lpage><pub-id pub-id-type="doi">10.1098/rsta.2009.0091</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzem Katherine</surname><given-names>M</given-names></name><name><surname>Glukhov Alexey</surname><given-names>V</given-names></name><name><surname>Efimov Igor</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Abstract 16014: the role of IKR in transmural repolarization abnormalities in human heart failure</article-title><source>Circulation</source><volume>124</volume><elocation-id>A16014</elocation-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Høydal</surname><given-names>MA</given-names></name><name><surname>Kirkeby-Garstad</surname><given-names>I</given-names></name><name><surname>Karevold</surname><given-names>A</given-names></name><name><surname>Wiseth</surname><given-names>R</given-names></name><name><surname>Haaverstad</surname><given-names>R</given-names></name><name><surname>Wahba</surname><given-names>A</given-names></name><name><surname>Stølen</surname><given-names>TL</given-names></name><name><surname>Contu</surname><given-names>R</given-names></name><name><surname>Condorelli</surname><given-names>G</given-names></name><name><surname>Ellingsen</surname><given-names>Ø</given-names></name><name><surname>Smith</surname><given-names>GL</given-names></name><name><surname>Kemi</surname><given-names>OJ</given-names></name><name><surname>Wisløff</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Human cardiomyocyte calcium handling and transverse tubules in mid-stage of post-myocardial-infarction heart failure</article-title><source>ESC Heart Failure</source><volume>5</volume><fpage>332</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1002/ehf2.12271</pub-id><pub-id pub-id-type="pmid">29431258</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hund</surname><given-names>TJ</given-names></name><name><surname>Decker</surname><given-names>KF</given-names></name><name><surname>Kanter</surname><given-names>E</given-names></name><name><surname>Mohler</surname><given-names>PJ</given-names></name><name><surname>Boyden</surname><given-names>PA</given-names></name><name><surname>Schuessler</surname><given-names>RB</given-names></name><name><surname>Yamada</surname><given-names>KA</given-names></name><name><surname>Rudy</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Role of activated CaMKII in abnormal calcium homeostasis and I(Na) remodeling after myocardial infarction: insights from mathematical modeling</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>45</volume><fpage>420</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2008.06.007</pub-id><pub-id pub-id-type="pmid">18639555</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Sakata</surname><given-names>T</given-names></name><name><surname>Takami</surname><given-names>M</given-names></name><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Tezuka</surname><given-names>N</given-names></name><name><surname>Nakae</surname><given-names>T</given-names></name><name><surname>Noro</surname><given-names>M</given-names></name><name><surname>Enjoji</surname><given-names>Y</given-names></name><name><surname>Abe</surname><given-names>R</given-names></name><name><surname>Sugi</surname><given-names>K</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction: a prospective study</article-title><source>Journal of the American College of Cardiology</source><volume>35</volume><fpage>722</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1016/s0735-1097(99)00590-2</pub-id><pub-id pub-id-type="pmid">10716476</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Cabo</surname><given-names>C</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Boyden</surname><given-names>PA</given-names></name><name><surname>Tseng</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Delayed rectifier K currents have reduced amplitudes and altered kinetics in myocytes from infarcted canine ventricle</article-title><source>Cardiovascular Research</source><volume>48</volume><fpage>34</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/s0008-6363(00)00159-0</pub-id><pub-id pub-id-type="pmid">11033106</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>MT</given-names></name><name><surname>Lokuta</surname><given-names>AJ</given-names></name><name><surname>Farrell</surname><given-names>EF</given-names></name><name><surname>Wolff</surname><given-names>MR</given-names></name><name><surname>Haworth</surname><given-names>RA</given-names></name><name><surname>Valdivia</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure</article-title><source>Circulation Research</source><volume>91</volume><fpage>1015</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1161/01.res.0000043663.08689.05</pub-id><pub-id pub-id-type="pmid">12456487</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JN</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>QTc: how long is too long?</article-title><source>British Journal of Sports Medicine</source><volume>43</volume><fpage>657</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1136/bjsm.2008.054734</pub-id><pub-id pub-id-type="pmid">19734499</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Land</surname><given-names>S</given-names></name><name><surname>Park-Holohan</surname><given-names>S-J</given-names></name><name><surname>Smith</surname><given-names>NP</given-names></name><name><surname>Dos Remedios</surname><given-names>CG</given-names></name><name><surname>Kentish</surname><given-names>JC</given-names></name><name><surname>Niederer</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A model of cardiac contraction based on novel measurements of tension development in human cardiomyocytes</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>106</volume><fpage>68</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2017.03.008</pub-id><pub-id pub-id-type="pmid">28392437</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levrero-Florencio</surname><given-names>F</given-names></name><name><surname>Margara</surname><given-names>F</given-names></name><name><surname>Zacur</surname><given-names>E</given-names></name><name><surname>Bueno-Orovio</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>ZJ</given-names></name><name><surname>Santiago</surname><given-names>A</given-names></name><name><surname>Aguado-Sierra</surname><given-names>J</given-names></name><name><surname>Houzeaux</surname><given-names>G</given-names></name><name><surname>Grau</surname><given-names>V</given-names></name><name><surname>Kay</surname><given-names>D</given-names></name><name><surname>Vázquez</surname><given-names>M</given-names></name><name><surname>Ruiz-Baier</surname><given-names>R</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Sensitivity analysis of a strongly-coupled human-based electromechanical cardiac model: Effect of mechanical parameters on physiologically relevant biomarkers</article-title><source>Computer Methods in Applied Mechanics and Engineering</source><volume>361</volume><elocation-id>112762</elocation-id><pub-id pub-id-type="doi">10.1016/j.cma.2019.112762</pub-id><pub-id pub-id-type="pmid">32565583</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>GR</given-names></name><name><surname>Lau</surname><given-names>CP</given-names></name><name><surname>Leung</surname><given-names>TK</given-names></name><name><surname>Nattel</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles</article-title><source>Heart Rhythm</source><volume>1</volume><fpage>460</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2004.06.003</pub-id><pub-id pub-id-type="pmid">15851200</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Camps</surname><given-names>J</given-names></name><name><surname>Jenny Wang</surname><given-names>Z</given-names></name><name><surname>Beetz</surname><given-names>M</given-names></name><name><surname>Banerjee</surname><given-names>A</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name><name><surname>Grau</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Toward enabling cardiac digital twins of myocardial infarction using deep computational models for inverse inference</article-title><source>IEEE Transactions on Medical Imaging</source><volume>43</volume><fpage>2466</fpage><lpage>2478</lpage><pub-id pub-id-type="doi">10.1109/TMI.2024.3367409</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licata</surname><given-names>A</given-names></name><name><surname>Aggarwal</surname><given-names>R</given-names></name><name><surname>Robinson</surname><given-names>RB</given-names></name><name><surname>Boyden</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Frequency dependent effects on Cai transients and cell shortening in myocytes that survive in the infarcted heart</article-title><source>Cardiovascular Research</source><volume>33</volume><fpage>341</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/s0008-6363(96)00246-5</pub-id><pub-id pub-id-type="pmid">9074698</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livshitz</surname><given-names>LM</given-names></name><name><surname>Rudy</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of Ca2+ and electrical alternans in cardiac myocytes: role of CAMKII and repolarizing currents</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>292</volume><fpage>H2854</fpage><lpage>H2866</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01347.2006</pub-id><pub-id pub-id-type="pmid">17277017</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewe</surname><given-names>A</given-names></name><name><surname>Wülfers</surname><given-names>EM</given-names></name><name><surname>Seemann</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cardiac ischemia—insights from computational models</article-title><source>Herzschrittmachertherapie + Elektrophysiologie</source><volume>29</volume><fpage>48</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1007/s00399-017-0539-6</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lue</surname><given-names>WM</given-names></name><name><surname>Boyden</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in Vmax and the transient outward current</article-title><source>Circulation</source><volume>85</volume><fpage>1175</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.85.3.1175</pub-id><pub-id pub-id-type="pmid">1371431</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maceira</surname><given-names>AM</given-names></name><name><surname>Prasad</surname><given-names>SK</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Pennell</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2006">2006a</year><article-title>Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance</article-title><source>Journal of Cardiovascular Magnetic Resonance</source><volume>8</volume><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1080/10976640600572889</pub-id><pub-id pub-id-type="pmid">16755827</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maceira</surname><given-names>AM</given-names></name><name><surname>Prasad</surname><given-names>SK</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Pennell</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2006">2006b</year><article-title>Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance</article-title><source>European Heart Journal</source><volume>27</volume><fpage>2879</fpage><lpage>2888</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehl336</pub-id><pub-id pub-id-type="pmid">17088316</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>LS</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>DeSantiago</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>JH</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release</article-title><source>Circulation Research</source><volume>92</volume><fpage>904</fpage><lpage>911</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000069685.20258.F1</pub-id><pub-id pub-id-type="pmid">12676813</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>LS</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart</article-title><source>Cardiovascular Research</source><volume>73</volume><fpage>631</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.11.005</pub-id><pub-id pub-id-type="pmid">17157285</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltsev</surname><given-names>VA</given-names></name><name><surname>Silverman</surname><given-names>N</given-names></name><name><surname>Sabbah</surname><given-names>HN</given-names></name><name><surname>Undrovinas</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability</article-title><source>European Journal of Heart Failure</source><volume>9</volume><fpage>219</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.ejheart.2006.08.007</pub-id><pub-id pub-id-type="pmid">17067855</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margara</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>ZJ</given-names></name><name><surname>Levrero-Florencio</surname><given-names>F</given-names></name><name><surname>Santiago</surname><given-names>A</given-names></name><name><surname>Vázquez</surname><given-names>M</given-names></name><name><surname>Bueno-Orovio</surname><given-names>A</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>In-silico human electro-mechanical ventricular modelling and simulation for drug-induced pro-arrhythmia and inotropic risk assessment</article-title><source>Progress in Biophysics and Molecular Biology</source><volume>159</volume><fpage>58</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2020.06.007</pub-id><pub-id pub-id-type="pmid">32710902</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>DT</given-names></name><name><surname>Shoraki</surname><given-names>A</given-names></name><name><surname>Nesto</surname><given-names>RW</given-names></name><name><surname>Rutter</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Influence of diabetes and/or myocardial infarction on prevalence of abnormal T-wave alternans</article-title><source>Annals of Noninvasive Electrocardiology</source><volume>14</volume><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1111/j.1542-474X.2009.00325.x</pub-id><pub-id pub-id-type="pmid">19804512</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendonca Costa</surname><given-names>C</given-names></name><name><surname>Plank</surname><given-names>G</given-names></name><name><surname>Rinaldi</surname><given-names>CA</given-names></name><name><surname>Niederer</surname><given-names>SA</given-names></name><name><surname>Bishop</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modeling the electrophysiological properties of the infarct border zone</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>356</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.00356</pub-id><pub-id pub-id-type="pmid">29686626</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mincholé</surname><given-names>A</given-names></name><name><surname>Zacur</surname><given-names>E</given-names></name><name><surname>Ariga</surname><given-names>R</given-names></name><name><surname>Grau</surname><given-names>V</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>MRI-based computational torso/biventricular multiscale models to investigate the impact of anatomical variability on the ECG QRS complex</article-title><source>Frontiers in Physiology</source><volume>10</volume><elocation-id>1103</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2019.01103</pub-id><pub-id pub-id-type="pmid">31507458</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemerovski</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>PK</given-names></name><name><surname>Pichler</surname><given-names>M</given-names></name><name><surname>Berman</surname><given-names>DS</given-names></name><name><surname>Shellock</surname><given-names>F</given-names></name><name><surname>Swan</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Radionuclide assessment of sequential changes in left and right ventricular function following first acute transmural myocardial infarction</article-title><source>American Heart Journal</source><volume>104</volume><fpage>709</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/0002-8703(82)90001-1</pub-id><pub-id pub-id-type="pmid">7124583</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ogiermann</surname><given-names>D</given-names></name><name><surname>Balzani</surname><given-names>D</given-names></name><name><surname>Perotti</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2021">2021</year><chapter-title>The effect of modeling assumptions on the ECG in monodomain and bidomain simulations</chapter-title><person-group person-group-type="editor"><name><surname>Ogiermann</surname><given-names>D</given-names></name></person-group><source>Functional Imaging and Modeling of the Heart</source><publisher-loc>Cham</publisher-loc><publisher-name>Springer International Publishing</publisher-name><fpage>503</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-78710-3_48</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Hara</surname><given-names>T</given-names></name><name><surname>Virág</surname><given-names>L</given-names></name><name><surname>Varró</surname><given-names>A</given-names></name><name><surname>Rudy</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation</article-title><source>PLOS Computational Biology</source><volume>7</volume><elocation-id>e1002061</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002061</pub-id><pub-id pub-id-type="pmid">21637795</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oikarinen</surname><given-names>L</given-names></name><name><surname>Viitasalo</surname><given-names>M</given-names></name><name><surname>Toivonen</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Dispersions of the QT interval in postmyocardial infarction patients presenting with ventricular tachycardia or with ventricular fibrillation</article-title><source>The American Journal of Cardiology</source><volume>81</volume><fpage>694</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1016/s0002-9149(97)01002-3</pub-id><pub-id pub-id-type="pmid">9527076</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>J-I</given-names></name><name><surname>Washio</surname><given-names>T</given-names></name><name><surname>Maehara</surname><given-names>A</given-names></name><name><surname>Momomura</surname><given-names>S-I</given-names></name><name><surname>Sugiura</surname><given-names>S</given-names></name><name><surname>Hisada</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Transmural and apicobasal gradients in repolarization contribute to T-wave genesis in human surface ECG</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>301</volume><fpage>H200</fpage><lpage>H208</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01241.2010</pub-id><pub-id pub-id-type="pmid">21460196</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkiömäki</surname><given-names>JS</given-names></name><name><surname>Koistinen</surname><given-names>MJ</given-names></name><name><surname>Yli-Mäyry</surname><given-names>S</given-names></name><name><surname>Huikuri</surname><given-names>HV</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction</article-title><source>Journal of the American College of Cardiology</source><volume>26</volume><fpage>174</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/0735-1097(95)00122-g</pub-id><pub-id pub-id-type="pmid">7797747</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piacentino</surname><given-names>V</given-names></name><name><surname>Weber</surname><given-names>CR</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Weisser-Thomas</surname><given-names>J</given-names></name><name><surname>Margulies</surname><given-names>KB</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name><name><surname>Houser</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cellular basis of abnormal calcium transients of failing human ventricular myocytes</article-title><source>Circulation Research</source><volume>92</volume><fpage>651</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000062469.83985.9B</pub-id><pub-id pub-id-type="pmid">12600875</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogwizd</surname><given-names>SM</given-names></name><name><surname>Hoyt</surname><given-names>RH</given-names></name><name><surname>Saffitz</surname><given-names>JE</given-names></name><name><surname>Corr</surname><given-names>PB</given-names></name><name><surname>Cox</surname><given-names>JL</given-names></name><name><surname>Cain</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart</article-title><source>Circulation</source><volume>86</volume><fpage>1872</fpage><lpage>1887</lpage><pub-id pub-id-type="doi">10.1161/01.cir.86.6.1872</pub-id><pub-id pub-id-type="pmid">1451259</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pu</surname><given-names>J</given-names></name><name><surname>Robinson</surname><given-names>RB</given-names></name><name><surname>Boyden</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Abnormalities in Ca(i)handling in myocytes that survive in the infarcted heart are not just due to alterations in repolarization</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>32</volume><fpage>1509</fpage><lpage>1523</lpage><pub-id pub-id-type="doi">10.1006/jmcc.2000.1184</pub-id><pub-id pub-id-type="pmid">10900177</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Z</given-names></name><name><surname>Weiss</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cardiac alternans: from bedside to bench and back</article-title><source>Circulation Research</source><volume>132</volume><fpage>127</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.122.321668</pub-id><pub-id pub-id-type="pmid">36603066</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajesh</surname><given-names>A</given-names></name><name><surname>Boyden Penelope</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Diminished Ca2+ and Ba2+ currents in myocytes surviving in the epicardial border zone of the 5-day infarcted canine heart</article-title><source>Circulation Research</source><volume>77</volume><fpage>1180</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1161/01.RES.77.6.1180</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridley</surname><given-names>PD</given-names></name><name><surname>Yacoub</surname><given-names>MH</given-names></name><name><surname>Curtis</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>A modified model of global ischaemia: application to the study of syncytial mechanisms of arrhythmogenesis</article-title><source>Cardiovascular Research</source><volume>26</volume><fpage>309</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1093/cvr/26.4.309</pub-id><pub-id pub-id-type="pmid">1638559</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sack</surname><given-names>KL</given-names></name><name><surname>Davies</surname><given-names>NH</given-names></name><name><surname>Guccione</surname><given-names>JM</given-names></name><name><surname>Franz</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Personalised computational cardiology: Patient-specific modelling in cardiac mechanics and biomaterial injection therapies for myocardial infarction</article-title><source>Heart Failure Reviews</source><volume>21</volume><fpage>815</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1007/s10741-016-9528-9</pub-id><pub-id pub-id-type="pmid">26833320</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago</surname><given-names>A</given-names></name><name><surname>Aguado-Sierra</surname><given-names>J</given-names></name><name><surname>Zavala-Aké</surname><given-names>M</given-names></name><name><surname>Doste-Beltran</surname><given-names>R</given-names></name><name><surname>Gómez</surname><given-names>S</given-names></name><name><surname>Arís</surname><given-names>R</given-names></name><name><surname>Cajas</surname><given-names>JC</given-names></name><name><surname>Casoni</surname><given-names>E</given-names></name><name><surname>Vázquez</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fully coupled fluid-electro-mechanical model of the human heart for supercomputers</article-title><source>International Journal for Numerical Methods in Biomedical Engineering</source><volume>34</volume><elocation-id>e3140</elocation-id><pub-id pub-id-type="doi">10.1002/cnm.3140</pub-id><pub-id pub-id-type="pmid">30117302</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Hiroe</surname><given-names>M</given-names></name><name><surname>Nozato</surname><given-names>T</given-names></name><name><surname>Hikita</surname><given-names>H</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Ohigashi</surname><given-names>H</given-names></name><name><surname>Tamura</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Isobe</surname><given-names>M</given-names></name><name><surname>Aonuma</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Early validation study of 64-slice multidetector computed tomography for the assessment of myocardial viability and the prediction of left ventricular remodelling after acute myocardial infarction</article-title><source>European Heart Journal</source><volume>29</volume><fpage>490</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehm630</pub-id><pub-id pub-id-type="pmid">18216032</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwinger</surname><given-names>RH</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Frank</surname><given-names>K</given-names></name><name><surname>Müller-Ehmsen</surname><given-names>J</given-names></name><name><surname>Brixius</surname><given-names>K</given-names></name><name><surname>McDonough</surname><given-names>AA</given-names></name><name><surname>Erdmann</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure</article-title><source>Circulation</source><volume>99</volume><fpage>2105</fpage><lpage>2112</lpage><pub-id pub-id-type="doi">10.1161/01.cir.99.16.2105</pub-id><pub-id pub-id-type="pmid">10217649</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shenthar</surname><given-names>J</given-names></name><name><surname>Deora</surname><given-names>S</given-names></name><name><surname>Rai</surname><given-names>M</given-names></name><name><surname>Nanjappa Manjunath</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Prolonged Tpeak-end and Tpeak-end/QT ratio as predictors of malignant ventricular arrhythmias in the acute phase of ST-segment elevation myocardial infarction: A prospective case-control study</article-title><source>Heart Rhythm</source><volume>12</volume><fpage>484</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2014.11.034</pub-id><pub-id pub-id-type="pmid">25557980</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>SD</given-names></name><name><surname>Zelenkofske</surname><given-names>S</given-names></name><name><surname>McMurray</surname><given-names>JJV</given-names></name><name><surname>Finn</surname><given-names>PV</given-names></name><name><surname>Velazquez</surname><given-names>E</given-names></name><name><surname>Ertl</surname><given-names>G</given-names></name><name><surname>Harsanyi</surname><given-names>A</given-names></name><name><surname>Rouleau</surname><given-names>JL</given-names></name><name><surname>Maggioni</surname><given-names>A</given-names></name><name><surname>Kober</surname><given-names>L</given-names></name><name><surname>White</surname><given-names>H</given-names></name><name><surname>Van de Werf</surname><given-names>F</given-names></name><name><surname>Pieper</surname><given-names>K</given-names></name><name><surname>Califf</surname><given-names>RM</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name><collab>Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators</collab></person-group><year iso-8601-date="2005">2005</year><article-title>Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both</article-title><source>The New England Journal of Medicine</source><volume>352</volume><fpage>2581</fpage><lpage>2588</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa043938</pub-id><pub-id pub-id-type="pmid">15972864</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spargias</surname><given-names>KS</given-names></name><name><surname>Lindsay</surname><given-names>SJ</given-names></name><name><surname>Kawar</surname><given-names>GI</given-names></name><name><surname>Greenwood</surname><given-names>DC</given-names></name><name><surname>Cowan</surname><given-names>JC</given-names></name><name><surname>Ball</surname><given-names>SG</given-names></name><name><surname>Hall</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure</article-title><source>European Heart Journal</source><volume>20</volume><fpage>1158</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1053/euhj.1998.1445</pub-id><pub-id pub-id-type="pmid">10448024</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spear</surname><given-names>JF</given-names></name><name><surname>Michelson</surname><given-names>EL</given-names></name><name><surname>Moore</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Cellular electrophysiologic characteristics of chronically infarcted myocardium in dogs susceptible to sustained ventricular tachyarrhythmias</article-title><source>Journal of the American College of Cardiology</source><volume>1</volume><fpage>1099</fpage><lpage>1110</lpage><pub-id pub-id-type="doi">10.1016/s0735-1097(83)80112-0</pub-id><pub-id pub-id-type="pmid">6833648</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>NT</given-names></name><name><surname>Orini</surname><given-names>M</given-names></name><name><surname>Providencia</surname><given-names>R</given-names></name><name><surname>Dhinoja</surname><given-names>MB</given-names></name><name><surname>Lowe</surname><given-names>MD</given-names></name><name><surname>Ahsan</surname><given-names>SY</given-names></name><name><surname>Chow</surname><given-names>AW</given-names></name><name><surname>Hunter</surname><given-names>RJ</given-names></name><name><surname>Schilling</surname><given-names>RJ</given-names></name><name><surname>Taggart</surname><given-names>P</given-names></name><name><surname>Lambiase</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Prolonged action potential duration and dynamic transmural action potential duration heterogeneity underlie vulnerability to ventricular tachycardia in patients undergoing ventricular tachycardia ablation</article-title><source>Europace</source><volume>21</volume><fpage>616</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1093/europace/euy260</pub-id><pub-id pub-id-type="pmid">30500897</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>PH</given-names></name><name><surname>Raabe</surname><given-names>DS</given-names></name><name><surname>Jaffe</surname><given-names>AS</given-names></name><name><surname>Gustafson</surname><given-names>N</given-names></name><name><surname>Muller</surname><given-names>JE</given-names></name><name><surname>Turi</surname><given-names>ZG</given-names></name><name><surname>Rutherford</surname><given-names>JD</given-names></name><name><surname>Poole</surname><given-names>WK</given-names></name><name><surname>Passamani</surname><given-names>E</given-names></name><name><surname>Willerson</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location</article-title><source>Journal of the American College of Cardiology</source><volume>11</volume><fpage>453</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1016/0735-1097(88)91517-3</pub-id><pub-id pub-id-type="pmid">3278032</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streeter</surname><given-names>DD</given-names></name><name><surname>Vaishnav</surname><given-names>RN</given-names></name><name><surname>Patel</surname><given-names>DJ</given-names></name><name><surname>Spotnitz</surname><given-names>HM</given-names></name><name><surname>Ross</surname><given-names>J</given-names></name><name><surname>Sonnenblick</surname><given-names>EH</given-names></name></person-group><year iso-8601-date="1970">1970</year><article-title>Stress distribution in the canine left ventricle during diastole and systole</article-title><source>Biophysical Journal</source><volume>10</volume><fpage>345</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(70)86306-8</pub-id><pub-id pub-id-type="pmid">5436883</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Stander</surname><given-names>N</given-names></name><name><surname>Jhun</surname><given-names>CS</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>GY</given-names></name><name><surname>Saeed</surname><given-names>M</given-names></name><name><surname>Wallace</surname><given-names>AW</given-names></name><name><surname>Tseng</surname><given-names>EE</given-names></name><name><surname>Baker</surname><given-names>AJ</given-names></name><name><surname>Saloner</surname><given-names>D</given-names></name><name><surname>Einstein</surname><given-names>DR</given-names></name><name><surname>Ratcliffe</surname><given-names>MB</given-names></name><name><surname>Guccione</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A computationally efficient formal optimization of regional myocardial contractility in A sheep with left ventricular aneurysm</article-title><source>Journal of Biomechanical Engineering</source><volume>131</volume><elocation-id>111001</elocation-id><pub-id pub-id-type="doi">10.1115/1.3148464</pub-id><pub-id pub-id-type="pmid">20016753</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tikkanen</surname><given-names>JT</given-names></name><name><surname>Kenttä</surname><given-names>T</given-names></name><name><surname>Porthan</surname><given-names>K</given-names></name><name><surname>Huikuri</surname><given-names>HV</given-names></name><name><surname>Junttila</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Electrocardiographic T wave abnormalities and the risk of sudden cardiac death: the finnish perspective</article-title><source>Annals of Noninvasive Electrocardiology</source><volume>20</volume><fpage>526</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1111/anec.12310</pub-id><pub-id pub-id-type="pmid">26391699</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomek</surname><given-names>J</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name><name><surname>Bub</surname><given-names>G</given-names></name><name><surname>Heijman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>β-Adrenergic receptor stimulation inhibits proarrhythmic alternans in postinfarction border zone cardiomyocytes: a computational analysis</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>313</volume><fpage>H338</fpage><lpage>H353</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00094.2017</pub-id><pub-id pub-id-type="pmid">28550171</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomek</surname><given-names>J</given-names></name><name><surname>Tomková</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Bub</surname><given-names>G</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modulation of cardiac alternans by altered sarcoplasmic reticulum calcium release: a simulation study</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>1306</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.01306</pub-id><pub-id pub-id-type="pmid">30283355</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomek</surname><given-names>J</given-names></name><name><surname>Bueno-Orovio</surname><given-names>A</given-names></name><name><surname>Passini</surname><given-names>E</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Minchole</surname><given-names>A</given-names></name><name><surname>Britton</surname><given-names>O</given-names></name><name><surname>Bartolucci</surname><given-names>C</given-names></name><name><surname>Severi</surname><given-names>S</given-names></name><name><surname>Shrier</surname><given-names>A</given-names></name><name><surname>Virag</surname><given-names>L</given-names></name><name><surname>Varro</surname><given-names>A</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block</article-title><source>eLife</source><volume>8</volume><elocation-id>e48890</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.48890</pub-id><pub-id pub-id-type="pmid">31868580</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ursell</surname><given-names>PC</given-names></name><name><surname>Gardner</surname><given-names>PI</given-names></name><name><surname>Albala</surname><given-names>A</given-names></name><name><surname>Fenoglio</surname><given-names>JJ</given-names></name><name><surname>Wit</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing</article-title><source>Circulation Research</source><volume>56</volume><fpage>436</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1161/01.res.56.3.436</pub-id><pub-id pub-id-type="pmid">3971515</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uslu</surname><given-names>H</given-names></name><name><surname>Cakmak</surname><given-names>N</given-names></name><name><surname>Erkan</surname><given-names>ME</given-names></name><name><surname>Hacımahmutoğlu</surname><given-names>S</given-names></name><name><surname>Yılmaz</surname><given-names>S</given-names></name><name><surname>Ozkan</surname><given-names>S</given-names></name><name><surname>Sayar</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Left ventricular remodeling assessment in patients with anterior acute myocardial infarction treated with successful primary percutaneous coronary intervention: an observational study</article-title><source>Anadolu Kardiyoloji Dergisi</source><volume>13</volume><fpage>675</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.5152/akd.2013.192</pub-id><pub-id pub-id-type="pmid">23996802</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaduganathan</surname><given-names>M</given-names></name><name><surname>Claggett</surname><given-names>BL</given-names></name><name><surname>Chatterjee</surname><given-names>NA</given-names></name><name><surname>Anand</surname><given-names>IS</given-names></name><name><surname>Sweitzer</surname><given-names>NK</given-names></name><name><surname>Fang</surname><given-names>JC</given-names></name><name><surname>O’Meara</surname><given-names>E</given-names></name><name><surname>Shah</surname><given-names>SJ</given-names></name><name><surname>Hegde</surname><given-names>SM</given-names></name><name><surname>Desai</surname><given-names>AS</given-names></name><name><surname>Lewis</surname><given-names>EF</given-names></name><name><surname>Rouleau</surname><given-names>J</given-names></name><name><surname>Pitt</surname><given-names>B</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Solomon</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Sudden death in heart failure with preserved ejection fraction: a competing risks analysis from the TOPCAT trial</article-title><source>JACC. Heart Failure</source><volume>6</volume><fpage>653</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/j.jchf.2018.02.014</pub-id><pub-id pub-id-type="pmid">29501806</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdivia</surname><given-names>CR</given-names></name><name><surname>Chu</surname><given-names>WW</given-names></name><name><surname>Pu</surname><given-names>J</given-names></name><name><surname>Foell</surname><given-names>JD</given-names></name><name><surname>Haworth</surname><given-names>RA</given-names></name><name><surname>Wolff</surname><given-names>MR</given-names></name><name><surname>Kamp</surname><given-names>TJ</given-names></name><name><surname>Makielski</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Increased late sodium current in myocytes from a canine heart failure model and from failing human heart</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>38</volume><fpage>475</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2004.12.012</pub-id><pub-id pub-id-type="pmid">15733907</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Leuven</surname><given-names>SL</given-names></name><name><surname>Waldman</surname><given-names>LK</given-names></name><name><surname>McCulloch</surname><given-names>AD</given-names></name><name><surname>Covell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Gradients of epicardial strain across the perfusion boundary during acute myocardial ischemia</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>267</volume><fpage>H2348</fpage><lpage>H2362</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.1994.267.6.H2348</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Veelen</surname><given-names>A</given-names></name><name><surname>Elias</surname><given-names>J</given-names></name><name><surname>van Dongen</surname><given-names>IM</given-names></name><name><surname>Hoebers</surname><given-names>LPC</given-names></name><name><surname>Claessen</surname><given-names>BEPM</given-names></name><name><surname>Ramunddal</surname><given-names>T</given-names></name><name><surname>Laanmets</surname><given-names>P</given-names></name><name><surname>Eriksen</surname><given-names>E</given-names></name><name><surname>van der Schaaf</surname><given-names>RJ</given-names></name><name><surname>Nijveldt</surname><given-names>R</given-names></name><name><surname>Henriques</surname><given-names>JPS</given-names></name><name><surname>Hirsch</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Recovery of right ventricular function and strain in patients with ST-segment elevation myocardial infarction and concurrent chronic total occlusion</article-title><source>The International Journal of Cardiovascular Imaging</source><volume>38</volume><fpage>631</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1007/s10554-021-02423-9</pub-id><pub-id pub-id-type="pmid">34554368</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaseghi</surname><given-names>M</given-names></name><name><surname>Salavatian</surname><given-names>S</given-names></name><name><surname>Rajendran</surname><given-names>PS</given-names></name><name><surname>Yagishita</surname><given-names>D</given-names></name><name><surname>Woodward</surname><given-names>WR</given-names></name><name><surname>Hamon</surname><given-names>D</given-names></name><name><surname>Yamakawa</surname><given-names>K</given-names></name><name><surname>Irie</surname><given-names>T</given-names></name><name><surname>Habecker</surname><given-names>BA</given-names></name><name><surname>Shivkumar</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Parasympathetic dysfunction and antiarrhythmic effect of vagal nerve stimulation following myocardial infarction</article-title><source>JCI Insight</source><volume>2</volume><elocation-id>e86715</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.86715</pub-id><pub-id pub-id-type="pmid">28814663</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vazquez</surname><given-names>R</given-names></name><name><surname>Bayes-Genis</surname><given-names>A</given-names></name><name><surname>Cygankiewicz</surname><given-names>I</given-names></name><name><surname>Pascual-Figal</surname><given-names>D</given-names></name><name><surname>Grigorian-Shamagian</surname><given-names>L</given-names></name><name><surname>Pavon</surname><given-names>R</given-names></name><name><surname>Gonzalez-Juanatey</surname><given-names>JR</given-names></name><name><surname>Cubero</surname><given-names>JM</given-names></name><name><surname>Pastor</surname><given-names>L</given-names></name><name><surname>Ordonez-Llanos</surname><given-names>J</given-names></name><name><surname>Cinca</surname><given-names>J</given-names></name><name><surname>de Luna</surname><given-names>AB</given-names></name><collab>on behalf of the MUSIC Investigators</collab></person-group><year iso-8601-date="2009">2009</year><article-title>The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure</article-title><source>European Heart Journal</source><volume>30</volume><fpage>1088</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehp032</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waks</surname><given-names>JW</given-names></name><name><surname>Sitlani</surname><given-names>CM</given-names></name><name><surname>Soliman</surname><given-names>EZ</given-names></name><name><surname>Kabir</surname><given-names>M</given-names></name><name><surname>Ghafoori</surname><given-names>E</given-names></name><name><surname>Biggs</surname><given-names>ML</given-names></name><name><surname>Henrikson</surname><given-names>CA</given-names></name><name><surname>Sotoodehnia</surname><given-names>N</given-names></name><name><surname>Biering-Sørensen</surname><given-names>T</given-names></name><name><surname>Agarwal</surname><given-names>SK</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Post</surname><given-names>WS</given-names></name><name><surname>Solomon</surname><given-names>SD</given-names></name><name><surname>Buxton</surname><given-names>AE</given-names></name><name><surname>Josephson</surname><given-names>ME</given-names></name><name><surname>Tereshchenko</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Global electric heterogeneity risk score for prediction of sudden cardiac death in the general population</article-title><source>Circulation</source><volume>133</volume><fpage>2222</fpage><lpage>2234</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.021306</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ZJ</given-names></name><name><surname>Santiago</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Margara</surname><given-names>F</given-names></name><name><surname>Levrero-Florencio</surname><given-names>F</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>C</given-names></name><name><surname>Dall’Armellina</surname><given-names>E</given-names></name><name><surname>Vazquez</surname><given-names>M</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Human biventricular electromechanical simulations on the progression of electrocardiographic and mechanical abnormalities in post-myocardial infarction</article-title><source>Europace</source><volume>23</volume><fpage>i143</fpage><lpage>i152</lpage><pub-id pub-id-type="doi">10.1093/europace/euaa405</pub-id><pub-id pub-id-type="pmid">33751088</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Post_MI_postprocessing</data-title><version designator="swh:1:rev:48c36cc0c5a8e853a4d97b18309493957e608091">swh:1:rev:48c36cc0c5a8e853a4d97b18309493957e608091</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:f27d72d390a8cb78fa43af16dbf2bad0f0f9d553;origin=https://github.com/jennyhelyanwe/post_MI_postprocessing;visit=swh:1:snp:186a3806b6eb2061558f5264a47b071c2be0e794;anchor=swh:1:rev:48c36cc0c5a8e853a4d97b18309493957e608091">https://archive.softwareheritage.org/swh:1:dir:f27d72d390a8cb78fa43af16dbf2bad0f0f9d553;origin=https://github.com/jennyhelyanwe/post_MI_postprocessing;visit=swh:1:snp:186a3806b6eb2061558f5264a47b071c2be0e794;anchor=swh:1:rev:48c36cc0c5a8e853a4d97b18309493957e608091</ext-link></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>JA</given-names></name><name><surname>Hussain</surname><given-names>W</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Peters</surname><given-names>NS</given-names></name><name><surname>Boyden</surname><given-names>PA</given-names></name><name><surname>Wit</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts</article-title><source>Circulation Research</source><volume>92</volume><fpage>437</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000059301.81035.06</pub-id><pub-id pub-id-type="pmid">12600896</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yerra</surname><given-names>L</given-names></name><name><surname>Anavekar</surname><given-names>N</given-names></name><name><surname>Skali</surname><given-names>H</given-names></name><name><surname>Zelenkofske</surname><given-names>S</given-names></name><name><surname>Velazquez</surname><given-names>E</given-names></name><name><surname>McMurray</surname><given-names>J</given-names></name><name><surname>Pfeffer</surname><given-names>M</given-names></name><name><surname>Solomon</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial</article-title><source>Heart Rhythm</source><volume>3</volume><fpage>313</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2005.11.024</pub-id><pub-id pub-id-type="pmid">16500304</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XD</given-names></name><name><surname>Coulibaly</surname><given-names>ZA</given-names></name><name><surname>Chen</surname><given-names>WC</given-names></name><name><surname>Ledford</surname><given-names>HA</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Sirish</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>G</given-names></name><name><surname>Jian</surname><given-names>Z</given-names></name><name><surname>Chuang</surname><given-names>F</given-names></name><name><surname>Brust-Mascher</surname><given-names>I</given-names></name><name><surname>Yamoah</surname><given-names>EN</given-names></name><name><surname>Chen-Izu</surname><given-names>Y</given-names></name><name><surname>Izu</surname><given-names>LT</given-names></name><name><surname>Chiamvimonvat</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Coupling of SK channels, L-type Ca<sup>2+</sup> channels, and ryanodine receptors in cardiomyocytes</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>4670</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-22843-3</pub-id><pub-id pub-id-type="pmid">29549309</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Bueno-Orovio</surname><given-names>A</given-names></name><name><surname>Orini</surname><given-names>M</given-names></name><name><surname>Hanson</surname><given-names>B</given-names></name><name><surname>Hayward</surname><given-names>M</given-names></name><name><surname>Taggart</surname><given-names>P</given-names></name><name><surname>Lambiase</surname><given-names>PD</given-names></name><name><surname>Burrage</surname><given-names>K</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In vivo and in silico investigation into mechanisms of frequency dependence of repolarization alternans in human ventricular cardiomyocytes</article-title><source>Circulation Research</source><volume>118</volume><fpage>266</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.307836</pub-id><pub-id pub-id-type="pmid">26602864</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Passini</surname><given-names>E</given-names></name><name><surname>Bueno-Orovio</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Vargas</surname><given-names>HM</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Blinded <italic>In Silico</italic> drug trial reveals the minimum set of ion channels for torsades de pointes risk assessment</article-title><source>Frontiers in Pharmacology</source><volume>10</volume><elocation-id>1643</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2019.01643</pub-id><pub-id pub-id-type="pmid">32082155</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zicha</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Stafford</surname><given-names>S</given-names></name><name><surname>Cha</surname><given-names>TJ</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Varro</surname><given-names>A</given-names></name><name><surname>Nattel</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts</article-title><source>The Journal of Physiology</source><volume>561</volume><fpage>735</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2004.075861</pub-id><pub-id pub-id-type="pmid">15498806</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><p>As the calcium activated potassium current (I<sub>KCa</sub>) were reported to be enhanced in heart failure, a new formulation of the I<sub>KCa</sub> was added into the ToR-ORd model based on published data (<xref ref-type="bibr" rid="bib16">Chang et al., 2013</xref>) to obtain an updated model named ToR-ORd-SK model. Due to the coupling of I<sub>KCa</sub> channels and the L-type calcium channels (<xref ref-type="bibr" rid="bib98">Zhang et al., 2018</xref>), the ratio of I<sub>KCa</sub> channels in the subspace was set to be the same as the L-type calcium channels in the model. The conductance of I<sub>KCa</sub> (gkca) was chosen to get a similar current density ratio between I<sub>KCa</sub> and I<sub>Kr</sub> as observed in minipig myocytes (<xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref>). The conductance of the background potassium current was scaled to 90% to adapt to the implementation of I<sub>KCa</sub>. The formulation of this new I<sub>KCa</sub> current is the following:</p><p>gkca = 0.003;</p><p>ikcan = 3.5;</p><p>kdikca = 6.05e-04</p><p>FractionI<sub>KCa</sub>ss = 0.8;</p><p>FractionI<sub>KCa</sub>i = 1-FractionI<sub>KCa</sub>ss;</p><p>I<sub>KCa</sub>_ss = <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>K</mml:mi><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:mi>C</mml:mi><mml:msubsup><mml:mi>a</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:msubsup><mml:mi>a</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mi>k</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>k</mml:mi><mml:mi>c</mml:mi><mml:msup><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>V</mml:mi><mml:mi>m</mml:mi><mml:mo>−</mml:mo><mml:mi>E</mml:mi><mml:mi>K</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula></p><p>I<sub>KCa</sub>_i = <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>K</mml:mi><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:mi>C</mml:mi><mml:msubsup><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:msubsup><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mi>k</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>k</mml:mi><mml:mi>c</mml:mi><mml:msup><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>V</mml:mi><mml:mi>m</mml:mi><mml:mo>−</mml:mo><mml:mi>E</mml:mi><mml:mi>K</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula></p><p>I<sub>KCa</sub> = I<sub>KCa</sub>_ss +I<sub>KCa</sub>_i;</p><fig id="app1fig1" position="float"><label>Appendix 1—figure 1.</label><caption><title>The ToR-ORd-SK model produced similar action potential (AP) traces as published human experimental data (<xref ref-type="bibr" rid="bib59">O’Hara et al., 2011</xref>).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig1-v1.tif"/></fig><p>An initial population of 500 human endocardial ventricular cell models was constructed based on the ToR-ORd-SK model by varying the conductances or magnitudes of I<sub>Na</sub>, I<sub>NaL</sub>, I<sub>to</sub>, I<sub>CaL</sub>, I<sub>Kr</sub>, I<sub>Ks</sub>, I<sub>K1</sub>, I<sub>NaCa</sub>, I<sub>NaK</sub>, J<sub>rel</sub>, and J<sub>up</sub> by up to ±50% using Latin Hypercube Sampling, and 253 models were accepted after pacing the models at 1 Hz and calibrated with human experimental data range in <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>. The accepted endocardial parameter scaling factors were applied to the epicardial and midmyocardial baseline models to generate the corresponding epicardial/midmyocardial population of models, and eight models were discarded since they generate early afterdepolarizations (EADs) at 1 Hz in midmyocardial cells.</p><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>Experimental ranges of AP and calcium transient (CaT) biomarkers used to calibrate the normal zone (NZ) endocardial population of models at a pacing cycle length (CL) of 1000ms based on human cardiomyocyte experiments (<xref ref-type="bibr" rid="bib18">Coppini et al., 2013</xref>; <xref ref-type="bibr" rid="bib12">Britton et al., 2017</xref>).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Biomakers at 1 Hz</th><th align="left" valign="bottom">minimum</th><th align="left" valign="bottom">maximum</th></tr></thead><tbody><tr><td align="left" valign="bottom">Vmax (mV)</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">55</td></tr><tr><td align="left" valign="bottom">RMP (mV)</td><td align="left" valign="bottom">–95</td><td align="left" valign="bottom">–80</td></tr><tr><td align="left" valign="bottom">dvdtmax (mV/ms)</td><td align="left" valign="bottom">100</td><td align="left" valign="bottom">1000</td></tr><tr><td align="left" valign="bottom">APD90 (ms)</td><td align="left" valign="bottom">180</td><td align="left" valign="bottom">440</td></tr><tr><td align="left" valign="bottom">APD50 (ms)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">350</td></tr><tr><td align="left" valign="bottom">APD40 (ms)</td><td align="left" valign="bottom">85</td><td align="left" valign="bottom">320</td></tr><tr><td align="left" valign="bottom">APD90-APD40 (ms)</td><td align="left" valign="bottom">50</td><td align="left" valign="bottom">150</td></tr><tr><td align="left" valign="bottom">CaTD90 (ms)</td><td align="left" valign="bottom">220</td><td align="left" valign="bottom">750</td></tr><tr><td align="left" valign="bottom">CaTD90 (ms)</td><td align="left" valign="bottom">120</td><td align="left" valign="bottom">420</td></tr><tr><td align="left" valign="bottom">CaTamp (mM)</td><td align="left" valign="bottom">2e-4</td><td align="left" valign="bottom">6e-4</td></tr><tr><td align="left" valign="bottom">CaTmax(mM)</td><td align="left" valign="bottom">2e-4</td><td align="left" valign="bottom">10e-4</td></tr><tr><td align="left" valign="bottom">CaTmin (mM)</td><td align="left" valign="bottom">0</td><td align="left" valign="bottom">4e-4</td></tr></tbody></table></table-wrap><fig id="app1fig2" position="float"><label>Appendix 1—figure 2.</label><caption><title>The AP and CaT traces of the population of NZ population of models.</title><p>The blue and red traces are the initial and the accepted population, respectively. The black trace is the baseline endocardial model.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig2-v1.tif"/></fig><sec sec-type="appendix" id="s8"><title>2. Human biventricular electromechanical models and calibrated simulation parameters</title><p>The parameters to reproduce the healthy baseline and infarcted models are presented in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>; <xref ref-type="table" rid="app1table3">Appendix 1—table 3</xref>.</p><p>The governing equations are listed here, and described in more detail elsewhere (<xref ref-type="bibr" rid="bib41">Levrero-Florencio et al., 2020</xref>):<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:mi>χ</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">∂</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi mathvariant="normal">∇</mml:mi><mml:mo>⋅</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">D</mml:mi><mml:mi mathvariant="normal">∇</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="normal">V</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">I</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula><disp-formula id="equ2"><mml:math id="m2"><mml:mi mathvariant="bold-italic">D</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold-italic">f</mml:mi><mml:mo>⨂</mml:mo><mml:mi mathvariant="bold-italic">f</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mo>⨂</mml:mo><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="bold-italic">n</mml:mi><mml:mo>⨂</mml:mo><mml:mi mathvariant="bold-italic">n</mml:mi></mml:math></disp-formula></p><p>where the orthotropic diffusivity tensor <inline-formula><mml:math id="inf3"><mml:mi mathvariant="bold-italic">D</mml:mi></mml:math></inline-formula> describes different diffusivities along the fibre, sheet, and sheet normal <inline-formula><mml:math id="inf4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="bold-italic">f</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold-italic">n</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> directions (values for <inline-formula><mml:math id="inf5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> given in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>), <inline-formula><mml:math id="inf6"><mml:mi>χ</mml:mi></mml:math></inline-formula> is the surface to volume ratio of the myocardial cell, <inline-formula><mml:math id="inf7"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> the membrane capacitance, <inline-formula><mml:math id="inf8"><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> the transmembrane potential, and <inline-formula><mml:math id="inf9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> are the ionic channel currents and stimulus current, respectively.</p><p>The passive mechanical properties of the myocardium is described in the following strain energy density function <inline-formula><mml:math id="inf10"><mml:mi>ψ</mml:mi></mml:math></inline-formula> in a nearly incompressible form of the Holzapfel Ogden orthotropic model (<xref ref-type="bibr" rid="bib32">Holzapfel and Ogden, 2009</xref>):<disp-formula id="equ3"><mml:math id="m3"><mml:mi>ψ</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mi>J</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>b</mml:mi></mml:mrow></mml:mfrac><mml:mfenced separators="|"><mml:mrow><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mi>f</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mfenced separators="|"><mml:mrow><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mn>4</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mfenced separators="|"><mml:mrow><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mn>8</mml:mn><mml:mi>f</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> is the bulk modulus, and the strain invariants <inline-formula><mml:math id="inf12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mn>8</mml:mn><mml:mi>f</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> are invariants of the right Cauchy-Green strain tensor <inline-formula><mml:math id="inf13"><mml:mi mathvariant="bold-italic">C</mml:mi></mml:math></inline-formula>, as described below:<disp-formula id="equ4"><mml:math id="m4"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi mathvariant="bold-italic">C</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="bold-italic">f</mml:mi><mml:mo>⋅</mml:mo><mml:mi mathvariant="bold-italic">C</mml:mi><mml:mi mathvariant="bold-italic">f</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mo>⋅</mml:mo><mml:mi mathvariant="bold-italic">C</mml:mi><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mn>8</mml:mn><mml:mi>f</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">f</mml:mi><mml:mo>⋅</mml:mo><mml:mi mathvariant="bold-italic">C</mml:mi><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mo>⋅</mml:mo><mml:mi mathvariant="bold-italic">C</mml:mi><mml:mi mathvariant="bold-italic">f</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>And the values for ‘a’ and ‘b’ coefficients are given in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>.</p><p>The active stress <inline-formula><mml:math id="inf14"><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> produced through calcium-dependent cross-bridge cycling is calculated as:<disp-formula id="equ5"><mml:math id="m5"><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mi>h</mml:mi><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mfenced separators="|"><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mi>S</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mi>w</mml:mi></mml:mrow></mml:msub><mml:mi>W</mml:mi></mml:mrow></mml:mfenced></mml:math></disp-formula></p><p>where a scaling factor <inline-formula><mml:math id="inf15"><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is applied in the biventricular model to achieve a physiological left ventricular ejection fraction in control, and is given in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>, <inline-formula><mml:math id="inf16"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> is a function of the fibre stretch ratio that describes the length-dependence of force production, <inline-formula><mml:math id="inf17"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>ζ</mml:mi><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mrow><mml:mi>w</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> are state variables describing distortion-decay, <inline-formula><mml:math id="inf18"><mml:mi>W</mml:mi><mml:mo>,</mml:mo><mml:mi>S</mml:mi></mml:math></inline-formula> are the proportion of cross-bridges in the pre- or post-powerstroke states, respectively, and <inline-formula><mml:math id="inf19"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is a steady-state duty ratio of cross-bridge cycling. Details of this can be found elsewhere (<xref ref-type="bibr" rid="bib40">Land et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Levrero-Florencio et al., 2020</xref>).</p><table-wrap id="app1table2" position="float"><label>Appendix 1—table 2.</label><caption><title>Calibrated electromechanical parameters for healthy baseline model, and modified parameters for post myocardial infarction models.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Name</th><th align="left" valign="bottom">Parameter</th><th align="left" valign="bottom">Value</th><th align="left" valign="bottom">Unit</th></tr></thead><tbody><tr><td align="left" valign="bottom" colspan="4">Healthy baseline electromechanical parameters</td></tr><tr><td align="left" valign="bottom" rowspan="3">diffusivity in fibre, sheet and sheet normal directions</td><td align="left" valign="bottom">d<sub>f</sub></td><td align="left" valign="bottom">0.00335</td><td align="left" valign="bottom">cm/mS</td></tr><tr><td align="left" valign="bottom">d<sub>s</sub></td><td align="left" valign="bottom">0.000723</td><td align="left" valign="bottom">cm/mS</td></tr><tr><td align="left" valign="bottom">d<sub>n</sub></td><td align="left" valign="bottom">0.000153</td><td align="left" valign="bottom">cm/mS</td></tr><tr><td align="left" valign="bottom">active mechanics: scaling parameter for active tension</td><td align="left" valign="bottom">T<sub>scale</sub></td><td align="left" valign="bottom">12</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">bulk modulus</td><td align="left" valign="bottom">K</td><td align="left" valign="bottom">12185000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom" rowspan="8">passive mechanics: exponential term in isotropic matrix, fibre, sheet and normal direction</td><td align="left" valign="bottom">a</td><td align="left" valign="bottom">20000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">b</td><td align="left" valign="bottom">9.242</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">a<sub>f</sub></td><td align="left" valign="bottom">30000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">b<sub>f</sub></td><td align="left" valign="bottom">15.972</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">a<sub>s</sub></td><td align="left" valign="bottom">20000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">b<sub>s</sub></td><td align="left" valign="bottom">10.446</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">a<sub>fs</sub></td><td align="left" valign="bottom">10000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">b<sub>fs</sub></td><td align="left" valign="bottom">11.602</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom" colspan="4">Scar and border zone diffusion parameters</td></tr><tr><td align="left" valign="bottom" rowspan="3">diffusivity in fibre, sheet and sheet normal directions</td><td align="left" valign="bottom">d<sub>f</sub></td><td align="left" valign="bottom">0.0012</td><td align="left" valign="bottom">cm/mS</td></tr><tr><td align="left" valign="bottom">d<sub>s</sub></td><td align="left" valign="bottom">0.00023</td><td align="left" valign="bottom">cm/mS</td></tr><tr><td align="left" valign="bottom">d<sub>n</sub></td><td align="left" valign="bottom">0.000003</td><td align="left" valign="bottom">cm/mS</td></tr><tr><td align="left" valign="bottom" colspan="4">Scar mechanical parameters</td></tr><tr><td align="left" valign="bottom">active mechanics: scaling parameter for active tension</td><td align="left" valign="bottom">T<sub>scale</sub></td><td align="left" valign="bottom">0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">bulk modulus</td><td align="left" valign="bottom">K</td><td align="left" valign="bottom">12185000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom" rowspan="8">passive mechanics: exponential term in isotropic matrix, fibre, sheet and normal direction</td><td align="left" valign="bottom">a</td><td align="left" valign="bottom">200000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">b</td><td align="left" valign="bottom">9.242</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">a<sub>f</sub></td><td align="left" valign="bottom">300000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">b<sub>f</sub></td><td align="left" valign="bottom">15.972</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">a<sub>s</sub></td><td align="left" valign="bottom">200000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">b<sub>s</sub></td><td align="left" valign="bottom">10.446</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">a<sub>fs</sub></td><td align="left" valign="bottom">100000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">b<sub>fs</sub></td><td align="left" valign="bottom">11.602</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><p>The pressure boundary condition on the left and right endocardial surfaces are controlled using the following set of piece-wise functions:</p><p>(1) <italic>Initialisation</italic>. Both ventricles were firstly inflated to an initial pressure <inline-formula><mml:math id="inf20"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> to reach a loaded resting endocardial volume, <inline-formula><mml:math id="inf21"><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>.</p><p>(2) <italic>Active inflation</italic>. The pressure in both ventricular chambers is linearly increased to the end diastolic pressure <inline-formula><mml:math id="inf22"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> over duration of t<sub>diastole</sub>. This phase mimics the atrial contraction phase of diastolic filling and it is considered the first phase in the cardiac cycle because it follows directly from sinoatrial stimulus.</p><p>(3) <italic>Isovolumetric contraction</italic>. Endocardial activation marks the beginning of this phase where stimulated myocytes begin generating active tension and the endocardial pressure (P) is allowed to increase such that the chamber volume (V) is kept approximately constant through the use of penalty terms:<disp-formula id="equ6"><mml:math id="m6"><mml:mi>d</mml:mi><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mi>d</mml:mi><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>∙</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf23"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are the penalty terms for volume difference and volume rate, respectively. Furthermore, while <inline-formula><mml:math id="inf25"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is a user defined constant, <inline-formula><mml:math id="inf26"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is defined as: <inline-formula><mml:math id="inf27"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>V</mml:mi></mml:mrow></mml:mfrac></mml:math></inline-formula></p><p>(4) Ejection. This phase is triggered when the ventricular pressure exceeds the arterial pressure, <inline-formula><mml:math id="inf28"><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>. A two-element Windkessel model is used to model the blood pressure of both the systemic and pulmonary circulation systems during ejection: <inline-formula><mml:math id="inf29"><mml:mi>C</mml:mi><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:math></inline-formula> where C and R are the compliance and impedance of the circulation systems.</p><p>(5) <italic>Isovolumetric relaxation</italic>. This phase is triggered by the reversal of ventricular volume change, i.e. <inline-formula><mml:math id="inf30"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>. Symmetrically with phase (2), here the pressure is allowed to decrease while the volume is kept constant.</p><p>(6) <italic>Passive filling</italic>. This phase is triggered when ventricular pressure is lower than a threshold pressure <inline-formula><mml:math id="inf31"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. During this phase the myocyte active tension is allowed to return to resting state and the volume is allowed to return to the initialised value <inline-formula><mml:math id="inf32"><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> through: <inline-formula><mml:math id="inf33"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>d</mml:mi><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>V</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mo>⋅</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula></p><p>where ventricular volumes were calculated at each time step using the divergence theorem (<xref ref-type="bibr" rid="bib41">Levrero-Florencio et al., 2020</xref>). Here, both the <inline-formula><mml:math id="inf34"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf35"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> parameters are user defined and have been selected to allow full recovery of the initialised volume before the end of the cycle length.</p><table-wrap id="app1table3" position="float"><label>Appendix 1—table 3.</label><caption><title>Parameters for boundary conditions and phase control at resting heart rate and fast pacing (in brackets).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Name</th><th align="left" valign="bottom">Parameter</th><th align="left" valign="bottom">LV</th><th align="left" valign="bottom">RV</th><th align="left" valign="bottom">Unit</th></tr></thead><tbody><tr><td align="left" valign="bottom">Pericardial stiffness</td><td align="left" valign="bottom">K<sub>epi</sub></td><td align="left" valign="bottom" colspan="2">10000</td><td align="left" valign="bottom">Ba cm<sup>–1</sup></td></tr><tr><td align="left" valign="bottom">Time to initial pressure</td><td align="left" valign="bottom"><bold>t</bold><sub>0</sub></td><td align="left" valign="bottom">0.02</td><td align="left" valign="bottom">0.02</td><td align="left" valign="bottom">s</td></tr><tr><td align="left" valign="bottom">Initial pressure</td><td align="left" valign="bottom">P<sub>0</sub></td><td align="left" valign="bottom">5000</td><td align="left" valign="bottom">5000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">Duration of passive diastolic filling</td><td align="left" valign="bottom">t<sub>diastole</sub></td><td align="left" valign="bottom">0.08 (0.03)</td><td align="left" valign="bottom">0.08 (0.03)</td><td align="left" valign="bottom">s</td></tr><tr><td align="left" valign="bottom">Pressure at end of diastole</td><td align="left" valign="bottom">P<sub>endd</sub></td><td align="left" valign="bottom">15000</td><td align="left" valign="bottom">15000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">Arterial compliance</td><td align="left" valign="bottom">C</td><td align="left" valign="bottom">0.00055908</td><td align="left" valign="bottom">0.00055908</td><td align="left" valign="bottom">cm<sup>3</sup> Ba<sup>−1</sup></td></tr><tr><td align="left" valign="bottom">Arterial resistance</td><td align="left" valign="bottom">R</td><td align="left" valign="bottom">250</td><td align="left" valign="bottom">100</td><td align="left" valign="bottom">Ba s cm<sup>−3</sup></td></tr><tr><td align="left" valign="bottom">Aortic pressure</td><td align="left" valign="bottom">P<sub>art0</sub></td><td align="left" valign="bottom">90000</td><td align="left" valign="bottom">20000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">Pressure at end of isovolumetric relaxation</td><td align="left" valign="bottom">P<sub>post</sub></td><td align="left" valign="bottom">10000</td><td align="left" valign="bottom">10000</td><td align="left" valign="bottom">Ba</td></tr><tr><td align="left" valign="bottom">Penalty parameters for isovolumetric contraction</td><td align="left" valign="bottom">C<sub>v</sub></td><td align="left" valign="bottom">1</td><td align="left" valign="bottom">1</td><td align="left" valign="bottom">cm<sup>3</sup> s<sup>–1</sup> Ba<sup>–1</sup></td></tr><tr><td align="left" valign="bottom">Penalty parameters for isovolumetric relaxation</td><td align="left" valign="bottom">C<sub>v</sub></td><td align="left" valign="bottom">0.2</td><td align="left" valign="bottom">0.2</td><td align="left" valign="bottom">cm<sup>3</sup> s<sup>–1</sup> Ba<sup>–1</sup></td></tr><tr><td align="left" valign="bottom">Penalty parameters for passive filling</td><td align="left" valign="bottom">C<sub>p</sub>, C<sub>v</sub></td><td align="left" valign="bottom">0.1,0.3</td><td align="left" valign="bottom">0.1,0.3</td><td align="left" valign="bottom">cm<sup>3</sup> Ba<sup>–1</sup>, cm<sup>3</sup> s<sup>–1</sup> Ba<sup>–1</sup></td></tr></tbody></table></table-wrap></sec><sec sec-type="appendix" id="s9"><title>3. ECG simulation and biomarker calculation</title><p>Simulated ECGs were evaluated at prescribed electrode locations on the torso surface using the pseudo-ECG method (<xref ref-type="bibr" rid="bib56">Mincholé et al., 2019</xref>), assuming the torso is an infinite volume conductor. The signals are normalised in the precordial leads according to the maximum amplitude, and they are then normalised separately for the limb leads. This addresses the limitation of this method in not being able to faithfully representing absolute amplitudes (<xref ref-type="bibr" rid="bib58">Ogiermann et al., 2021</xref>). Only the precordial leads were evaluated because the biomarkers calculated for these leads were the most reliable.</p><p>ECG biomarkers as listed in <xref ref-type="table" rid="app1table8">Appendix 1—table 8</xref> were evaluated using a Python code as follows:</p><list list-type="order"><list-item><p>Separate each beat using the pacing R-to-R interval.</p></list-item><list-item><p>Resample the signal to 1000 Hz.</p></list-item><list-item><p>For each beat, use the voltage at end of each beat to offset the signal.</p></list-item><list-item><p>Evaluate the first and second order derivative of the voltage signal, apply filter on the derivatives using python package scipy.signal.lfilter with filtering parameters tuned manually to achieve best results for steps (4), (5) and (6). Normalize the absolute value of the filtered signal using the maximum absolute value.</p></list-item><list-item><p>Identify beginning of QRS by searching from the beginning of signal and finding the first time at which the first derivative becomes higher than the threshold 0.01*max(V)/30.</p></list-item><list-item><p>Identify the end of QRS manually.</p></list-item><list-item><p>Identify the end of T wave by searching from the end of signal and finding the first time point at which the first derivative becomes higher than the threshold 0.01*max(V)/30.</p></list-item><list-item><p>Isolate the signal segment from the end of QRS to the end of T wave and evaluate the peak absolute value to find T-wave peak and identify its timing.</p></list-item><list-item><p>Isolate the signal segment from the end of QRS to the peak of T wave. Evaluate mean dV using a window width of 3, then, beginning at the end of the QRS, the onset of T wave is identified as the time step at which the second derivative of voltage first becomes larger than 0.12*max(V)/30.</p></list-item><list-item><p>Evaluate the required biomarkers using the landmark points identified.</p></list-item></list><p>An example of the output of this delineation method is as below, showing QRS duration, QT duration, and T-wave duration (units ms) are shown after the lead name. Due to low reliability of this method in delineating the QRS complex, only the QT duration and T wave characteristics are reported in the main manuscript.</p></sec><sec sec-type="appendix" id="s10"><title>4. Border zone (BZ), remote zone (RZ) and scar ionic remodeling and their effects on AP and CaT biomarkers</title><p>For acute post-MI (within a week post-occlusion), three types of BZ remodelling (Acute BZ1-3) were considered based on previous modelling work and experimental canine data collected within 5 d post-MI (<xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib20">Decker and Rudy, 2010</xref>; <xref ref-type="bibr" rid="bib6">Arevalo et al., 2016</xref>; <xref ref-type="bibr" rid="bib82">Tomek et al., 2017</xref>). For chronic post-MI, ionic current remodelling measured from minipigs 5 mo post-MI with heart failure were used to generate Chronic BZ (affecting only the BZ) and Chronic RZ1 (also affecting the remote myocardium). Another type of remodelling, Chronic RZ2, was established based on multiple experimental data from failing human cardiomyocytes (<xref ref-type="bibr" rid="bib72">Schwinger et al., 1999</xref>; <xref ref-type="bibr" rid="bib38">Jiang et al., 2002</xref>; <xref ref-type="bibr" rid="bib42">Li et al., 2004</xref>; <xref ref-type="bibr" rid="bib101">Zicha et al., 2004</xref>; <xref ref-type="bibr" rid="bib88">Valdivia et al., 2005</xref>; <xref ref-type="bibr" rid="bib52">Maltsev et al., 2007</xref>; <xref ref-type="bibr" rid="bib33">Holzem Katherine et al., 2011</xref>; <xref ref-type="bibr" rid="bib16">Chang et al., 2013</xref>; <xref ref-type="bibr" rid="bib23">Elshrif and Cherry, 2014</xref>; <xref ref-type="bibr" rid="bib28">Gomez et al., 2014</xref>; <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Høydal et al., 2018</xref>). Furthermore, reduction of sodium current (<xref ref-type="bibr" rid="bib88">Valdivia et al., 2005</xref>) and SERCA (<xref ref-type="bibr" rid="bib38">Jiang et al., 2002</xref>), with enhanced CaMKII activity and slower calcium release (<xref ref-type="bibr" rid="bib31">Hoch et al., 1999</xref>; <xref ref-type="bibr" rid="bib51">Maier and Bers, 2007</xref>) were also implemented in Chronic BZ, RZ1 and RZ2, as observed in human failing cardiomyocytes. The remodelling in the infarcted scar region was modelled as previously published (<xref ref-type="bibr" rid="bib94">Wang et al., 2021</xref>), which generated prolonged action potential than the normal zone as observed in the activation recovery interval (ARI) data of post infarction human and pigs (<xref ref-type="bibr" rid="bib91">Vaseghi et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Srinivasan et al., 2019</xref>).</p><table-wrap id="app1table4" position="float"><label>Appendix 1—table 4.</label><caption><title>Ionic current remodelling for the acute and chronic stage BZ and RZs.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Scaling</th><th align="left" valign="bottom">Acute BZ1</th><th align="left" valign="bottom">Acute BZ2</th><th align="left" valign="bottom">Acute BZ3</th><th align="left" valign="bottom">Chronic BZ</th><th align="left" valign="bottom">Chronic RZ1</th><th align="left" valign="bottom">Chronic RZ2</th><th align="left" valign="bottom">Infarct</th></tr></thead><tbody><tr><td align="left" valign="bottom">G<sub>Na</sub></td><td align="left" valign="bottom">0.4 <xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib20">Decker and Rudy, 2010</xref></td><td align="left" valign="bottom">0.38 <xref ref-type="bibr" rid="bib6">Arevalo et al., 2016</xref></td><td align="left" valign="bottom">0.4 <xref ref-type="bibr" rid="bib82">Tomek et al., 2017</xref></td><td align="left" valign="bottom">0.43 <xref ref-type="bibr" rid="bib88">Valdivia et al., 2005</xref></td><td align="left" valign="bottom">0.43 <xref ref-type="bibr" rid="bib88">Valdivia et al., 2005</xref></td><td align="left" valign="bottom">0.43 <xref ref-type="bibr" rid="bib88">Valdivia et al., 2005</xref></td><td align="left" valign="bottom">0.4</td></tr><tr><td align="left" valign="bottom">G<sub>NaL</sub></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1.275 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom">1.413 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom">2 <xref ref-type="bibr" rid="bib88">Valdivia et al., 2005</xref>; <xref ref-type="bibr" rid="bib52">Maltsev et al., 2007</xref></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">G<sub>to</sub></td><td align="left" valign="bottom">0.1 <xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib20">Decker and Rudy, 2010</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">0 <xref ref-type="bibr" rid="bib82">Tomek et al., 2017</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.6 <xref ref-type="bibr" rid="bib8">Beuckelmann et al., 1993</xref>; <xref ref-type="bibr" rid="bib42">Li et al., 2004</xref></td><td align="left" valign="bottom">0</td></tr><tr><td align="left" valign="bottom">G<sub>CaL</sub></td><td align="left" valign="bottom">0.64 <xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib20">Decker and Rudy, 2010</xref></td><td align="left" valign="bottom">0.31 <xref ref-type="bibr" rid="bib6">Arevalo et al., 2016</xref></td><td align="left" valign="bottom">0.64 <xref ref-type="bibr" rid="bib82">Tomek et al., 2017</xref></td><td align="left" valign="bottom">0.7 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.64</td></tr><tr><td align="left" valign="bottom">G<sub>Kr</sub></td><td align="left" valign="bottom">0.7 <xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib20">Decker and Rudy, 2010</xref></td><td align="left" valign="bottom">0.3 <xref ref-type="bibr" rid="bib6">Arevalo et al., 2016</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">0.89 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom">0.87 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom">0.6 <xref ref-type="bibr" rid="bib3">Ambrosi et al., 2013</xref></td><td align="left" valign="bottom">0.7</td></tr><tr><td align="left" valign="bottom">G<sub>Ks</sub></td><td align="left" valign="bottom">0.2 <xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib20">Decker and Rudy, 2010</xref></td><td align="left" valign="bottom">0.2 <xref ref-type="bibr" rid="bib6">Arevalo et al., 2016</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.4 <xref ref-type="bibr" rid="bib42">Li et al., 2004</xref></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">G<sub>K1</sub></td><td align="left" valign="bottom">0.3 <xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib20">Decker and Rudy, 2010</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">0.6 <xref ref-type="bibr" rid="bib82">Tomek et al., 2017</xref></td><td align="left" valign="bottom">0.76 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">0.6 <xref ref-type="bibr" rid="bib8">Beuckelmann et al., 1993</xref>; <xref ref-type="bibr" rid="bib42">Li et al., 2004</xref></td><td align="left" valign="bottom">0.6</td></tr><tr><td align="left" valign="bottom">G<sub>NaK</sub></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.6 <xref ref-type="bibr" rid="bib72">Schwinger et al., 1999</xref></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">P<sub>Jup</sub></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.4 <xref ref-type="bibr" rid="bib38">Jiang et al., 2002</xref>; <xref ref-type="bibr" rid="bib34">Høydal et al., 2018</xref></td><td align="left" valign="bottom">0.4 <xref ref-type="bibr" rid="bib38">Jiang et al., 2002</xref>; <xref ref-type="bibr" rid="bib34">Høydal et al., 2018</xref></td><td align="left" valign="bottom">0.3 <xref ref-type="bibr" rid="bib38">Jiang et al., 2002</xref>; <xref ref-type="bibr" rid="bib34">Høydal et al., 2018</xref></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">G<sub>KCa</sub></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">2 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom">2 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom">3.75 <xref ref-type="bibr" rid="bib16">Chang et al., 2013</xref></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">G<sub>ClCa</sub></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1.25 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom">1.25 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom">1.25 <xref ref-type="bibr" rid="bib30">Hegyi et al., 2018</xref></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">aCaMK</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1.5 <xref ref-type="bibr" rid="bib82">Tomek et al., 2017</xref></td><td align="left" valign="bottom">1.5 <xref ref-type="bibr" rid="bib31">Hoch et al., 1999</xref>; <xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref></td><td align="left" valign="bottom">1.5 <xref ref-type="bibr" rid="bib31">Hoch et al., 1999</xref>; <xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref></td><td align="left" valign="bottom">1.5 <xref ref-type="bibr" rid="bib31">Hoch et al., 1999</xref>; <xref ref-type="bibr" rid="bib35">Hund et al., 2008</xref></td><td align="left" valign="bottom">1.5</td></tr><tr><td align="left" valign="bottom">Tau<sub>relp</sub></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">6 <xref ref-type="bibr" rid="bib50">Maier et al., 2003</xref></td><td align="left" valign="bottom">6 <xref ref-type="bibr" rid="bib50">Maier et al., 2003</xref></td><td align="left" valign="bottom">6 <xref ref-type="bibr" rid="bib50">Maier et al., 2003</xref></td><td align="left" valign="bottom">6 <xref ref-type="bibr" rid="bib50">Maier et al., 2003</xref></td><td align="left" valign="bottom">6</td></tr><tr><td align="left" valign="bottom">G<sub>Cab</sub></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1.33 <xref ref-type="bibr" rid="bib82">Tomek et al., 2017</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1.33</td></tr></tbody></table></table-wrap><table-wrap id="app1table5" position="float"><label>Appendix 1—table 5.</label><caption><title>Comparison of the simulated AP, CaT and active tension (Ta) biomarkers with post myocardial infarction (MI) acute stage canine experimental data and chronic stage human experimental data.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom">Biomarkers</th><th align="left" valign="bottom">Experimental values</th><th align="left" valign="bottom">Simulated values</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="5">Acute Post-MI Stage</td><td align="left" valign="bottom">Canine epi NZ APD (ms) (mean ± SD)</td><td align="left" valign="bottom">295±34 <xref ref-type="bibr" rid="bib47">Lue and Boyden, 1992</xref> 210±15 <xref ref-type="bibr" rid="bib25">Gardner et al., 1985</xref> 219±39 <xref ref-type="bibr" rid="bib76">Spear et al., 1983</xref> Overall: [180, 329]</td><td align="char" char="." valign="bottom">227</td></tr><tr><td align="left" valign="bottom">Canine epi BZ APD (ms) (mean ± SD)</td><td align="left" valign="bottom">346±60 <xref ref-type="bibr" rid="bib47">Lue and Boyden, 1992</xref> 170±15 <xref ref-type="bibr" rid="bib25">Gardner et al., 1985</xref> 220±26 <xref ref-type="bibr" rid="bib76">Spear et al., 1983</xref> Overall: [194, 406]</td><td align="left" valign="bottom">BZ1: 284, BZ2: 256, BZ3: 208</td></tr><tr><td align="left" valign="bottom">Canine epi BZ Systolic Cai EBZ/NZ (%)</td><td align="char" char="." valign="bottom">74% <xref ref-type="bibr" rid="bib44">Licata et al., 1997</xref></td><td align="left" valign="bottom" rowspan="2">NZ: 686, BZ1: 517 (75%), BZ2: 133 (20%), BZ3: 457 (67%),</td></tr><tr><td align="left" valign="bottom">Canine epi BZ Voltage Clamp Cai at 0 mV EBZ/NZ</td><td align="char" char="." valign="bottom">53% <xref ref-type="bibr" rid="bib65">Pu et al., 2000</xref></td></tr><tr><td align="left" valign="bottom">Canine Cell shortening EBZ/NZ %</td><td align="char" char="." valign="bottom">12% <xref ref-type="bibr" rid="bib44">Licata et al., 1997</xref></td><td align="left" valign="bottom">NZ systolic Ta: 40, BZ1: 24 (60%), BZ2: 0.37 (1%), BZ3: 20 (50%)</td></tr><tr><td align="left" valign="bottom" rowspan="5">Chronic Post-MI Stage</td><td align="left" valign="bottom">Human Mid Systolic Cai Failing/Non-Failing (%)</td><td align="left" valign="bottom">49% <xref ref-type="bibr" rid="bib63">Piacentino et al., 2003</xref></td><td align="left" valign="bottom" rowspan="2">NZ (800 ms CL):1219, RZ1: 744 (60%), RZ2: 608 (50%)</td></tr><tr><td align="left" valign="bottom">Human Mid Systolic Cai MI/normal (%) 1 Hz</td><td align="left" valign="bottom">37.5% <xref ref-type="bibr" rid="bib34">Høydal et al., 2018</xref></td></tr><tr><td align="left" valign="bottom">Human Mid Diastolic Cai Failing/Non-Failing (%)</td><td align="left" valign="bottom">96% <xref ref-type="bibr" rid="bib63">Piacentino et al., 2003</xref></td><td align="left" valign="bottom" rowspan="2">NZ (800 ms CL): 80, RZ1: 37 (46%), RZ2: 39 (49%) NZ (500 ms CL): 86, RZ1: 52 (61%), RZ2: 62 (72%)</td></tr><tr><td align="left" valign="bottom">Human Mid Diastolic Cai MI/normal (%) 1 Hz</td><td align="left" valign="bottom">115% <xref ref-type="bibr" rid="bib34">Høydal et al., 2018</xref></td></tr><tr><td align="left" valign="bottom">Human Mid Cell shortening MI/normal (%) 1 Hz</td><td align="left" valign="bottom">33% <xref ref-type="bibr" rid="bib34">Høydal et al., 2018</xref></td><td align="left" valign="bottom">NZ systolic Ta (800 ms CL): 65, RZ1: 58 (89%), RZ2: 45 (70%)</td></tr></tbody></table></table-wrap><table-wrap id="app1table6" position="float"><label>Appendix 1—table 6.</label><caption><title>Simulated AP, CaT and Ta biomarkers from baseline NZ, BZ and RZ epi-, mid-, and endocardial single cell models.</title><p>For the acute stage, the Acute BZ1 and BZ2 induced significant APD prolongation, while the BZ3 led to mild APD shortening. The Acute BZ1 and BZ3 had similar degree of reduction in systolic Ca and Ta, whereas the Acute BZ2 had more severe loss of contractility. For the chronic stage, the Chronic RZ1 and RZ2 had similar decrease in systolic Ca and Ta than control, but the RZ2 had more severe APD prolongation than the Chronic RZ1.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Type</th><th align="left" valign="bottom">APD90 (ms)</th><th align="left" valign="bottom">CaTD90 (ms)</th><th align="left" valign="bottom">Diastolic Ca (nM)</th><th align="left" valign="bottom">Systolic Ca (nM)</th><th align="left" valign="bottom">Diastolic Ta (kPa)</th><th align="left" valign="bottom">Systolic Ta (kPa)</th></tr></thead><tbody><tr><td align="left" valign="bottom">Control (800ms)</td><td align="left" valign="bottom">epi: 227, mid: 336,<break/>endo: 263</td><td align="left" valign="bottom">epi: 298, mid: 333,<break/>endo: 336</td><td align="left" valign="bottom">epi: 62.32,<break/>mid: 79.74,<break/>endo: 70.70</td><td align="left" valign="bottom">epi: 686.27,<break/>mid: 1218.83, endo: 477.71</td><td align="left" valign="bottom">epi: 0.06, mid: 0.10,<break/>endo: 0.07</td><td align="left" valign="bottom">epi: 40.00,<break/>mid: 65.47,<break/>endo: 23.87</td></tr><tr><td align="left" valign="bottom">Acute BZ1</td><td align="left" valign="bottom">epi: 284, mid: 391,<break/>endo: 315</td><td align="left" valign="bottom">epi: 289, mid: 339,<break/>endo: 325</td><td align="left" valign="bottom">epi: 59.63,<break/>mid: 63.52,<break/>endo: 65.62</td><td align="left" valign="bottom">epi: 517.13,<break/>mid: 691.30,<break/>endo: 342.98</td><td align="left" valign="bottom">epi: 0.05, mid: 0.06,<break/>endo: 0.06</td><td align="left" valign="bottom">epi: 24.33,<break/>mid: 44.78,<break/>endo: 10.46</td></tr><tr><td align="left" valign="bottom">Acute BZ2</td><td align="left" valign="bottom">epi: 256, mid: 373,<break/>endo: 341</td><td align="left" valign="bottom">epi: 266, mid: 342,<break/>endo: 334</td><td align="left" valign="bottom">epi: 45.11,<break/>mid: 57.08,<break/>endo: 57.98</td><td align="left" valign="bottom">epi: 133.09,<break/>mid: 326.57,<break/>endo: 184.93</td><td align="left" valign="bottom">epi: 0.03, mid: 0.05,<break/>endo: 0.05</td><td align="left" valign="bottom">epi: 0.37, mid: 8.97,<break/>endo: 1.48</td></tr><tr><td align="left" valign="bottom">Acute BZ3</td><td align="left" valign="bottom">epi: 208, mid: 316,<break/>endo: 247</td><td align="left" valign="bottom">epi: 256, mid: 295,<break/>endo: 288</td><td align="left" valign="bottom">epi: 49.05,<break/>mid: 60.49,<break/>endo: 59.79</td><td align="left" valign="bottom">epi: 457.49,<break/>mid: 834.58,<break/>endo: 352.71</td><td align="left" valign="bottom">epi: 0.03, mid: 0.05,<break/>endo: 0.05</td><td align="left" valign="bottom">epi: 19.66,<break/>mid: 52.08,<break/>endo: 11.18</td></tr><tr><td align="left" valign="bottom">Chronic BZ</td><td align="left" valign="bottom">epi: 235, mid: 362,<break/>endo: 293</td><td align="left" valign="bottom">epi: 419, mid: 444, endo: 474</td><td align="left" valign="bottom">epi: 41.90, mid: 40.80, endo: 50.59</td><td align="left" valign="bottom">epi: 324.87, mid: 499.97, endo: 285.67</td><td align="left" valign="bottom">epi: 0.03, mid: 0.03, endo: 0.04</td><td align="left" valign="bottom">epi: 10.44, mid: 31.40, endo: 7.76</td></tr><tr><td align="left" valign="bottom">Chronic RZ1</td><td align="left" valign="bottom">epi: 247, mid: 411,<break/>endo: 313</td><td align="left" valign="bottom">epi: 426, mid: 462, endo: 478</td><td align="left" valign="bottom">epi: 39.64, mid: 37.47, endo: 49.34</td><td align="left" valign="bottom">epi: 459.72, mid: 744.07, endo: 387.91</td><td align="left" valign="bottom">epi: 0.03, mid: 0.05, endo: 0.04</td><td align="left" valign="bottom">epi: 25.67, mid: 57.56, endo: 18.40</td></tr><tr><td align="left" valign="bottom">Chronic RZ2</td><td align="left" valign="bottom">epi: 392, mid: 591,<break/>endo: 467</td><td align="left" valign="bottom">epi: 498, mid: 569, endo: 557</td><td align="left" valign="bottom">epi: 39.77, mid: 38.61, endo: 49.51</td><td align="left" valign="bottom">epi: 444.67, mid: 607.59, endo: 361.11</td><td align="left" valign="bottom">epi: 0.03, mid: 0.09, endo: 0.05</td><td align="left" valign="bottom">epi: 25.14, mid: 44.80, endo: 16.17</td></tr><tr><td align="left" valign="bottom">Acute and (chronic) scar</td><td align="left" valign="bottom">epi: 250, mid: 366,<break/>endo: 295</td><td align="left" valign="bottom">epi: 261, mid: 304, endo: 296</td><td align="left" valign="bottom">epi: 49.17, mid: 62.49, endo: 59.70</td><td align="left" valign="bottom">epi: 502.85, mid: 883.02, endo: 375.70</td><td align="left" valign="bottom">epi: 0.03 (0), mid: 0.06 (0), endo: 0.05 (0)</td><td align="left" valign="bottom">epi: 24.23 (0), mid: 53.21 (0), endo: 13.28 (0)</td></tr><tr><td align="left" valign="bottom">Control (500ms)</td><td align="left" valign="bottom">epi: 210, mid: 306,<break/>endo: 240</td><td align="left" valign="bottom">epi: 265, mid: 276, endo: 298</td><td align="left" valign="bottom">epi: 58.61, mid: 85.60, endo: 67.91</td><td align="left" valign="bottom">epi: 760.33, mid: 1740.38, endo: 531.49</td><td align="left" valign="bottom">epi: 0.38, mid: 1.81, endo: 0.33</td><td align="left" valign="bottom">epi: 42.77, mid: 68.04, endo: 27.54</td></tr><tr><td align="left" valign="bottom">RZ1 (500ms)</td><td align="left" valign="bottom">epi: 226, mid: 296, endo: 271</td><td align="left" valign="bottom">epi: 370, mid: 384, endo: 396</td><td align="left" valign="bottom">epi: 47.10, mid: 52.52, endo: 65.07</td><td align="left" valign="bottom">epi: 470.50, mid: 712.75, endo: 385.73</td><td align="left" valign="bottom">epi: 0.50, mid: 2.04, endo: 0.51</td><td align="left" valign="bottom">epi: 25.84, mid: 51.69, endo: 17.28</td></tr><tr><td align="left" valign="bottom">RZ2 (500ms)</td><td align="left" valign="bottom">epi: 316, mid: 395, endo: 366</td><td align="left" valign="bottom">epi: 389, mid: 401, endo: 410</td><td align="left" valign="bottom">epi: 50.88, mid: 61.53, endo: 65.99</td><td align="left" valign="bottom">epi: 425.66, mid: 605.85, endo: 337.64</td><td align="left" valign="bottom">epi: 0.52, mid: 1.94, endo: 0.46</td><td align="left" valign="bottom">epi: 21.20, mid: 41.79, endo: 12.23</td></tr></tbody></table></table-wrap></sec><sec sec-type="appendix" id="s11"><title>5. Validation using clinical and experimental data</title><p>The clinical ECGs in <xref ref-type="fig" rid="fig1">Figure 1</xref> of main manuscript were extracted from the following:</p><p>Acute BZ1 comparison (T-wave inversion): PTB Diagnostic ECG Database (<xref ref-type="bibr" rid="bib27">Goldberger et al., 2000</xref>; <xref ref-type="bibr" rid="bib11">Bousseljot et al., 2009</xref>), patient number 014 who had anterior infarction. The ECG was taken 10 days after infarction.</p><p>Acute BZ2 comparison (Brugada phenocopy): Extracted from <xref ref-type="fig" rid="fig1">Figure 1B</xref> of a clinical paper describing Brugada phenocopy (<xref ref-type="bibr" rid="bib5">Anselm et al., 2014</xref>) and enhanced using bespoke python script. The patient had acute inferior ST segment elevation myocardial infarction with right ventricular involvement.</p><p>Acute BZ3 comparison (Normal ST-T): PTB Diagnostic ECG Database (<xref ref-type="bibr" rid="bib27">Goldberger et al., 2000</xref>; <xref ref-type="bibr" rid="bib11">Bousseljot et al., 2009</xref>), patient number 051 who had antero-septal infarction. The ECG was taken 10 d after infarction.</p><p>Chronic RZ1 comparison (Slight QT prolongation): PTB Diagnostic ECG Database (<xref ref-type="bibr" rid="bib27">Goldberger et al., 2000</xref>; <xref ref-type="bibr" rid="bib11">Bousseljot et al., 2009</xref>), patient number 042 who had antero-septal infarction. The ECG was taken at ~20 mo follow up.</p><p>Chronic RZ2 comparison (Large T-wave): PTB Diagnostic ECG Database (<xref ref-type="bibr" rid="bib27">Goldberger et al., 2000</xref>; <xref ref-type="bibr" rid="bib11">Bousseljot et al., 2009</xref>), patient number 033 who had antero-septal infarction. The ECG was taken 3 mo after infarction.</p><table-wrap id="app1table7" position="float"><label>Appendix 1—table 7.</label><caption><title>Comparison of the ECG and mechanical biomarkers from biventricular electromechanical simulations against literature values at resting heart rate.</title><p>QTc was calculated using Bazett’s formula from the simulated QT intervals. Post-MI RVEF values were from ST-segment elevation myocardial infarction patients whose culprit and chronic total occlusion were not in the right coronary artery. VA: ventricular arrhythmia; VT: ventricular tachycardia; SDB: sleep disordered breathing. Our simulated ECG and mechanical biomarker values are mostly consistent with the clinically reported biomarker ranges.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Biomarkers</th><th align="left" valign="bottom" colspan="2">Control</th><th align="left" valign="bottom" colspan="2">Acute Stage Post-MI</th><th align="left" valign="bottom" colspan="2">Chronic Stage Post-MI</th></tr></thead><tbody><tr><td align="left" valign="bottom">Electrophysiological Biomarkers</td><td align="left" valign="bottom">Literature</td><td align="left" valign="bottom">Simulation</td><td align="left" valign="bottom">Literature</td><td align="left" valign="bottom">Simulation</td><td align="left" valign="bottom">Literature</td><td align="left" valign="bottom">Simulation</td></tr><tr><td align="left" valign="bottom">QRS duration (ms)</td><td align="left" valign="bottom">96 ± 9 in men, 85 ± 6 in women <xref ref-type="bibr" rid="bib15">Carlsson et al., 2006</xref></td><td align="char" char="plusmn" valign="bottom">79 ± 2</td><td align="char" char="plusmn" valign="bottom">88 ± 35 <xref ref-type="bibr" rid="bib97">Yerra et al., 2006</xref></td><td align="char" char="plusmn" valign="bottom">91±5, 95±9, 92±6</td><td align="left" valign="bottom">Max 127 ± 16 without VT<break/>Min 81 ± 15 without VT <xref ref-type="bibr" rid="bib62">Perkiömäki et al., 1995</xref> <break/>Max 137 ± 25 with VT<break/>Min 89 ± 20 with VT <xref ref-type="bibr" rid="bib62">Perkiömäki et al., 1995</xref></td><td align="char" char="plusmn" valign="bottom">94 ± 6, 93 ± 5</td></tr><tr><td align="left" valign="bottom">QTc interval (Bazett formula) (ms)</td><td align="left" valign="bottom">350–440 <xref ref-type="bibr" rid="bib39">Johnson and Ackerman, 2009</xref></td><td align="char" char="plusmn" valign="bottom">360 ± 1</td><td align="left" valign="bottom">423 ± 50 without VA <xref ref-type="bibr" rid="bib1">Ahnve, 1985</xref><break/>460±40 with VA <xref ref-type="bibr" rid="bib1">Ahnve, 1985</xref></td><td align="char" char="plusmn" valign="bottom">398 ± 27, 415 ± 4, 376 ± 5</td><td align="left" valign="bottom">Max 448 ± 39 without VT<break/>Min 383 ± 20 without VT <xref ref-type="bibr" rid="bib62">Perkiömäki et al., 1995</xref><break/>Max 493 ± 51 with VT<break/>Min 388 ± 30 with VT ve stiffness parameters were calibrated based on <xref ref-type="bibr" rid="bib62">Perkiömäki et al., 1995</xref></td><td align="char" char="plusmn" valign="bottom">430 ± 4, 578 ± 3</td></tr><tr><td align="left" valign="bottom">Mechanical Biomarkers</td><td align="left" valign="bottom">Literature</td><td align="left" valign="bottom">Simulation</td><td align="left" valign="bottom">Literature</td><td align="left" valign="bottom">Simulation</td><td align="left" valign="bottom">Literature</td><td align="left" valign="bottom">Simulation</td></tr><tr><td align="left" valign="bottom">LVEDV (mL)</td><td align="left" valign="bottom">142 ± 21 (SSFP-CMR) <xref ref-type="bibr" rid="bib48">Maceira et al., 2006a</xref></td><td align="char" char="." valign="bottom">129</td><td align="char" char="plusmn" valign="bottom">116 ± 15 <xref ref-type="bibr" rid="bib86">Uslu et al., 2013</xref></td><td align="char" char="ndash" valign="bottom">124–125</td><td align="char" char="plusmn" valign="bottom">106 ± 12 <xref ref-type="bibr" rid="bib86">Uslu et al., 2013</xref></td><td align="char" char="." valign="bottom">126</td></tr><tr><td align="left" valign="bottom">RVEDV (mL)</td><td align="left" valign="bottom">144 ± 23 (SSFP-CMR) <xref ref-type="bibr" rid="bib49">Maceira et al., 2006b</xref></td><td align="char" char="." valign="bottom">131</td><td align="left" valign="bottom">129 ± 28 with SDB <xref ref-type="bibr" rid="bib13">Buchner et al., 2015</xref><break/>132 ± 28 without SDB <xref ref-type="bibr" rid="bib13">Buchner et al., 2015</xref></td><td align="char" char="." valign="bottom">131</td><td align="left" valign="bottom">143 ± 29 with SDB <xref ref-type="bibr" rid="bib13">Buchner et al., 2015</xref><break/>132 ± 31 without SDB <xref ref-type="bibr" rid="bib13">Buchner et al., 2015</xref></td><td align="char" char="." valign="bottom">133</td></tr><tr><td align="left" valign="bottom">LVESV (mL)</td><td align="left" valign="bottom">47 ± 10 (SSFP-CMR) <xref ref-type="bibr" rid="bib48">Maceira et al., 2006a</xref></td><td align="char" char="." valign="bottom">60</td><td align="char" char="plusmn" valign="bottom">61 ± 12 <xref ref-type="bibr" rid="bib86">Uslu et al., 2013</xref></td><td align="left" valign="bottom">65~72</td><td align="char" char="plusmn" valign="bottom">52 ± 10 <xref ref-type="bibr" rid="bib86">Uslu et al., 2013</xref></td><td align="char" char="." valign="bottom">65</td></tr><tr><td align="left" valign="bottom">RVESV (mL)</td><td align="left" valign="bottom">50±14 (SSFP-CMR) <xref ref-type="bibr" rid="bib49">Maceira et al., 2006b</xref></td><td align="char" char="." valign="bottom">63</td><td align="left" valign="bottom">56 21 with SDB <xref ref-type="bibr" rid="bib13">Buchner et al., 2015</xref><break/>53 ± 16 without SDB <xref ref-type="bibr" rid="bib13">Buchner et al., 2015</xref></td><td align="char" char="." valign="bottom">64</td><td align="left" valign="bottom">58 ± 21 with SDB <xref ref-type="bibr" rid="bib13">Buchner et al., 2015</xref><break/>51 ± 15 without SDB <xref ref-type="bibr" rid="bib13">Buchner et al., 2015</xref></td><td align="char" char="." valign="bottom">64</td></tr><tr><td align="left" valign="bottom">LVEF (%)</td><td align="left" valign="bottom">67 ± 4.6 (SSFP-CMR) <xref ref-type="bibr" rid="bib48">Maceira et al., 2006a</xref>, 62±7 (RNV) <xref ref-type="bibr" rid="bib57">Nemerovski et al., 1982</xref></td><td align="char" char="." valign="bottom">53</td><td align="char" char="plusmn" valign="bottom">48 ± 8 <xref ref-type="bibr" rid="bib86">Uslu et al., 2013</xref></td><td align="left" valign="bottom">43~47</td><td align="char" char="plusmn" valign="bottom">52 ± 7 <xref ref-type="bibr" rid="bib86">Uslu et al., 2013</xref></td><td align="char" char="." valign="bottom">48</td></tr><tr><td align="left" valign="bottom">RVEF (%)</td><td align="left" valign="bottom">48 ± 5 (RNV) <xref ref-type="bibr" rid="bib57">Nemerovski et al., 1982</xref></td><td align="char" char="." valign="bottom">52</td><td align="left" valign="bottom">53.0 ± 7.1 <xref ref-type="bibr" rid="bib90">van Veelen et al., 2022</xref></td><td align="char" char="." valign="bottom">51</td><td align="left" valign="bottom">55.9 ± 5.4 <xref ref-type="bibr" rid="bib90">van Veelen et al., 2022</xref></td><td align="char" char="." valign="bottom">52</td></tr></tbody></table></table-wrap></sec><sec sec-type="appendix" id="s12"><title>6. Sensitivity analysis of ECG and LVEF to electrophysiological heterogeneities, calcium sensitivity, and sheet active tension</title><p>We performed the following sets of electromechanical simulations varying the apex-to-base and transmural heterogeneities, calcium sensitivity, and sheet active tension, in order to evaluate the effect of these on ECG morphology and LVEF.</p><p>The baseline apex-to-base gradient is evaluated by scaling the conductance of the slow delayed rectifier potassium current (GKs) according to:<disp-formula id="equ7"><mml:math id="m7"><mml:mi>s</mml:mi><mml:mi>f</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mn>0.2</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:math></disp-formula><disp-formula id="equ8"><mml:math id="m8"><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mi>z</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:math></disp-formula></p><p>where z is the normalised longitudinal coordinate that is equal to zero at the apex and one at the base. This gives a scaling factor of 5 at the apex and 0.2 at the base (i.e., [0.2, 5]). We vary the magnitude of this gradient by changing the basis of exponential for the sf equation through the values [0.1, 0.2, 0.3], to achieve ranges of [0.1, 10], [0.2, 5], [0.3, 3.3] for the scaling factor (<xref ref-type="fig" rid="app1fig3">Appendix 1—figure 3A</xref>). In addition, we also reverse the gradient direction thus:<disp-formula id="equ9"><mml:math id="m9"><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mi>z</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:math></disp-formula></p><p>The effect of changes in range of the apex-to-base gradient is negligible in LVEF (<xref ref-type="fig" rid="app1fig3">Appendix 1—figure 3B</xref>) and ECG morphology (<xref ref-type="fig" rid="app1fig3">Appendix 1—figure 3C</xref>) except in leads V4 and V5, where the amplitude of the T-wave decreased with decreasing range of GKs scaling. A complete reversal of the gradient caused a more dramatic decrease in T-wave amplitude and reduction in T-wave duration apparent in V3 to V5 (<xref ref-type="fig" rid="app1fig3">Appendix 1—figure 3C</xref>, red line), with no changes in LVEF.</p><fig id="app1fig3" position="float"><label>Appendix 1—figure 3.</label><caption><title>Effects of apex-to-base gradient (<bold>A</bold>) on pressure-volume, LVEF (<bold>B</bold>), and ECG morphology (<bold>C</bold>).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig3-v1.tif"/></fig><p>The baseline transmural heterogeneity has a 30%, 40%, and 30% split of endocardial, mid-myocardial, and epicardial cell types across the wall (<xref ref-type="fig" rid="app1fig4">Appendix 1—figure 4A</xref>). To modify this, we created two other transmural compositions where the mid-myocardial layer is removed, and the endo- vs. epicardial split is varied from 30%–70% to 50%–50% (<xref ref-type="fig" rid="app1fig4">Appendix 1—figure 4A</xref>). The removal of the mid-myocardial layer caused an increase in end systolic volume, a reduction in LVEF, and a decreased T-wave amplitude and increased QT interval across all precordial leads (compare green and blue). Increasing the proportion of epicardial cell type (compare red and blue) caused a reduction in T-wave amplitude and an increase in QT interval. The polarity of the T-wave remained unchanged.</p><fig id="app1fig4" position="float"><label>Appendix 1—figure 4.</label><caption><title>Effects of transmural electrophysiological heterogeneity (<bold>A</bold>) on pressure-volume, LVEF (<bold>B</bold>), and ECG morphology (<bold>C</bold>).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig4-v1.tif"/></fig><p>Additionally, we altered the calcium sensitivity of troponin binding in the excitation-contraction coupling (Ca50 parameter from the baseline value <xref ref-type="bibr" rid="bib40">Land et al., 2017</xref>) of 0.805 <inline-formula><mml:math id="inf36"><mml:mi>μ</mml:mi><mml:mi>M</mml:mi></mml:math></inline-formula> to a range of values: [0.5, 0.7, 1.0]. This had no effect on the ECG (<xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5A</xref>). With increasing Ca50 values, there was an increase in end diastolic volume and end systolic volume, resulting in negligible changes to the LVEF, except in the case of 0.5, where the LVEF is reduced by 2% (<xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5B</xref>).</p><fig id="app1fig5" position="float"><label>Appendix 1—figure 5.</label><caption><title>Effects of troponin calcium sensitivity on pressure-volume, LVEF (<bold>A</bold>), and ECG morphology (<bold>B</bold>).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig5-v1.tif"/></fig><p>Finally, we also altered the sheet-direction active tension from the baseline, where it is 30% of the fibre active tension, to a range of values: [0%, 50%, 60%]. With increasing percentage sheet activation LVEF increased (<xref ref-type="fig" rid="app1fig6">Appendix 1—figure 6A</xref>) with negligible effect on ECG morphology (<xref ref-type="fig" rid="app1fig6">Appendix 1—figure 6B</xref>). Sheet activation above and including 50% caused numerical instabilities that caused the simulation to terminate prematurely during the isovolumic contraction phase of the cardiac cycle.</p><fig id="app1fig6" position="float"><label>Appendix 1—figure 6.</label><caption><title>Effects of sheet activation percentage on pressure-volume, LVEF (<bold>A</bold>), and ECG morphology (<bold>B</bold>).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig6-v1.tif"/></fig></sec><sec sec-type="appendix" id="s13"><title>7. Biventricular electromechanical simulations of acute and chronic post-MI, ECG and pressure volume characteristics</title><p>Additional results of simulations for the acute and chronic post-MI phenotypes:</p><fig id="app1fig7" position="float"><label>Appendix 1—figure 7.</label><caption><title>Simulated acute stage 12-lead ECGs for Acute BZ1-3.</title><p>Acute BZ1 caused T wave inversion in precordial leads of V3 and V4, where the QT prolongation was more significant. Acute BZ2 caused Brugada phenocopy in leads V3-V5, while Acute BZ3 produced similar ECG morphology as the control case.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig7-v1.tif"/></fig><fig id="app1fig8" position="float"><label>Appendix 1—figure 8.</label><caption><title>Simulated chronic stage 12-lead ECGs for Chronic RZ1 and Chronic RZ2, both combined with Chronic BZ.</title><p>Both produced normal ECG morphology, and T waves are wider and taller in the anterior leads (V2–V4) of Chronic RZ2.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig8-v1.tif"/></fig><fig id="app1fig9" position="float"><label>Appendix 1—figure 9.</label><caption><title>Simulated acute stage 12-lead ECGs for Acute BZ1-3 with contractility turned off in the BZs.</title><p>Acute BZ1 caused T wave inversion in precordial leads of V3 and V4, where the QT prolongation was more significant. Acute BZ2 caused Brugada phenocopy in leads V3-V5, while Acute BZ3 produced similar ECG morphology as the control case.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig9-v1.tif"/></fig><table-wrap id="app1table8" position="float"><label>Appendix 1—table 8.</label><caption><title>Simulated ECG biomarkers from biventricular electromechanical simulations for the acute and the chronic post-MI stages.</title><p>For the acute stage, Acute BZ1 and BZ2 caused significant QT prolongation, longer T peak to T end, whereas the Acute BZ3 induced milder effects. For the chronic stage, both Chronic RZ1 and RZ2 led to QT prolongation, with RZ2 also generating longer T wave duration, T peak to T end, and T start to T peak than control and RZ1 at CL = 800ms. At fast pacing of CL = 500ms, both Chronic RZ1 and RZ2 caused longer QT, T wave and T start to T peak durations. For both stages, the QT dispersions did not reflect the repolarization dispersion very well.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">ECG biomarkers</th><th align="left" valign="bottom">Control</th><th align="left" valign="bottom">Acute BZ1</th><th align="left" valign="bottom">Acute BZ2</th><th align="left" valign="bottom">Acute BZ3</th><th align="left" valign="bottom">Chronic RZ1</th><th align="left" valign="bottom">Chronic RZ2</th><th align="left" valign="bottom">Control CL = 500ms</th><th align="left" valign="bottom">Chronic RZ1 CL = 500ms</th><th align="left" valign="bottom">Chronic RZ2 CL = 500ms</th></tr></thead><tbody><tr><td align="left" valign="bottom">QRS duration<break/>(ms)</td><td align="left" valign="bottom">79±2</td><td align="left" valign="bottom">91±5</td><td align="left" valign="bottom">95±9</td><td align="left" valign="bottom">92±6</td><td align="left" valign="bottom">94±6</td><td align="left" valign="bottom">93±5</td><td align="left" valign="bottom">86±7</td><td align="left" valign="bottom">86±7</td><td align="left" valign="bottom">86±7</td></tr><tr><td align="left" valign="bottom">T duration (ms)</td><td align="left" valign="bottom">96±17</td><td align="left" valign="bottom">163±40</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">113±18</td><td align="left" valign="bottom">122±42</td><td align="left" valign="bottom">291±20</td><td align="left" valign="bottom">97±19</td><td align="left" valign="bottom">100±15</td><td align="left" valign="bottom">140±37</td></tr><tr><td align="left" valign="bottom">T peak to T end (ms)</td><td align="left" valign="bottom">59±10</td><td align="left" valign="bottom">101±31</td><td align="left" valign="bottom">122±46</td><td align="left" valign="bottom">68±8</td><td align="left" valign="bottom">68±11</td><td align="left" valign="bottom">153±30</td><td align="left" valign="bottom">57±8</td><td align="left" valign="bottom">55±12</td><td align="left" valign="bottom">82±17</td></tr><tr><td align="left" valign="bottom">T start to T peak (ms)</td><td align="left" valign="bottom">38±8</td><td align="left" valign="bottom">61±30</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">45±10</td><td align="left" valign="bottom">54±32</td><td align="left" valign="bottom">138±12</td><td align="left" valign="bottom">40±11</td><td align="left" valign="bottom">45±6</td><td align="left" valign="bottom">58±22</td></tr><tr><td align="left" valign="bottom">QT interval (ms)</td><td align="left" valign="bottom">322±1</td><td align="left" valign="bottom">356±24</td><td align="left" valign="bottom">371±3</td><td align="left" valign="bottom">336±5</td><td align="left" valign="bottom">385±4</td><td align="left" valign="bottom">578±3</td><td align="left" valign="bottom">305±2</td><td align="left" valign="bottom">344±4</td><td align="left" valign="bottom">419±4</td></tr><tr><td align="left" valign="bottom">QT dispersion (precordial) (ms)</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">55</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">7</td><td align="left" valign="bottom">4</td><td align="left" valign="bottom">6</td><td align="left" valign="bottom">5</td></tr></tbody></table></table-wrap></sec><sec sec-type="appendix" id="s14"><title>8. Electrophysiological characteristics of post-MI in more detail</title><p>The simulated transmural gradients of activation times, repolarisation times, and action potential duration (APD90) are shown in more detail below. Despite the inclusion of the mid-myocardial cell type that has elevated APD90 in the biventricular model, the transmural profile of APD90 in the simulated APD90 map is monotonically decreasing from endocardium to epicardium due to electronic coupling effects.</p><fig id="app1fig10" position="float"><label>Appendix 1—figure 10.</label><caption><title>Transmural activation time (AT), repolarisation time (RT), and action potential duration at 90% repolarisation (APD90) are shown for the acute (top panel) and chronic (bottom panel) phenotypes.</title><p>A mid-ventricular anterior transmural slice is taken from the left ventricle that shows the cross-section of the anterior infarction and border zones. The transmural gradient is evaluated as the quantity of interest at the epicardium minus that at the endocardium, and is given as dAT, dRT, and dAPD90 values for each cross-section, evaluated at the beginning and end of the yellow arrows. APD90 is plotted across a transmural line as indicated by the yellow arrow.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig10-v1.tif"/></fig></sec><sec sec-type="appendix" id="s15"><title>9. Explanation of the BZ2 activation pattern</title><p>Compared to the other cases, the acute BZ2 had the strongest inhibition of the L-type calcium current, and therefore the least safe epicardial conduction. Due to the transmural differences of the L-type calcium channel expression, the infarct zone in the midmyocardium had a higher level of the calcium current than the epicardial BZ, which explained the more robust conduction in the infarct zone than in the BZ.</p><fig id="app1fig11" position="float"><label>Appendix 1—figure 11.</label><caption><title>Single cell simulations of the action potential (left), L-type calcium ionic current (middle) and sodium ionic current (right) compared between the scar region and the acute BZ2 help to explain the activation pattern in BZ2.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig11-v1.tif"/></fig><table-wrap id="app1table9" position="float"><label>Appendix 1—table 9.</label><caption><title>Simulated pressure-volume mechanical biomarkers for each heart beat from biventricular electromechanical simulations for acute and chronic stages post-MI: left and right end diastolic volumes (EDVL, EDVR), left and right stroke volumes (SVL, SVR), left and right ventricular ejection fractions (LVEF, RVEF).</title><p>For the acute stage, Acute BZ1 and Acute BZ3 generated the same degree of reduction in SVL and LVEF, whereas the Acute BZ2 induced the smallest SVL and LVEF. For the chronic stage, both Chronic RZ1 and Chronic RZ2 produced the same SVL and LVEF at both pacing rates despite their difference in the degree of repolarization heterogeneity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom">Pressure-volume Biomarkers</th><th align="left" valign="bottom">Control</th><th align="left" valign="bottom">Acute BZ1</th><th align="left" valign="bottom">Acute BZ2</th><th align="left" valign="bottom">Acute BZ3</th><th align="left" valign="bottom">Chronic RZ1</th><th align="left" valign="bottom">Chronic RZ2</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom" rowspan="8">800 ms CL</td><td align="left" valign="bottom">EDVL (mL)</td><td align="left" valign="bottom">129, 129, 129</td><td align="left" valign="bottom">124,124,124</td><td align="left" valign="bottom">124,125,125</td><td align="left" valign="bottom">124,124,124</td><td align="left" valign="bottom">127, 126, 126</td><td align="left" valign="bottom">127, 126, 126</td></tr><tr><td align="left" valign="bottom">EDVR (mL)</td><td align="left" valign="bottom">130,131,131</td><td align="left" valign="bottom">130,131,131</td><td align="left" valign="bottom">130,131,131</td><td align="left" valign="bottom">130,131,131</td><td align="left" valign="bottom">132,133,133</td><td align="left" valign="bottom">132,133,133</td></tr><tr><td align="left" valign="bottom">SVL (mL)</td><td align="left" valign="bottom">68, 69, 69</td><td align="left" valign="bottom">59,59,59</td><td align="left" valign="bottom">53,53,53</td><td align="left" valign="bottom">59,59,59</td><td align="left" valign="bottom">62, 61, 61</td><td align="left" valign="bottom">62, 61, 61</td></tr><tr><td align="left" valign="bottom">SVR (mL)</td><td align="left" valign="bottom">68,68,68</td><td align="left" valign="bottom">67,67,67</td><td align="left" valign="bottom">67,67,67</td><td align="left" valign="bottom">67,67,67</td><td align="left" valign="bottom">69,69,69</td><td align="left" valign="bottom">69,69,69</td></tr><tr><td align="left" valign="bottom">LVEF (%)</td><td align="left" valign="bottom">53,53,53</td><td align="left" valign="bottom">47,47,47</td><td align="left" valign="bottom">43,43,43</td><td align="left" valign="bottom">47,47,47</td><td align="left" valign="bottom">49, 48, 48</td><td align="left" valign="bottom">49, 48, 48</td></tr><tr><td align="left" valign="bottom">RVEF (%)</td><td align="left" valign="bottom">52,52,52</td><td align="left" valign="bottom">51,51,51</td><td align="left" valign="bottom">51,51,51</td><td align="left" valign="bottom">51,51,51</td><td align="left" valign="bottom">52,52,52</td><td align="left" valign="bottom">52,52,52</td></tr><tr><td align="left" valign="bottom">Peak left systolic pressure (kPa)</td><td align="left" valign="bottom">12,12,12</td><td align="left" valign="bottom">11,11,11</td><td align="left" valign="bottom">11,11,11</td><td align="left" valign="bottom">11,11,11</td><td align="left" valign="bottom">11, 11, 11</td><td align="left" valign="bottom">11, 11, 11</td></tr><tr><td align="left" valign="bottom">Peak right systolic pressure (kPa)</td><td align="left" valign="bottom">4,4,4</td><td align="left" valign="bottom">4,4,4</td><td align="left" valign="bottom">4,4,4</td><td align="left" valign="bottom">4,4,4</td><td align="left" valign="bottom">4,4,4</td><td align="left" valign="bottom">4,4,4</td></tr><tr><td align="char" char="." valign="bottom" rowspan="8">500 ms CL</td><td align="left" valign="bottom">EDVL (mL)</td><td align="left" valign="bottom">111,112,113, 113,113,113</td><td align="left" valign="bottom" rowspan="8" colspan="3">NA</td><td align="left" valign="bottom">114,107,111, 108,110,108</td><td align="left" valign="bottom">116,108,111, 109,110,109</td></tr><tr><td align="left" valign="bottom">EDVR (mL)</td><td align="left" valign="bottom">123,122,123, 123,123,123</td><td align="left" valign="bottom">125,117,122, 119,121,119</td><td align="left" valign="bottom">126,119,123, 120,121,120</td></tr><tr><td align="left" valign="bottom">SVL (mL)</td><td align="left" valign="bottom">53,53,54, 54,54,54</td><td align="left" valign="bottom">50,43,47, 44,45,44</td><td align="left" valign="bottom">51,43,46, 44,45,44</td></tr><tr><td align="left" valign="bottom">SVR (mL)</td><td align="left" valign="bottom">61,61,61, 61,61,61</td><td align="left" valign="bottom">64,56,62, 56,60,57</td><td align="left" valign="bottom">65,57,62, 59,60,59</td></tr><tr><td align="left" valign="bottom">LVEF (%)</td><td align="left" valign="bottom">47,47,47, 47,47,47</td><td align="left" valign="bottom">44,39,42, 40,41,40</td><td align="left" valign="bottom">44,39,41, 40,41,40</td></tr><tr><td align="left" valign="bottom">RVEF (%)</td><td align="left" valign="bottom">49,49,49, 49,49,49</td><td align="left" valign="bottom">51,47,50, 47,50,48</td><td align="left" valign="bottom">51,48,50, 49,49,49</td></tr><tr><td align="left" valign="bottom">Peak left systolic pressure (kPa)</td><td align="left" valign="bottom">11,11,11, 11,11,11</td><td align="left" valign="bottom">10,10,10, 10,10,10</td><td align="left" valign="bottom">10,10,10, 10,10,10</td></tr><tr><td align="left" valign="bottom">Peak right systolic pressure (kPa)</td><td align="left" valign="bottom">4,4,4, 4,4,4</td><td align="left" valign="bottom">4,4,4, 4,4,4</td><td align="left" valign="bottom">4,4,4, 4,4,4</td></tr></tbody></table></table-wrap></sec><sec sec-type="appendix" id="s16"><title>10. Post-MI SERCA and CaMKII remodeling promote alternans generations in models with more preserved calcium magnitudes</title><p>In our cellular population of post-MI models, higher inducibility of alternans were observed at both the acute and the chronic stages at fast pacing (<xref ref-type="fig" rid="app1fig12">Appendix 1—figure 12</xref>).</p><fig id="app1fig12" position="float"><label>Appendix 1—figure 12.</label><caption><title>The effects of the BZ and RZ remodelling of the acute and chronic stages on alternans generation in the population of 245 population of models at CL = 500ms, 400ms and 300ms.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig12-v1.tif"/></fig><p>All three types of chronic post-MI remodeling promoted alternans generation, especially in the epicardial and midmyocardial populations (<xref ref-type="table" rid="app1table10">Appendix 1—table 10</xref>). Alternans in the midmyocardial layer were mostly due to EADs, whereas the epicardial alternans were repolarization alternans (<xref ref-type="fig" rid="app1fig13">Appendix 1—figures 13</xref> and <xref ref-type="fig" rid="app1fig14">14</xref>).</p><table-wrap id="app1table10" position="float"><label>Appendix 1—table 10.</label><caption><title>Number of alternans induced by three chronic remodelling at CL = 500, 400 and 300ms in endocardial, midmyocardial and epicardial population of models.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Population of models (n=245)</th><th align="left" valign="bottom">No. of alternans at CL = 300ms</th><th align="left" valign="bottom">No. of alternans at CL = 400ms</th><th align="left" valign="bottom">No. of alternans at CL = 500ms</th><th align="left" valign="bottom">Key parameters for alternans</th></tr></thead><tbody><tr><td align="left" valign="bottom">Chronic BZ</td><td align="left" valign="bottom">Mid (110)&gt;Epi (47)</td><td align="left" valign="bottom">Mid only (84)</td><td align="left" valign="bottom">Mid only (10)</td><td align="left" valign="bottom">↑G<sub>CaL</sub>, ↑G<sub>Kr</sub>, ↑P<sub>Jup</sub></td></tr><tr><td align="left" valign="bottom">Chronic RZ1</td><td align="left" valign="bottom">Epi (195)&gt;Mid (81)&gt;Endo (60)</td><td align="left" valign="bottom">Mid (158)&gt;Epi (110)&gt;Endo (4)</td><td align="left" valign="bottom">Mid (67)&gt;Epi (1)</td><td align="left" valign="bottom">↑G<sub>CaL</sub>, ↑P<sub>Jup</sub></td></tr><tr><td align="left" valign="bottom">Chronic RZ2</td><td align="left" valign="bottom">Epi (88)&gt;Mid (48)&gt;Endo (2)</td><td align="left" valign="bottom">Mid (58)&gt;Epi (42)</td><td align="left" valign="bottom">Mid (37)&gt;Endo (8)&gt;Epi (3)</td><td align="left" valign="bottom">↑G<sub>CaL</sub>, ↑G<sub>Kr</sub>, ↓G<sub>NCX</sub>, ↑P<sub>Jup</sub>, ↑P<sub>Jrel</sub></td></tr></tbody></table></table-wrap><fig id="app1fig13" position="float"><label>Appendix 1—figure 13.</label><caption><title>Ten representative alternans in the epicardial population of Chronic RZ1, showing calcium-driven repolarization alternans without EADs.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig13-v1.tif"/></fig><fig id="app1fig14" position="float"><label>Appendix 1—figure 14.</label><caption><title>Ten representative alternans in the midmyocardial population of Chronic BZ, showing EAD as a major cause of big alternans.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig14-v1.tif"/></fig><p>Here we investigated: (1) what are the key individual post-MI ionic current remodeling contributing to the generation of alternans, and (2) what are the underlying ionic currents in the population of models that determine whether a post-MI model is prone for alternans induction?</p><p>In order to illustrate the underlying mechanisms, the baseline chronic remote zone model (with Chronic RZ1 remodeling) was chosen as an example in <xref ref-type="fig" rid="app1fig15">Appendix 1—figure 15</xref>. At CL = 300ms, the model had alternations of long and short APDs in the odd and even beats (blue solid traces), and it was clear that the alternans was associated with the insufficient calcium re-uptake and slow calcium recovery in junctional sarcoplasmic reticulum (JSR). When the inhibition of SERCA pump (J<sub>up</sub>) was switched off (red dashed traces), alternans disappeared along with a significant increase of the JSR calcium level. Apart from the insufficient calcium re-uptake in the remodeling, higher CaMKII activation and slower calcium release further contributed to the alternans. When CaMKII activation and J<sub>rel</sub> kinetics were switched back to normal (yellow dashed traces), the duration of calcium release was shorter, and there was more time for JSR calcium to recover before the next beat, leading to the elimination of alternans (yellow dashed traces).</p><fig id="app1fig15" position="float"><label>Appendix 1—figure 15.</label><caption><title>Inhibition of J<sub>up</sub> and slower calcium release (J<sub>rel</sub>) caused by enhanced CaMKII activity promoted alternans.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig15-v1.tif"/></fig><p>On the other hand, I<sub>KCa</sub> augmentation played a protective role against alternans generation by shortening APD and therefore regulating calcium dynamics (<xref ref-type="fig" rid="app1fig16">Appendix 1—figures 16</xref> and <xref ref-type="fig" rid="app1fig17">17</xref>):</p><fig id="app1fig16" position="float"><label>Appendix 1—figure 16.</label><caption><title>Effects of I<sub>KCa</sub> enhancement on alternans generation in the chronic stage.</title><p>Left: switching I<sub>KCa</sub> activity back to normal (black traces) caused AP prolongation and bigger alternans. Weaker I<sub>KCa</sub> also led to stronger CaT (bottom right, black solid line) and larger calcium release in the longer beat (black solid line) that was more difficult for calcium level to recover in JSR (upper right, black solid line).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig16-v1.tif"/></fig><fig id="app1fig17" position="float"><label>Appendix 1—figure 17.</label><caption><title>CaMKII and I<sub>KCa</sub> had opposite roles on alternans inducibility in chronic ionic current remodelling.</title><p>Enhanced I<sub>KCa</sub> tended to inhibit alternans generation (<bold>A</bold>), whereas augmented CaMKII promoted alternans (<bold>B</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig17-v1.tif"/></fig><p>As stronger G<sub>CaL</sub> and stronger P<sub>Jup</sub> were consistently observed in the chronic population of alternans models (<xref ref-type="table" rid="app1table10">Appendix 1—table 10</xref>), the effects of reversing these trends were investigated. In a representative alternans model, when G<sub>CaL</sub> was inhibited by 20% (<xref ref-type="bibr" rid="bib43">Li et al., 2024</xref>, the purple trace), the smaller calcium influx led to weaker calcium release, causing a milder reduction of JSR calcium level that was easier to refill, and leading to the elimination of alternans. If J<sub>up</sub> was further inhibited by 20% (<xref ref-type="fig" rid="app1fig18">Appendix 1—figure 18</xref>, the green trace), the slower calcium re-uptake led to lower initial JSR calcium level at the beginning of a beat, resulting in a smaller J<sub>rel</sub> and a milder JSR calcium reduction that was also easier to refill. However, G<sub>CaL</sub> and J<sub>up</sub> inhibition suppressed alternans generation at the cost of reducing CaT magnitude (<xref ref-type="fig" rid="app1fig18">Appendix 1—figure 18</xref>, CaT panel).</p><p>Although the chronic remodeling in the RZ decreased CaT amplitude compared with the NZ, the alternans models among the remodeling population can have relatively preserved CaT amplitudes (<xref ref-type="fig" rid="app1fig19">Appendix 1—figure 19</xref>). The relatively higher G<sub>CaL</sub> and P<sub>Jup</sub> in the alternans models contribute to bigger CaT<sub>max</sub> and smaller CaT<sub>min</sub> (<xref ref-type="table" rid="app1table10">Appendix 1—table 10</xref>, <xref ref-type="fig" rid="app1fig19">Appendix 1—figure 19</xref>). This suggests that models that were prone to alternans development may display a relative preserved CaT amplitude and LVEF.</p><fig id="app1fig18" position="float"><label>Appendix 1—figure 18.</label><caption><title>With chronic post-MI ionic current remodelling, alternans models needed stronger G<sub>CaL</sub> and more preserved P<sub>Jup</sub> to enable alternans generation.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig18-v1.tif"/></fig><fig id="app1fig19" position="float"><label>Appendix 1—figure 19.</label><caption><title>Alternans models had bigger CaT<sub>max</sub> than the non-alternating models in the epicardial populations with chronic post-MI remodelling (all with <italic>P</italic>&lt;0.001).</title><p>In addition, alternans models tended to have smaller CaT<sub>min</sub> in epicardial populations of Chronic RZ1 (<italic>P</italic>&lt;0.001) and RZ2 (<italic>P</italic>&lt;0.05), while the difference was not statistically significant for Chronic BZ.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig19-v1.tif"/></fig></sec><sec sec-type="appendix" id="s17"><title>11. Post-MI I<sub>Kr</sub> and I<sub>NaL</sub> remodeling promote EAD generations in models with preserved calcium magnitudes</title><p>All three types of chronic post-MI ionic remodeling promoted EADs and repolarization failure (RFs), and midmyocardium was most prone for the development of EAD (<xref ref-type="fig" rid="app1fig20">Appendix 1—figure 20</xref>, <xref ref-type="table" rid="app1table11">Appendix 1—table 11</xref>).</p><fig id="app1fig20" position="float"><label>Appendix 1—figure 20.</label><caption><title>Midmyocardium was most prone for the development of EAD under chronic post-MI remodelling.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig20-v1.tif"/></fig><p>Cellular early afterdepolarizations (EADs) or repolarization failure (RF) were promoted in the post-MI population of chronic models, and we investigated the following two questions: (1) what are the key individual post-MI ionic remodeling contributing to the generation of EADs, and (2) what are the underlying ionic currents that determine whether a post-MI model is prone to EAD development?</p><p>To illustrate the effects of the individual chronic ionic remodeling on the inducibility of EADs, a representative model was chosen from the population (<xref ref-type="fig" rid="app1fig21">Appendix 1—figure 21</xref>), which had a normal AP at a CL of 1000ms in NZ (the blue trace). When the Chronic BZ ionic remodeling was introduced, an EAD was generated (the red trace). Removing the I<sub>NaL</sub> remodeling did not eliminate the EAD (the yellow trace), and similarly when I<sub>Kr</sub> inhibition was removed, EAD was still maintained (the purple trace). However, when both I<sub>NaL</sub> augmentation and I<sub>Kr</sub> inhibition were absent, the EAD was eliminated (the green trace). Although I<sub>NaL</sub> and I<sub>Kr</sub> remodeling were the key factors inducing EAD generation in the chronic stage, I<sub>CaL</sub> re-activation was also a necessary mechanism (the light blue trace).</p><fig id="app1fig21" position="float"><label>Appendix 1—figure 21.</label><caption><title>Chronic ionic current remodelling promotes EAD generation through the enhanced I<sub>NaL</sub> and suppressed I<sub>Kr</sub>, which facilitate I<sub>CaL</sub> reactivation.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig21-v1.tif"/></fig><table-wrap id="app1table11" position="float"><label>Appendix 1—table 11.</label><caption><title>Number of EADs and RFs induced by three chronic remodelling in endocardial, midmyocardial and epicardial population of models.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Population of models (n=245)</th><th align="left" valign="bottom">No. of EADs and RFs at CL = 1000ms</th><th align="left" valign="bottom">Key parameters for EADs and RFs</th></tr></thead><tbody><tr><td align="left" valign="bottom">Chronic BZ</td><td align="left" valign="bottom">Mid only (11)</td><td align="left" valign="bottom">↑G<sub>CaL</sub>, ↓G<sub>Kr</sub>, ↑G<sub>NCX</sub></td></tr><tr><td align="left" valign="bottom">Chronic RZ1</td><td align="left" valign="bottom">Mid only (52)</td><td align="left" valign="bottom">↑G<sub>CaL</sub>, ↓G<sub>Kr</sub>, ↑G<sub>NCX</sub></td></tr><tr><td align="left" valign="bottom">Chronic RZ2</td><td align="left" valign="bottom">Mid (118)&gt;Epi (9)&gt;Endo (1)</td><td align="left" valign="bottom">↑G<sub>CaL</sub>, ↓G<sub>Kr</sub>, ↑G<sub>NCX</sub>, ↑P<sub>Jup</sub></td></tr></tbody></table></table-wrap><p>By comparing the parameters of EAD models against the non-EAD models in the chronic populations, stronger G<sub>CaL</sub>, G<sub>NCX</sub> and weaker G<sub>Kr</sub> were consistently observed in the EAD populations (<xref ref-type="table" rid="app1table11">Appendix 1—table 11</xref>). Due to the stronger G<sub>CaL</sub> and G<sub>NCX</sub>, the EAD models also displayed a stronger CaT<sub>max</sub> and a lower CaT<sub>min</sub> in all three ionic remodeling populations (<xref ref-type="fig" rid="app1fig22">Appendix 1—figure 22</xref>). Therefore, these results suggested that models which were prone to EAD development may present as a relative preserved LVEF.</p><fig id="app1fig22" position="float"><label>Appendix 1—figure 22.</label><caption><title>EAD models tended to have stronger CaT<sub>max</sub> and weaker CaT<sub>min</sub> in the population of Chronic BZ, RZ1 and RZ2 models (all with <italic>P</italic>&lt;0.001).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig22-v1.tif"/></fig></sec><sec sec-type="appendix" id="s18"><title>12. Both sarcolemmal and calcium dynamics remodeling are necessary for the generation of post-MI EAD alternans</title><p>As shown in <xref ref-type="fig" rid="app1fig14">Appendix 1—figure 14</xref>, EADs can be a major cause of big alternans in the midmyocardial population of chronic post-MI models. Theoretically, calcium alternans can induce EADs under proper conditions, and EADs may display an alternating pattern which occurs in every other beat (<xref ref-type="bibr" rid="bib66">Qu and Weiss, 2023</xref>). To explore whether the EAD alternans were predominantly EAD or alternans, the 10 representative EAD alternans examples in <xref ref-type="fig" rid="app1fig14">Appendix 1—figure 14</xref> were simulated without either EAD related remodelling (I<sub>NaL</sub> and I<sub>Kr</sub>) or alternans related remodelling (P<sub>Jup</sub> and CaMKII). EAD alternans disappear when either of the two types of remodelling was switched off (<xref ref-type="fig" rid="app1fig23">Appendix 1—figures 23</xref> and <xref ref-type="fig" rid="app1fig24">24</xref>), indicating both the sarcolemmal ionic current remodelling and the altered calcium dynamics are necessary conditions for the generation of these EAD alternans.</p><fig id="app1fig23" position="float"><label>Appendix 1—figure 23.</label><caption><title>Chronic BZ remodelling induced EAD alternans in the ten representative midmyocardial models, but when these models were simulated without I<sub>Kr</sub> and I<sub>NaL</sub> remodelling, neither EAD nor alternans occurred.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig23-v1.tif"/></fig><fig id="app1fig24" position="float"><label>Appendix 1—figure 24.</label><caption><title>Chronic BZ remodelling induced EAD alternans in the ten representative midmyocardial models, but when these models were simulated without P<sub>Jup</sub> (SERCA) and CaMKII remodelling, neither EAD nor alternans occurred.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93002-app1-fig24-v1.tif"/></fig></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93002.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chiamvimonvat</surname><given-names>Nipavan</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of California, Davis</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This computational study integrates detailed electrophysiology and mechanical contraction predictions, which are often modeled separately. The findings of this <bold>important</bold> work are that abnormal ECGs that are associated with higher risk of sudden cardiac death are predicted to have almost no relationship with left ventricular ejection fraction, which is conventionally used as a risk factor for arrhythmia. The conclusions are based on <bold>compelling</bold> evidence for the need of incorporating additional risk factors for assessing post-myocardial infarction patients.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93002.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this study from Zhou, Wang, and colleagues, the authors utilize biventricular electromechanical simulations to illustrate how different degrees of ionic remodeling can contribute to different ECG morphologies that are observed in either acute or chronic post-myocardial infarction (MI) patients. Interestingly, the simulations show that abnormal ECG phenotypes - associated with higher risk of sudden cardiac death - are predicted to have almost no correspondence with left ventricular ejection fraction, which is conventionally used as a risk factor for arrhythmia.</p><p>Strengths:</p><p>The numerical simulations are state-of-the-art, integrating detailed electrophysiology and mechanical contraction predictions, which are often modeled separately. The population of ventricular simulations provide mechanistic interpretation, down to the level of single cell ionic current remodeling, for different types of ECG morphologies observed in post-MI patients. Collectively, these results demonstrate compelling and significant evidence for the need of incorporating additional risk factors for assessing post-MI patients.</p><p>The authors have addressed all of my previous concerns in this updated version.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93002.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors constructed a multi-scale modeling and simulation methods to investigate the electrical and mechanical properties under acute and chronic myocardial infarction (MI). The simulated three acute MI conditions and two chronic MI conditions. They showed that these conditions gave rise to distinct ECG characteristics that have seen in clinical settings. They showed that the post-MI remodeling reduced ejection fraction up to 10% due to weaker calcium current or SR calcium uptake, but the reduction of ejection fraction is not sensitive to remodeling of the repolarization heterogeneities.</p><p>Strengths:</p><p>The major strength of this study is the construction of the computer modeling that simulates both electrical behavior and mechanical behavior for post-MI remodeling. The links of different heterogeneities due to MI remodeling to different ECG characteristics provide some useful information for understanding the complex clinical problems.</p><p>Weaknesses:</p><p>The rationale (e.g., physiological or medical bases) for choosing the 3 acute MI and 2 chronic MI settings is not clear. Although the authors presented a huge number of simulation data, in particular in the supplemental materials, it is not clearly stated what novel findings or mechanistic insights that this study gained beyond the current understanding of the problem.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93002.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Xin</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhinuo Jenny</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Camps</surname><given-names>Julia</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Tomek</surname><given-names>Jakub</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Santiago</surname><given-names>Alfonso</given-names></name><role specific-use="author">Author</role><aff><institution>Barcelona Supercomputing Centre</institution><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Quintanas</surname><given-names>Adria</given-names></name><role specific-use="author">Author</role><aff><institution>Barcelona Supercomputing Centre</institution><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Vazquez</surname><given-names>Mariano</given-names></name><role specific-use="author">Author</role><aff><institution>Barcelona Supercomputing Centre</institution><addr-line><named-content content-type="city">Barcelona</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Vaseghi</surname><given-names>Marmar</given-names></name><role specific-use="author">Author</role><aff><institution>UCLA Cardiac Arrhythmia Center</institution><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>In this study by Zhou, Wang, and colleagues, the authors utilize biventricular electromechanical simulations to illustrate how different degrees of ionic remodeling can contribute to different ECG morphologies that are observed in either acute or chronic post-myocardial infarction (MI) patients. Interestingly, the simulations show that abnormal ECG phenotypes - associated with a higher risk of sudden cardiac death - are predicted to have almost no correspondence with left ventricular ejection fraction, which is conventionally used as a risk factor for arrhythmia.</p><p>Strengths:</p><p>The numerical simulations are state-of-the-art, integrating detailed electrophysiology and mechanical contraction predictions, which are often modeled separately. The simulation provides mechanistic interpretation, down to the level of single-cell ionic current remodeling, for different types of ECG morphologies observed in post-MI patients. Collectively, these results demonstrate compelling and significant evidence for the need to incorporate additional risk factors for assessing post-MI patients.</p><p>Weaknesses:</p><p>The study is rigorous and well-performed. However, some aspects of the methodology could be clearer, and the authors could also address some aspects of the robustness of the results. Specifically, does variability in ionic currents inherent in different patients, or the location/size of the infarct and surrounding remodeled tissue impact the presentation of these ECG morphologies?</p></disp-quote><p>We thank the reviewer for their considered evaluation. In response to the reviewer’s comments regarding variability in ionic currents, we have added simulations using a n=17 populations of models with variability in ionic conductances in the baseline ToR-ORd model to the paper, to show the effect of such variation on the post-MI ECG presentation in acute and chronic conditions. This is now described in the Methods [lines 140, 158-161, 242-244, 245-246, 261-263], and shown in the methods Figure 1A, 1B. The ECG results using this population of models are shown in Figure 2C and described in [lines 333-335] and the pressure volume results using the population of models are shown in Figure 5A and 5B and described in [lines 417-418, 442-444, 448-450]. The population of models showed consistent patterns in both the ECG and LVEF as the baseline model, this is discussed in [lines 563-564, 688-690].</p><p>Regarding the effect of scar location and size on the ECG, we refer the reader and reviewer to a related paper where this is explored in depth using a formal sensitivity analysis and deep learning inference (<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/38373128/">https://pubmed.ncbi.nlm.nih.gov/38373128/</ext-link>). This is better able to do justice to this question rather than overloading this paper with additional investigations. We include a reference to this paper in the discussion section [lines 694-695].</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>The authors constructed multi-scale modeling and simulation methods to investigate the electrical and mechanical properties of acute and chronic myocardial infarction (MI). They simulated three acute MI conditions and two chronic MI conditions. They showed that these conditions gave rise to distinct ECG characteristics that have been seen in clinical settings. They showed that the post-MI remodeling reduced ejection fraction up to 10% due to weaker calcium current or SR calcium uptake, but the reduction of ejection fraction is not sensitive to remodeling of the repolarization heterogeneities.</p><p>Strengths:</p><p>The major strength of this study is the construction of computer modeling that simulates both electrical behavior and mechanical behavior for post-MI remodeling. The links of different heterogeneities due to MI remodeling to different ECG characteristics provide some useful information for understanding complex clinical problems.</p><p>Weaknesses:</p><p>The rationale (e.g., physiological or medical bases) for choosing the 3 acute MI and 2 chronic MI settings is not clear. Although the authors presented a huge number of simulation data, in particular in the supplemental materials, it is not clearly stated what novel findings or mechanistic insights this study gained beyond the current understanding of the problem.</p></disp-quote><p>We thank the reviewer for their careful evaluations of our work. The justification for selecting the 3 acute MI and 2 chronic MI states is based on clinical and experimental reports, as summarised in the Methods section [lines 245-247, 252-256, 264-266]. We have also highlighted the key novelty and significance of the study in the Discussion [lines 579-582].</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>(1) This was clarified very late in the Discussion, but for most of the paper, I was unclear if heart geometry was the same for all simulations. Presumably, this includes the size and location of the infarct, BZ, and RZ. It would be helpful to clarify this in the Methods.</p></disp-quote><p>This has been clarified in the first paragraph of the Methods section [lines 142-145].</p><disp-quote content-type="editor-comment"><p>(2) On lines 224-226, the Methods refers to implementing several population members from the ToR-ORd model (in addition to the baseline) into the biventricular EM simulations. Is this in reference to the simulations shown in Figures 6 and 7, or different simulations? Please clarify.</p></disp-quote><p>We now randomly select 17 of the 245 cell models in the population to be embedded in ventricular simulations, to produce a ventricular population of models. This allows us to explore the effect that physiological variability in the baseline ionic conductances has on the phenotypic representation of ionic remodellings in the ECG and LVEF. An explanation of this can be found in the Methods section [lines 241-244].</p><p>For Figures 6 and 7, we selected two arrhythmic cell models from the n=245 population of cell models to be embedded into two ventricular simulations to demonstrate the arrhythmic potential of the cellular model at ventricular scale. This has been clarified in Methods [lines 269-271].</p><disp-quote content-type="editor-comment"><p>Additionally, for the cases where a population member is used, are all regions of the ventricles &quot;scaled&quot; in the same manner, or were only the properties of the particular region drawn from the population modified relative to baseline (e.g., mid-myocardial cells in Figure 6)?</p></disp-quote><p>The cells were embedded according to transmural heterogeneity in the remote zone for Figures 6 and 7. This has been clarified in the Methods [line 271-273].</p><disp-quote content-type="editor-comment"><p>(3) Interestingly, the study finds that the ionic remodeling in different peri-infarct regions to be most critical in the ECG phenotype, which at least strongly suggests that inherent intra-patient variability in ion channel expression could also be critical.</p><p>This is related to the comment on the use of population members. If the authors utilized one of the ventricular myocyte population members as the 'reference' (instead of the baseline ToR-ORd parameters) and applied the same types of remodeling as in Figures 3 and 4, would they expect the same ECG morphologies?</p></disp-quote><p>We have now performed this test and selected 17 cell models from the population to create a ventricular population of models. On top of this ventricular population, we have applied the remodellings, and showed that the simulated ECG morphologies were mostly consistent across these 20 members (Figure 2C).</p><disp-quote content-type="editor-comment"><p>(4) Related, do the authors expect that the location and/or size of the infarct and peri-infarct regions would impact the different ECG morphologies?</p></disp-quote><p>Regarding the effect of scar location and size on the ECG, we refer the reader and reviewer to a related paper where this is explored in depth using a formal sensitivity analysis and deep learning inference (<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/38373128/">https://pubmed.ncbi.nlm.nih.gov/38373128/</ext-link>). We feel this is better able to do justice to this question rather than overloading this paper with additional investigations. We include a reference to this paper in the discussion section [lines 694-695].</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>(1) Although the authors listed the parameters and cited the papers for the origins of the parameter changes in SM4 and table S4, it should be summarized in the methods section what are the major changes or differences for the 5 conditions. Furthermore, it should be stated what is the rationale for choosing these conditions. Are these choices based on clinical classifications or experimental conditions?</p></disp-quote><p>The major differences between the 5 conditions have now been summarised in the Methods [lines 252-256, 264-266]. These remodellings have been collated from a range of experimental measurements in both human and animal data, which are summarised in Table S4. This has been clarified in Methods [lines 245-247].</p><disp-quote content-type="editor-comment"><p>(2) Figure 3C and Figure 4C do not add any additional information beyond the conductance changes listed in Table 4, and I'd suggest removing them from the figures. On the other hand, it took me some time to look at Table 4 to figure out the corresponding changes. As commented above, the remodeling changes should be summarized in the main text to help reading.</p></disp-quote><p>Figure 3C and 4C provide a visual explanation of the ionic remodellings in these conditions to echo the added descriptions in the text [lines 252-256, 264-266]. For this reason, we have elected to keep those figures in the manuscript.</p><disp-quote content-type="editor-comment"><p>(3) The authors presented a large amount of data in Supplemental Materials, some may be unnecessary and some are difficult to follow. For example; (1) There is a lot of data in Table S6, there is a simple mention in the main text and Table S6 legend. A summary of the data is needed for the readers to understand the properties of the different conditions, instead of letting the readers figure them out from the table. The same should be done for other tables and figures. There are some format issues for the tables, which mess up some of the numbers and text. (2) The data shown in Figures S25-29 provide almost no new information beyond the well-known effects of ionic currents on EAD genesis, i.e., EADs are promoted by inward currents and suppressed by outward currents. The data for alternans (Figures S18-22) are a little more complex than the cases for EADs, I think that they can be simplified.</p></disp-quote><p>Thanks for the suggestions. We have now extracted the key information from Table S6- S9 and summarized them in the caption. We have also fixed the layout of the tables in this revision. The supplementary sections on alternans and EADs are simplified with the key parameters related to these proarrhythmic phenomena summarized in tables instead of showing all boxplots of parameter distributions (Tables S10 and S11).</p><disp-quote content-type="editor-comment"><p>(4) The authors showed two mechanisms of alternans: EAD-driven and Ca-driven alternans in chronic MI. There are several distinct mechanisms of alternans including EAD-induced alternans (see the recent review by Qu and Weiss, Circ Res 132, 127(2023)). Theoretically, calcium alternans can also induce EAD alternans under proper conditions, can you rule out that the EAD alternans are not due to Ca alternans? The results in Fig.7D may say the opposite. There are some chicken-or-egg issues here.</p></disp-quote><p>In Figure 7D, we showed that the epicardial cell type (blue trace) had stable EADs at fast pacing with no calcium alternans, while both the endocardial (red trace) and mid-myocardial (green trace) cell types failed to fully repolarise in every other beat. To explore whether the EAD alternans are driven by calcium alternans, we tested the effects of switching off the alternans related remodelling, and the APs tuned out to be normal. On the other hand, when we turned off the EAD related remodelling, neither EADs nor alternans occurred. Therefore, the results show the two types of ionic current remodelling are both necessary for the generation of EAD alternans (lines 656-659 in the discussion and SM9).</p><disp-quote content-type="editor-comment"><p>(5) As for the formation of ectopic beats, it can be caused by EADs but it can caused by repolarization gradient, they are not the same and differ in different AP models (Liu et al, CircAE 12, e007571 (2019), Zhang et al, Biophy J 120, 352(2021)). It is not clear here whether the primary cause is repolarization gradient or EADs. At tissue, EADs tend to be suppressed by repolarization gradient, there is a goldilocks between the EAD amplitude and repolarization gradient for an ectopic beat to form.</p></disp-quote><p>When isolated cells that showed EAD were embedded in ventricular tissue, we saw ectopic wave propagation. This was because the EADs in the RZ generated conduction block, which enabled a large repolarisation gradient to form between the BZ and RZ, thereby leading to ectopy. This has been clarified in the Results [lines 507-510].</p><p>Additionally, we have clarified the presence of the EADs in the ventricular simulations by labelling where this occurs in the green, purple, and yellow traces in Figure 7C. This was easily missed before due to the stretched proportions of the traces in the x-axis, which is necessary to show clearly the repolarisation gradients that drive ectopy.</p><disp-quote content-type="editor-comment"><p>(6) The authors showed many population simulations. I guess that they are all in single cells. If the population simulations were done in the whole heart, it should be stated how many models were simulated. If only one of the population models was selected for the whole heart for each case, it should clarify the rationale for choosing one of the many models. If populations of cells were modeled in the whole heart, clarify how the models were distributed in the heart.</p></disp-quote><p>We now randomly select 17 of the 245 cell models in the population to be embedded in ventricular simulations, to produce a ventricular population of models. This allows us to explore the effect that physiological variability in the baseline ionic conductances has on the phenotypic representation of ionic remodellings in the ECG and LVEF. An explanation of this can be found in the Methods section [lines 241-244]. Whenever the cell models are embedded in the relevant zones, they are uniformly distributed according to the transmural heterogeneity [lines 271-273].</p><disp-quote content-type="editor-comment"><p>(7) QRS intervals in the simulations are much wider than the real recordings from patients (Figure 2 and Table S8). At least, a QRS of 120 ms for normal control is too wide and probably not normal.</p></disp-quote><p>We have manually measured QRS duration and updated the delineation method to calculate the other biomarkers. The new values now lie within normal ranges and have been updated in SM Table S7 and S8 and in Figure 2, and the new delineation method has been included in SM2.</p></body></sub-article></article>